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Efflux pumps confer multidrug resistance to bacteria by exporting drugs and 
preventing them from reaching their target. The most abundant and best studied efflux 
pump in Salmonella Typhimurium is AcrB. The biological function of AcrB was 
unexplored. Therefore, the impact of loss of AcrB-mediated efflux was studied in S. 
Typhimurium, using an AcrB D408A mutant, which expressed an inactive form of AcrB.  
Transcriptomic studies revealed significant differences between the AcrB D408A 
mutant and previously constructed ∆acrB and acrB::aph mutants, which did not 
express AcrB. The acrB::aph mutant differed in the motility phenotype from the other 
two mutants. However, all three mutants were multidrug hypersusceptible and were 
attenuated when compared against their parental wild-type strain. AcrB-mediated 
efflux also had a role in quorum sensing, persister formation and maintenance of the 
overall metabolic state of Salmonella. Analysis of the effluxome of AcrB in S. 
Typhimurium and E. coli revealed that fatty acids/alcohols are a common substrate of 
AcrB in both species and acylcarnitines were exclusive to S. Typhimurium. 
This study presents a novel model to analyse the physiological role of RND efflux 
pumps and demonstrates that AcrB is more than just a mechanism of antibiotic 
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1.1 Gram-positive and Gram-negative bacteria: Composition of the bacterial 
cell envelope 
Bacteria are unicellular organisms capable of self-replicating. As with any other cell, 
they possess an envelope that surrounds their cytoplasm and genetic material. 
However, the composition of the bacterial cell envelope is more complex than that of 
mammalian cells (Silhavy et al., 2010). 
The bacterial cell envelope is typically composed of a cytoplasmic membrane formed 
by a bilayer of phospholipids, followed by a layer of peptidoglycan. Peptidoglycan is a 
polymer formed of chains of N-acetyl glucosamine-β-1,4-N-acetyl muramic acid cross-
linked by side chains of short peptides (de Pedro and Cava, 2015). It confers rigidity 
to the cell, determines the shape of bacteria and protects them against osmotic shock. 
It also determines the affinity of crystal violet-iodine for the cell envelope allowing 
bacteria to be classified into two groups: Gram-positive and Gram-negative. Gram-
positive bacteria retain the dye complex due to their 30-100 nm thick peptidoglycan 
layer. Gram-negative bacteria, with 7-8 nm of peptidoglycan, do not retain the dye 
complex (Silhavy et al., 2010). 
In Gram-positive bacteria, the peptidoglycan is the outermost layer of the cell 
envelope. In contrast, Gram-negative bacteria have an outer membrane surrounding 
their peptidoglycan (Figure 1.1). The outer membrane serves as a selective 
permeability barrier and protects Gram-negative bacteria against environmental 
stresses. Unlike the cytoplasmic membrane (also referred to as inner membrane in 
Gram-negative bacteria), the outer membrane is formed of a bilayer of glycolipids and 
phospholipids, with glycolipids on the outer leaflet of the bilayer, interacting with the 
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Figure 1.1 Cell envelope of Gram-negative bacteria. 
 
 
LPS, lipopolyssacharide; OMPs, outer membrane proteins; OM, outer membrane; CM, cytoplasmic or inner membrane. From Maldonado et al. 
(2016). 
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external environment, and phospholipids on the inner leaflet, facing the periplasmic 
space or periplasm (May and Silhavy, 2017). The periplasm is an aqueous 
compartment in between the inner membrane and outer membrane, where the 
peptidoglycan is found. The OM is anchored to the peptidoglycan via the Lpp 
lipoprotein, also called Braun’s lipoprotein (Silhavy et al., 2010).  
The most abundant glycolipid in the outer membrane is lipopolysaccharide (LPS), also 
known as endotoxin due to its association with toxic shock in patients with septicaemia 
caused by Gram-negative bacteria (Raetz and Whitfield, 2002). LPS is formed of three 
moieties: lipid A, core oligosaccharide and O-antigen. Lipid A is formed of a 
glucosamine dimer backbone, with acyl chains attached to it. This moiety anchors LPS 
to the outer membrane and is responsible for the reduced permeability of the outer 
membrane when compared to the cytoplasmic membrane. The degree of acylation of 
lipid A determines the degree of permeability of the outer membrane (Nikaido, 2003, 
Maldonado et al., 2016). The core of the LPS molecule is made of oligosaccharides 
that form a linear structure. Similar to lipid A, phosphorylation of core oligosaccharides 
has been shown to decrease the permeability of the outer membrane (Walsh et al., 
2000, Nikaido, 2003). The O-antigen is an oligosaccharide formed of repeating sugar 
residues but, unlike the core, the O-antigen can be linear or branched. This moiety of 
the LPS does not contribute significantly to the outer membrane permeability (Nikaido, 
2003). However, it is highly immunogenic and has a role in virulence of multiple 
species of Gram-negative bacteria (Maldonado et al., 2016). For example, Salmonella 
enterica alters its LPS to avoid or delay detection by the host’s immune system, thus 
facilitating the infection process (Slauch et al., 1996, Duerr et al., 2009).  
As the outer membrane is almost impermeable, it requires proteins to facilitate the 
diffusion of small molecules into the periplasm. Outer membrane proteins (OMPs) are 
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typically lipoproteins anchored to the lipid bilayer, formed of transmembrane β-barrels 
(Figure 1.1). Some of the best characterised OMPs are pore-forming proteins called 
porins, such as OmpC and OmpF. These form channels across the outer membrane 
to facilitate diffusion of small molecules into the cell (May and Silhavy, 2017).   
 
1.2 Classification and nomenclature of Salmonella spp. 
Salmonella spp. are Gram-negative, facultative intracellular bacilli that belong to the 
Enterobacteriaceae family.  Salmonella was first isolated from pigs in 1885 by 
Theobald Smith and initially referred to as the ‘hog cholera bacillus’. Later, it was 
renamed Salmonella after Dr. Daniel E. Salmon, an American veterinarian and 
colleague of Smith (Agbaje et al., 2011).  
Bacteria from the genus Salmonella are easily identifiable due to their common 
biochemical profiles and genetic similarities, but identification at species level is more 
difficult. In 1966, Salmonella species were first assigned by Kauffmann according to 
their surface antigenic patterns. Genetic analyses in the 1970s reclassified all known 
salmonellae into two species: S. enterica or S. bongori, and the previously considered 
species were assigned as serovars (Agbaje et al., 2011). Since then, nearly 2600 
serovars have been described. The correct way to refer to Salmonella spp. serovars 
is by writing the genus, followed by the species, subspecies and serovar; for example, 
Salmonella enterica subsp. enterica ser. Typhimurium. For the purpose of this thesis, 
all Salmonella serovars will be abbreviated as genus followed by serovar name; for 
example, Salmonella Typhimurium or S. Typhimurium.  
 
- 6 - 
 
S. enterica is subdivided into six subspecies with most mammalian disease causing 
Salmonella found within S. enterica subsp. enterica (Lamas et al., 2018). S. bongori 
is commonly associated with infections in reptiles. However, there have been rare 
cases of S. bongori infecting humans (Andino and Hanning, 2015, Gal-Mor et al., 
2014).  
S. enterica gained importance as a human pathogen during World War II, when the 
Medical Research Council of Great Britain showed that an increase in cases of food 
poisoning was associated with the consumption of egg-derived products contaminated 
with Salmonella spp. (Steele, 1963). Further studies identified Salmonella as a cause 
of zoonotic infections, where bacteria are transmitted from animals to humans and 
vice versa. Most S. enterica serovars can infect a wide range of hosts; however, some 
serovars are restricted to a single host.  For example, S. Typhi is a strict human 
pathogen with no other known reservoirs, while S. Typhimurium infects a wide range 
of animals including poultry, mice, cattle and humans. 
 
1.3  Clinical manifestations of Salmonella enterica infections in humans 
The typical description of an infection caused by Salmonella sp. is salmonellosis. 
Clinical manifestations of salmonellosis in humans vary depending on the serovar 
causing the infection as well as the patient’s age and any other diseases they might 
have. Generally, S. Typhi and S. Paratyphi (typhoidal Salmonella) cause typhoid fever 
or enteric fever, while non-typhoidal Salmonella (NTS) cause acute gastroenteritis. 
The representative serovars of NTS are S. Typhimurium and S. Enteriditis. Patients 
infected with NTS develop diarrhoea, vomiting, nausea and abdominal pain after an 
incubation period of 6 to 72 hours (World Health Organization, 2017c); these 
 
- 7 - 
 
symptoms last up to 7 days in immunocompetent patients (Andino and Hanning, 
2015). However, NTS gastroenteritis can develop into a systemic infection, 
characterised by bacteraemia, fever and chills among other symptoms. This form of 
NTS is refered to as iNTS (invasive non-typhoidal Salmonella) and is commonly 
associated to high risk populations such as infants, immunocompromised and elder 
patients.  Complicated iNTS infections can develop into focal extraintestinal infections, 
where the systemic spread of the pathogen can cause further localised infections in 
specific organs. Examples of extraintestinal infections are meningitis, osteomyelitis, 
pneumonia, endovascular infections, myositis and infection of other soft tissues (Wen 
et al., 2017). Rare cases of septic arthritis caused by contaminated prosthetic joints 
have also been reported (Gupta et al., 2014). 
Enteric fever is a form of invasive disease exclusive of typhoidal serovars. It is 
characterised by the presence of fever; other symptoms may include headache, rash 
and abdominal pain. Some patients have diarrhoea but this symptom is rare in 
typhoidal fever (Waddington et al., 2014). Untreated patients infected with typhoidal 
Salmonella can enter an asymptomatic chronic carrier state. This happens in 1 to 4% 
of patients and contributes to the epidemiology of the disease, since chronic carriers 
of typhoidal salmonellae shed from 106 to 1010 pathogens per gram of faecal matter 
for 12 months or longer (Gal-Mor et al., 2014, Waddington et al., 2014). 
A chronic carrier state in NTS has not been as thoroughly studied as in typhoidal 
salmonellae. Studies dating back to 1987 indicate that only 0.15% of healthy adults 
and 3.9% of children become chronic carriers (Gunn et al., 2014). A study from 
Thailand showed that 98.8% of patients continue shedding NTS 12 days after 
clearance of the gastrointestinal symptoms. The same study stated that the duration 
of NTS excretion was around five weeks (Sirinavin et al., 2004). However, a recent 
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study from Israel showed that approximately 2.2% of all NTS gastroenteritis cases 
developed into a chronic carrier state where shedding of Salmonella continued from 
30 days to 8.3 years post-infection (Marzel et al., 2016).  
 
1.4 Pathogenesis and virulence factors of Salmonella 
A typical Salmonella infection starts when contaminated food is ingested. The infective 
dose varies between 100 to 109 CFU depending on the serovar of NTS, the gastric 
acidity of the patient and the type of food consumed (Kothary and Babu, 2001, Hara-
Kudo and Takatori, 2011). It is thought that foods with high protein and/or fat content 
such as ice cream and cheese will protect Salmonella from the acidic pH of the 
stomach favouring the infection (Kothary and Babu, 2001).  
The infection can be separated into multiple stages: 1) colonisation of intestinal 
epithelial cells and M cells, 2) internalisation or invasion, 3) multiplication and, 4) in 
infections caused by iNTS and typhoidal serovars, systemic dissemination through 
macrophages (Wiedemann et al., 2014). An overview of the pathogenesis of S. 
enterica, as observed in murine infection models, is shown in Figure 1.2. 
 
1.4.1 Colonisation of the gastrointestinal tract by Salmonella 
The first challenge Salmonella spp. encounters after being ingested is the acidic pH 
of the stomach followed by the gut microbiome during colonisation. The microbiome 
of a healthy individual will provide physical resistance against colonisation. To 
outcompete the microbiome, Salmonella induces an inflammatory response, which 
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Figure 1.2 Pathogenesis of Salmonella enterica infections. 
 
 
A S. enterica infection can be divided into four stages, these are indicated in the figure 
alongside the main virulence factors involved in each stage. Figure was constructed with 
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generates reactive oxygen and nitrogen species (ROS and RNS, respectively). Most 
enterobacteria are unable to survive these reactive species. However, Salmonella can 
metabolise these chemical species into tetrathionate and nitrates, respectively, and 
use them as respiration acceptors (Ilyas et al., 2017). 
The inflammatory response starts when Salmonella outer membrane components 
such as LPS and flagellins are recognised by the innate immune system. This causes 
rapid infiltration of neutrophils which are responsible for the production of the ROS and 
RNS (Figure 1.2). The interaction of Salmonella Pathogenicity Island (SPI) 1 effectors 
with intestinal epithelial cells favours the inflammatory response through activation of 
NF-B and the release of IL-1β and IL-23 pro-inflammatory cytokines (Santos et al., 
2009). SPI-1 effectors also favour the production of RNS by macrophages, which 
provides an advantage to Salmonella during colonisation (Cherayil et al., 2000). The 
induction of inflammation in the gut is responsible for the typical diarrhoea observed 
in NTS infections. 
SPIs are horizontally-acquired genetic elements that encode virulence factors and are 
involved in multiple stages of the infection. They are highly conserved within 
Salmonella species and serovars. S. Typhimurium, for example, carries 17 of the 21 
SPIs identified in the genus Salmonella (Ilyas et al., 2017). Among the virulence 
factors encoded in SPIs, the secretion systems and their effector proteins are the best 
studied. Secretion systems are needle-like complexes that Salmonella uses to inject 
effector proteins into eukaryotic and prokaryotic cells. SPI-1 encodes a type III 
secretion system (T3SS) which interacts with eukaryotic cells (see section 1.4.2). An 
example of SPI that targets prokaryotic cells is SPI-6, which encodes a type VI 
secretion system (T6SS) that secretes the Tae4 antibacterial amidase. It has been 
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proposed that Tae4 is used by Salmonella to kill commensal bacteria and subvert the 
gut microbiome (Sana et al., 2016). (Figure 1.2)  
Once the microbiome has been breached, Salmonella colonises the mammalian gut 
via interaction with antigen-sampling M cells (Peyer’s patch) and intestinal epithelial 
cells. Salmonella migrates to these cells through chemotaxis and flagella-dependent 
motility. Flagella-dependent motility can be classified in to swimming and swarming. 
Swimming consists of the movement of single bacterium through a liquid or semisolid 
environment. Swarming is characterised by groups of bacteria that intertwine their 
flagella to form a raft-like structure, which then moves across a solid or semisolid 
surface. Both types of motility are required to establish an infection, particularly during 
the colonisation stage. Swimming is mainly used to find an adequate niche for bacteria 
to infect and multiply (Friedlander et al., 2013), while swarming facilitates adhesion 
and biofilm formation, leading to persistent infections (Kearns, 2010).  
Colonisation of intestinal epithelial cells occurs through two stages: an initial reversible 
attachment followed by a strong irreversible adhesion mediated by bacterial factors 
(Wiedemann et al., 2014). Attachment and adhesion are mediated by flagella, LPS, 
fimbriae and non-fimbrial adhesins such SiiE and BapA. It has been proposed that 
MisL, a SPI-3 encoded protein, play a role in colonisation as it binds to fibronectin, 
abundant on epithelial cells when the inflammatory response is activated (Ilyas et al., 
2017). The combination of adhesins of each serovar dictates their host specificity 
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1.4.2 Internalisation of or invasion by Salmonella 
Following adhesion to the host cell, internalisation of bacteria occurs. In M cells, 
Salmonella is internalised by endocytosis. However, in non-phagocytic epithelial cells, 
two mechanisms of invasion have been described: trigger and zipper. Both involve 
rearrangement of the eukaryotic host cell’s cytoskeleton. The trigger mechanism is 
associated with the formation of ‘membrane ruffles’, allowing bacteria to be 
internalised in vacuoles. This mechanism is dependent on the expression of the SPI-
1 type III secretion system (T3SS-1) (Boumart et al., 2014, Wiedemann et al., 2014) . 
The effectors secreted by T3SS-1 include SopB, encoded in SPI-5, which facilitates 
the formation of membrane ruffles. SPI-4 also favours internalisation of Salmonella 
into epithelial cells via the SiiE adhesin, which allow bacteria in close proximity to the 
invasion site to be engulfed by the membrane ruffle (Lorkowski et al., 2014).  
SPI-1 expression is regulated by HilA, this protein is induced by the mild alkaline pH 
of the intestinal lumen as well as low oxygen content and high osmolarity (López et 
al., 2012). Interestingly, the LoiA protein encoded in SPI-14 regulates the expression 
of SPI-1 in response to low oxygen content. This then modulates the trigger invasion 
mechanism (Jiang et al., 2017).  
The expression of SPI-1 and 2 is bistable. Bistability refers to the presence of two 
phenotypes in a genetically identical population. Bistability in the expression of SPIs 
results in a fully virulent subpopulation and a non-infective one (Stewart and Cookson, 
2012). The latter is suggested to be a reservoir of live bacteria and may be a way in 
which Salmonella transmission is ensured if the infection fails (Arnoldini et al., 2014, 
Koirala et al., 2014). 
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The zipper mechanism has only been described in three NTS serovars: Typhimurium, 
Enteriditis and Dublin. It comprises the recognition of a specific bacterial ligand by a 
receptor on the host cell that leads to local accumulation of actin, observed as ‘tight 
membrane extensions’; this last mechanism is likely to be mediated by the Rck or 
PagN invasins, but further studies are required (Boumart et al., 2014). 
 
1.4.3 Intracellular survival and multiplication 
After invasion of epithelial cells or uptake by phagocytic cells, Salmonella remains in 
vacuoles named Salmonella containing vacuoles (SCV). The SCV is characterised by 
a variety of host membrane markers. These markers are also indicators of the state of 
maturation of the SCV. For example, an early SCV is characterised by high levels of 
phosphatidyl-3-phosphate, whereas the appearance of lysosome-associated 
membrane proteins (LAMPs) mark the formation of a mature SCV (Knuff and Finlay, 
2017).  
Inside the cells, lysosomes bind to vacuoles to degrade the contents of the latter. 
However, S. Typhimurium avoids the union of the SCV to lysosomes by injecting SPI-
2 effectors into the cytoplasm of the host cell via T3SS-2. SPI-2 expression is triggered 
by the low pH and the low magnesium ion content inside the SCV. Simultaneously, 
these conditions repress the expression of hilA, downregulating SPI-1 (Ilyas et al., 
2017). The switch between expression of SPI-1 and SPI-2 is also mediated by a small 
RNA (sRNA), PinT (Westermann et al., 2016).  
Subsequently, SPI-2 effectors are used to transport the SCV to the perinuclear region 
near the Golgi apparatus; this location allows Salmonella to capture nutrients from 
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transport vesicles, facilitating the maturation of the SCV (López et al., 2012, 
Wiedemann et al., 2014). (Figure 1.2) 
Salmonella can only replicate inside a mature SCV when sufficient nutrients have been 
incorporated into the vacuole. This stage is characterised by the production of 
Salmonella induced-tubules (SITs), tubulovesicular extensions that are extended 
throughout the host cell’s microtubule network (López et al., 2012).  The most 
abundant type of SITs are Salmonella-induced filaments (SIFs). Recent studies 
suggest that SIFs have a role in nutrient acquisition for the SCV (Popp et al., 2015) 
and might help accommodate bacteria during replication (Knuff and Finlay, 2017); 
however, their function remains unclear. 
S. Typhimurium is also found free in the host cell cytosol. This has been observed in 
vitro in epithelial cells, macrophages and fibroblasts. However, S. Typhimurium cannot 
replicate in the cytosol of phagocytic cells and only replicates in the cytosol of epithelial 
cells. Cytosolic replication occurs in approximately 20% of the infected epithelial cells 
(Malik-Kale et al., 2012, Knodler, 2015). The release of Salmonella into the cytosol 
happens as a defect in SCV maturation. Analyses of the cytosolic population revealed 
that it expressed mainly SPI-1 with almost negligible levels of expression of SPI-2, 
whereas its vacuolar counterpart expressed mainly SPI-2. As the cytosol is a richer 
environment than the SCV, the cytosolic population enters a hyper-replicative state. 
This and the expression of T3SS-1 effectors leads to pyroptosis of the host cell 
(Knodler, 2015). Pyroptosis is characterised by the rapid rupture of the membrane 
which releases inflammatory cytokines and, in this case, motile Salmonella expressing 
SPI-1 that can then spread and infect other epithelial cells.  
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The cytosolic population has also been observed in vivo in extruded enterocytes from 
chicks, cattle and mice, but with considerably lower numbers of bacteria than reported 
for in vitro experiments (Knodler, 2015). Cytosolic replication of Salmonella in 
macrophages is inhibited by a yet unknown mechanism. Furthermore, release of 
Salmonella from the SCV in a macrophage leads to immediate pyroptosis through 
activation of caspases. Free Salmonella are then phagocytosed by neutrophils, where 
it can form SCVs or perish (Jennings et al., 2017).  
Micro-RNAs (miRNA) have been associated with Salmonella intracellular survival. 
Bacteria cannot produce miRNAs; however, Salmonella exploits the RNA processing 
machinery of the host to generate its own miRNAs. These miRNAs interfere with the 
eukaryotic gene expression at a posttranscriptional level, facilitating intracellular 
survival of Salmonella (Gu et al., 2017).  
 
1.4.4 Systemic dissemination 
Generally, NTS multiply inside intestinal epithelial cells limiting the infection to the 
intestines; however, iNTS and typhoidal Salmonella traverse the epithelial cell barrier 
to infect the underlying lymphoid tissues and multiply within macrophages. 
Salmonella-infected macrophages will then spread the infection to blood, liver and 
spleen causing a systemic  infection (Gal-Mor et al., 2014). 
Apart from surviving inside SCVs, Salmonella avoids detection by the immune system 
through surface-antigenic changes. For example, SPI-12 encodes the OafA acetylase, 
which alters the outer membrane O-antigen affecting its recognition by the immune 
system. Similarly, the SPI-11 proteins PagD, EnvE and EnvF can remodel the 
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membrane making it unrecognisable by the cells from the immune system (Ilyas et al., 
2017).  
 
1.5 Epidemiology and treatment 
Salmonellosis is associated with the consumption of contaminated water and a wide 
range of foods. These include pork, poultry, eggs and dairy products; rare outbreaks 
related to the consumption of contaminated flour, nuts and chocolate have also been 
documented (Andino and Hanning, 2015). Fruits and vegetables that have been in 
contact with manure or farm animals can also transmit the infection (Gal-Mor et al., 
2014, Wiedemann et al., 2014). In recent years, the exposure to exotic pets has also 
been deemed a risk factor in the acquisition of NTS (Barrett and Fhogartaigh, 2017).  
NTS gastroenteritis was estimated to affect 78 million people and cause 59,000 deaths 
globally in 2010 (Havelaar et al., 2015). In England and Wales alone, around 8,000 to 
10,000 cases are reported each year. In low and medium income countries, NTS are 
considered one of the leading causes of deaths and hospitalisations (Andino and 
Hanning, 2015).  
Salmonellosis affects all age ranges from infants to >80 year-olds. Recent surveillance 
information shows that the highest incidence of salmonellosis happens among children 
under the age of 10 (Kwambana-Adams et al., 2015, Public Health England, 2017), 
where the disease outcome is the most severe. 
S. Typhimurium and S. Enteriditis are responsible for 80% of all human cases 
worldwide (Wen et al., 2017). These serovars alongside S. Dublin cause the majority 
of the cases of invasive disease in high and low income countries (Marks et al., 2017, 
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Haselbeck et al., 2017). It is estimated that iNTS infections cause around 600,000 
deaths per year, most of which occur in Africa (Haselbeck et al., 2017), where 
malnourishment and co-infection with HIV and/or malaria contribute to the systemic 
dissemination of the disease (Feasey et al., 2015). 
As NTS infections are generally limited to a mild gastroenteritis, patients do not require 
treatment.  In cases of severe diarrhoea and vomiting, rehydration and electrolyte 
replacement are recommended. Treatment of NTS gastroenteritis with antibiotics is 
not recommended as it can cause patients to become asymptomatic carriers, an 
important factor in the spreading of the disease. However, in immunocompromised 
patients, infants and elderly patients, antibiotic treatment might be needed and is 
compulsory in cases of invasive disease (World Health Organization, 2017c).  
Clinically used antibiotics against NTS include penicillins, chloramphenicol, 
trimethoprim-sulfamethoxazole, fluoroquinolones, azithromycin and third-generation 
cephalosporins (Wen et al., 2017). Penicillins, such as ampicillin and amoxicillin, 
chloramphenicol and trimethoprim-sulfamethoxazole are not recommended due to the 
increasing number of resistant NTS. The preferred antibiotics to treat NTS 
gastroenteritis are ciprofloxacin, a fluoroquinolone, and azithromycin (Barrett and 
Fhogartaigh, 2017). For iNTS, ciprofloxacin is the first-line treatment. Levofloxacin and 
moxifloxacin (alternative fluoroquinolones) as well as extended spectrum third-
generation cephalosporins, ceftriaxone and cefotaxime, are used as alternatives in 
cases of ciprofloxacin-resistance (Kariuki et al., 2015). Unfortunately, NTS and iNTS 
resistant to ciprofloxacin and ceftriaxone are increasing. A surveillance study carried 
out in Australia showed that the number of ciprofloxacin-resistant NTS increased from 
0.1% in 1995 to 7.8% in 2015.  Resistance to third-generation cephalosporins 
increased from 0.1% in 2002 to 1% in 2015 (Williamson et al., 2017). Similarly, in the 
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USA, the percentage of ceftriaxone-resistant iNTS isolated from bloodstream 
increased from 2.7% (1997 to 2007) to 5% in recent years (2003 to 2013) (Wen et al., 
2017).  
Bacteria can be resistant to one or more antibiotics at the same time. When resistance 
to three or more antibiotics occur, the isolate is termed “multidrug resistant” (MDR) 
(Hur et al., 2012). MDR Salmonella emerged at the beginning of the 1990s. By 2013, 
they were identified by the World Health Organisation (WHO) as a “serious public 
health concern” and in 2017, fluoroquinolone-resistant Salmonella were classified as 
a high-priority microorganism in the bacterial pathogen list for research and 
development of the WHO (World Health Organization, 2017b).  
 
1.6 Antibiotic resistance in bacteria 
MDR bacteria are a public health threat as they reduce the effectiveness of antibiotic 
therapy.  Antibiotic-resistant bacteria started appearing almost as soon as antibiotics 
were discovered. For example, Prontosil, a sulphonamide and the first antibiotic to be 
used in the clinical environment, became available in 1932 to treat Gram-positive 
infections; a few years later, in 1939, clinical isolates of Streptococcus pneumoniae 
resistant to the sulphonamide were reported (Miller and Bohnhoff, 1950). Other 
examples are shown in Figure 1.3. 
It is generally accepted that MDR bacteria have emerged due to the widespread use 
of antibiotics in people, animals and the environment (World Health Organization, 
2017a). However, it is important to note that drug resistance is not always 
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From Hogberg et al. (2010).  
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acquired as some bacteria are intrinsically resistant to some classes or specific 
antibiotics (Blair et al., 2015c). For example, Gram-negative bacteria are intrinsically 
resistant to vancomycin as the antibiotic cannot traverse their outer membrane 
(Tsuchido and Takano, 1988). On the other hand, vancomycin is fully active against 
Gram-positive bacteria; however, they can acquire mutations or additional genetic 
elements that confer resistance against the antibiotic, such as the Tn1546 transposon 
in Enterococcus spp. (Cetinkaya et al., 2000).  
Bacteria acquire resistance to antibiotics through five main mechanisms: 1) direct 
modification of antibiotics, 2) modification and/or protection of drug targets, 3) reduced 
membrane permeability to antibiotics, 4) increased efflux (Blair et al., 2015c) and 5) 
metabolic bypass (Table 1.1). 
 
1.7  Bacterial efflux pumps and MDR 
Bacteria use efflux pumps to transport a variety of compounds from the inside to the 
outside of the cell. These include fatty acids, dyes, metabolites, detergents and 
antibiotics. Bacterial efflux pumps are classified into seven families: the major 
facilitator superfamily (MFS), the small multidrug resistance (SMR) family, the 
resistance-nodulation-division (RND) superfamily, the multidrug and toxin extrusion 
(MATE) family, the ATP-binding cassette (ABC) superfamily and two recently 
discovered families, the proteobacterial antimicrobial compound efflux (PACE) family 
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Table 1.1 Mechanisms of antibiotic resistance in bacteria.  
Mechanism Description Examples 
Direct modification of 
antibiotics 
Bacteria secrete enzymes to hydrolyse or chemically modify 
antibiotics to inactivate them. 
 β-lactamases hydrolyse penicillins (β-lactams). 
 Amynoglycoside-modyfying enzymes confer 
resistance to kanamycin. 
Modification and/or 
protection of drug targets 
Antibiotics generally bind to specific targets, mostly proteins, 
in bacteria. Mutations that change the structure of the target 
proteins are common as they affect the binding of the 
antibiotic without affecting the function of the protein. 
Protection of the target through overexpression of the target, 
methylation and addition of peptides is also common. 
 Mutations in gyrA confer resistance to 
fluoroquinolones. 
 Methylation of the 16s rRNA through genes of the 
erm family confer resistance to aminoglycosides. 
 Protection of topoisomerase IV and DNA gyrase 
via pentapeptide repeat proteins (PRPs) confer 
resistance to quinolones. 
Reduced membrane 
permeability to antibiotics 
In Gram-negative bacteria, hydrophilic antibiotics diffuse 
through OM porins. Downregulation of porins results in 
decreased diffusion of antibiotics into the bacterium. 
 Decreased expression of OmpC contributes 
towards resistance to β-lactams. 
 Substitution of OmpF by OmpX is associated with 
nalidixic acid resistance. 
Increased efflux of 
antibiotics 
Overexpression of efflux pumps prevents intracellular 
accumulation of antibiotics as pumps actively extrude drugs 
from the bacterial cell. 
 Overexpression of AcrAB-TolC RND efflux 
complex in Enterobacteriaceae contributes 
towards resistance to a variety of antibiotics. 
 Overexpression of LmrS MFS efflux pump confers 
resistance to linezolid in Staphylococcus aureus. 
Metabolic bypass This mechanism is observed for antibiotics that target 
essential metabolic genes. It consists in the acquisition of 
genes that encode a resistant version of the target protein, 
but has the same function. Therefore, when the target 
protein is inhibited by drugs, the alternative resistant protein 
can function in the pathway. 
 Trimethoprim-sulphamethoxazole inhibits 
essential proteins in the biosynthesis of folate in 
bacteria. Resistant versions of these proteins are 
encoded in transposons from the Tn21 family and 
are horizontally transferred between 
Enterobacteriaceae. 
Adapted from Blair et al. (2015) and Munita and Arias (2016). 
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Figure 1.4 Bacterial multidrug resistance efflux pumps. 
 
 
Examples of the best studied pumps in each family is shown. X-ray crystallography structures are shown where known. Adapted from Chitsaz 
and Brown (2017) and Du et al. (2018).  
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Transporters from the ABC and AbgT family have a dual activity as importers and 
exporters. The role of ABC transporters in nutrient uptake and export of cell wall 
precursors and toxic metabolites has been well studied (Chitsaz and Brown, 2017). In 
contrast, transporters from the AbgT family have only gained attention in recent years. 
AbgT transporters are named after the E. coli folic acid precursor importer AbgT. They 
were initially classified as importers until the MtrF protein in Neisseria gonorrhoeae, a 
homologue of AbgT, was shown to be involved in resistance towards hydrophobic 
antibiotics through an efflux-mediated mechanism (Veal and Shafer, 2003). AbgT-
family pumps have not been identified as MDR efflux pumps in enteric bacteria 
(Delmar and Yu, 2016). 
Efflux pumps from the PACE family were recently discovered in Acinetobacter 
baumannii after exposure to the biocide chlorhexidine. The paradigm PACE pump is 
AceI and homologous pumps have been found in multiple bacterial species. However, 
no reports have been made of PACE transporters in members of the 
Enterobacteriaceae family (Hassan et al., 2015). 
Efflux pumps are classified as active transporters as they require energy to translocate 
their substrates. Based on the source of energy they use, pumps can be classified into 
primary and secondary transporters. Primary transporters use energy from hydrolysis 
of ATP, whereas secondary transporters obtain energy from electrochemical gradients 
formed through the diffusion of protons or ions through a membrane (Elbourne et al., 
2017). Except for ABC pumps, most of the pump families are secondary transporters 
and their main source of energy is the proton-motive force (PMF). This is generated 
by the difference in pH between the environment and the inside of the cell. The PMF 
in Gram-negative bacteria is generated in the periplasmic space, which tends to be 
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more acidic than the cytoplasm. Additionally, some pumps from the MATE family use 
a Na+ gradient as energy source as well as PMF (Du et al., 2018).  
Efflux pumps are located in the cytoplasmic membrane. This means that in Gram-
positive bacteria they can export drugs directly to the outside of the cell. However, in 
Gram-negative bacteria they need to interact with an outer membrane efflux protein 
from the outer membrane factor (OMF) family to extrude antibiotics and other 
substrates from the cell. RND pumps, such as AcrB, form complexes with the TolC 
OMF. These pump-OMF complexes are stabilised by membrane fusion proteins 
(MFP), also called periplasmic adaptor proteins. Therefore, RND pumps are normally 
found as tripartite complexes that span the periplasm (Murakami et al., 2006). Some 
transporters from the ABC and MFS families also form complexes with TolC, examples 
of these are the MacB ABC pump and the EmrB MFS pump (Chitsaz and Brown, 
2017). However, most non-RND pumps do not interact with OMFs. These pumps are 
referred to as single-component pumps and they only efflux their substrates into the 
periplasm, from where the drug can diffuse back into the cytoplasm. To avoid re-entry 
of the drug into the cytoplasm, drugs in the periplasm are extruded from the bacterial 
cell via a tripartite pump, usually an RND pump (Li et al., 2015). 
RND pumps can only transport drugs from the periplasm, unlike ABC pumps which 
can transport drugs from the cytoplasm. A recent study has shown that AcrB, the 
paradigm RND pump, has an entrance channel facing the cytoplasm. This channel is 
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1.8  RND efflux pumps: The paradigm AcrAB-TolC complex 
According to their substrates specificity, RND efflux pumps are sub-classified into the 
hydrophobic and amphiphilic efflux (HAE-RND) and the heavy metal efflux (HME-
RND) families (Anes et al., 2015). S. Typhimurium and E. coli have between 9 to 11 
RND efflux pumps, most of which belong to the HAE-RND subfamily and are involved 
in export of multiple drugs and solvents (Elbourne et al., 2017). The RND pumps 
present in S. Typhimurium SL1344, a commonly used laboratory strain and the strain 
used in this work, are shown in Table 1.2.   
Of all RND pumps in Enterobacteriaceae, AcrB is the most abundant and best studied 
RND pump associated with MDR. AcrB is highly conserved among 
Enterobacteriaceae and it is also highly similar to the MexB RND pump from 
Pseudomonas aeruginosa (Figure 1.5).  
AcrB works as part of a tripartite complex with the TolC OMF and the AcrA MFP 
(Seeger et al., 2008, Symmons et al., 2009). AcrA, the MFP, is composed of four 
domains: an α-hairpin domain, a lipoyl domain, a β-barrel domain and a membrane 
proximal domain (Anes et al., 2015). The last three domains interact with AcrB, 
whereas the α-hairpin domain interacts with TolC. AcrA confers stability to the pump-
OMF assembly and is hypothesised to be involved in substrate recognition of the 
pump. acrA-deletion mutants have altered drug-susceptibility phenotypes (Blair et al., 
2009), but how the protein influences drug-susceptibility remains unknown. 
The OMF, TolC, is formed of three β-barrel protomers embedded in the OM. TolC 
ends in an α-helix bundle tube inserted in the periplasm. The α-helix bundle 
differentiates OMFs from porins as the latter are formed exclusively of β-barrels 
(Zgurskaya et al., 2011). When TolC is not interacting with efflux pumps, it is found in
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Table 1.2 RND efflux pumps encoded in the chromosome of S. Typhimurium SL1344.  
Protein name Gene name* Substrate Description* Subtype 
SL1344_0346 Not annotated Multidrug/solvent efflux (HAE1 subfamily) Efflux pump membrane transporter HAE1 
SL1344_0402 secD Protein export (SecDF) Protein translocase subunit SecD SecDF 
SL1344_0468 acrB Multidrug/solvent efflux (HAE1 subfamily) Efflux pump membrane transporter HAE1 
SL1344_1374 ydhJ Multidrug efflux Hypothetical HlyD-family protein No Subtype 
SL1344_2104 yegN/mdtB Multidrug/solvent efflux (HAE1 subfamily) Multidrug resistance protein MdtB HAE1 
SL1344_2105 yegO/mdtC Multidrug/solvent efflux (HAE1 subfamily) Multidrug resistance protein MdtC HAE1 
SL1344_2444 acrD Multidrug/solvent efflux (HAE1 subfamily) Efflux pump membrane transporter HAE1 
SL1344_3337 yhcQ/aaeA Multidrug efflux p-hydroxybenzoic acid efflux pump subunit AaeA No Subtype 
SL1344_3364 acrF Multidrug/solvent efflux (HAE1 subfamily) Efflux pump membrane transporter HAE1 
(*) Gene names and description were obtained by searching the protein name code in the Uniprot database. Adapted from TransportDB (Elbourne 
et al., 2017). 
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Figure 1.5 Protein sequence similarity of AcrB in Enterobacteriaceae and its homologue MexB in P. aeruginosa. 
 
Dendrogram shows the species and protein analysed, the number on each branch shows the percentage of non-identical residues between 
species or clades. Protein sequences were obtained from Uniprot and sequence similarity was determined by PID (percentage identity). Type of 
analysis done was average distance. Analyses and dendrogram were constructed with Jalview. 
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a closed conformation to avoid entrance of undesirable substances into the periplasm. 
Some evidence suggest that the inner channel of TolC will only open when the OMF 
comes in contact with the pump (Anes et al., 2015). TolC interacts with multiple pumps 
from different families; therefore, it is considered a ‘promiscuous’ protein and it is 
believed to be constantly assembling and disassembling from multiple pumps in order 
to facilitate efflux. Deletion or inactivation of tolC prevents efflux from a variety of 
pumps and gives rise to a multidrug hypersusceptible phenotype. Surprisingly, only a 
small proportion of TolC (~5%) is required to maintain full efflux activity in bacteria 
(Krishnamoorthy et al., 2013). 
AcrB is a trimeric protein with three domains: docking domain, pore domain and 
transmembrane domain. Each of the three protomers or subunits of AcrB is formed of 
12 transmembrane α-helices (TM1 to TM12) and the protomers are held together by 
a connecting loop.  Drug binding occurs in the pore domain (also known as porter 
domain) which is subdivided into four subdomains. In this domain, each protomer has 
a lateral cleft, hypothesised to be the binding site of AcrA (Figure 1.6). Each AcrB 
protomer has three access channels and two binding pockets, referred to as proximal 
and distal binding pockets. The accessibility to these sites depends on the 
conformation of the pump. The binding pockets in each protomer of the AcrB protein 
can acquire different conformations to facilitate the transport of the drug through the 
pump, these conformations are known as loose (L), tight (T) and open (O), also 
referred to as access, extrusion and binding conformations (Murakami et al., 2006, 
Seeger et al., 2008, Sun et al., 2014) (Figure 1.7). The conformational changes are 
dependent upon PMF, generated by translocation of protons through the pump 
(Takatsuka and Nikaido, 2009).  TM4, TM10 and TM11 are responsible for proton 
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A) Front view of AcrB. Each protomer is shown in a different colour. Top view of the B) docking 
domain, C) pore domain and D) transmembrane domain. From Seeger et al., 2008. 
Reproduced with permission of the Copyright Clearance Centre (license ID: 4426680321298, 
confirmation number: 11748015). 
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Figure 1.7 Depiction of the functional rotation mechanism. 
 
 
Schematic of the top and front view of AcrB during functional rotation. L, O and T indicate the loose, tight and open conformations of the pump, 
respectively. From Du et al. (2018). 
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translocation via five residues: D407 (TM4), D408 (TM4), K908 (TM10), T978 (TM11) 
and R971 (TM11) (Figure 1.6A, B) (Murakami et al., 2006, Seeger et al., 2008, Su et 
al., 2006, Sun et al., 2014, Eicher et al., 2014). In silico studies have suggested that 
transport through AcrB is mediated by unidirectional peristaltic movements dependent 
on conformational changes of the pump, which allow the target drug to be pushed 
through the pump and into TolC (Seeger et al., 2006, Feng et al., 2012).  
A small accessory protein, AcrZ, has also been shown to interact with AcrB. AcrZ is 
formed predominantly of α-helices. It is found in the inner membrane, interacting with 
the transmembrane domain of AcrB (Du et al., 2014). The function of AcrZ in the 
complex is unclear, but may be involved in modulating substrate specificity of the 
pump (Hobbs et al., 2012, Du et al., 2015). 
The assembly of the pump complex happens spontaneously. However, the 
stoichiometry of the assembly is still under debate. It is accepted that each complex 
has one AcrB pump and one TolC OMP, both of which are formed of three protomers 
each. The number of MFPs remains unclear as some reports indicate that there are 
three AcrA proteins per complex (3:3:3) (Symmons et al., 2009), whereas other studies 
show six (3:6:3) (Janganan et al., 2011, Daury et al., 2016). Another debate is the 
interaction of the OMP with the pump. Initial studies suggested that TolC sits on top of 
AcrB, in a tip-to-tip interaction  (Pos, 2009). The direct interaction of AcrB with TolC 
triggers conformational changes within the OMF that allows opening of its inner 
channel and subsequent extrusion of substrates. In this model AcrA is wrapped around 
TolC and AcrB; therefore, it is named the “Adaptor Wrapping Model” (Anes et al., 2015) 
(Figure 1.8). Recent crystallography studies supports a model where AcrB and TolC 
do not interact with each other and the whole complex is held together by AcrA, which 
is found attached to AcrB and interacting tip-to-tip with TolC (Du et al., 2014). This 
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model is referred to as the “Adaptor Bridging Model”, in which the opening of TolC is 
mediated by AcrA (Anes et al., 2015). However, molecular docking simulation studies 
and thermodynamics analyses support the direct interaction of AcrB with TolC (Touze 
et al., 2004, Schmidt et al., 2016). It is important to note that the functional assembly 
of the complex has not been uncovered. Therefore, these models could represent 
different stages of the efflux process and are not mutually exclusive.  
 
1.8.1 Regulation of AcrAB expression 
The acrAB genes are found as part of the same operon, the expression of which is 
under direct control of the local regulator AcrR, a repressor from the TetR family. acrR 
is found upstream of the acrAB operon and is transcribed divergently (Figure 1.9). 
AcrR binds upstream of the acrAB operon and its overexpression results in repression 
of AcrAB (Ma et al., 1996). MDR human and animal isolates with mutations in acrR 
have been identified. These mutations affect the ability of AcrR to repress the acrAB 
operon, causing overexpression of the pump (Webber et al., 2005). 
The transcription repressor EnvR (also known as AcrS) binds to the same region as 
AcrR in the promoter region of the acrAB operon. The envR gene is located upstream 
of the acrEF operon in E. coli, which encodes another RND efflux pump and its MFP, 
respectively. However, EnvR does not affect expression of AcrEF (Hirakawa et al., 
2008).  
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Figure 1.8 Models of AcrAB-TolC. 
 
The adaptor wrapping model depicts AcrB and TolC interacting tip-to-tip, with AcrA units wrapped around both transmembrane proteins (from 
Yamaguchi et al., 2015). In the adaptor bridging model there is no interaction between AcrB and TolC. AcrB interacts directly with AcrA and AcrA 
interacts with TolC tip-to-tip (from Wang et al., 2017). 
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Figure 1.9 Transcription factors that affect the expression of the acrAB operon. 
 
Genes encoding acrAB are shown in purple. The local transcription regulator, acrR, is shown in orange. Boxes marked with a 
discontinuous line indicate those promoters/repressors for which more experimental evidence is required. Figure adapted from 
ecocyc.org 
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The transcription of acrAB is also regulated by global transcription factors. These 
belong to the AraC/XylS family of transcription activators and they are encoded by 
marA, soxS, rob and ramA.  These transcription factors are found in all 
Enterobacteriaceae, except for RamA, which is not in E. coli but has been described 
in S. enterica, Enterobacter cloacae, and Klebsiella pneumoniae. All of these 
transcription activators are predicted to bind to a sequence upstream of acrAB called 
the marbox, a highly degenerate sequences of approximately 20bp found in multiple 
sites throughout the genome of Enterobacteriaceae (Weston et al., 2017). 
Some studies have shown that two-component signalling systems (TCSS) also 
regulate the expression of AcrAB. TCSS are formed of an inner membrane sensor 
protein or histidine kinase and a cytoplasmic effector protein. From microarray data, 
PhoP, the cytoplasmic effector protein from the PhoPQ system, was identified as a 
possible repressor that binds upstream of the acrAB operon in E. coli and S. enterica 
(Monsieurs et al., 2005). The CpxRA TCSS, involved in sensing membrane stress, 
indirectly regulates the expression of acrAB by controlling transcription of marA in E. 
coli. The cytoplasmic effector protein CpxR was shown to bind the promoter of the mar 
operon in E. coli and act as a transcription activator (Weatherspoon-Griffin et al., 
2014). Therefore, activation of the CpxRA TCSS results in overexpression of MarA, 
leading to upregulation of acrAB. Another protein that indirectly regulates expression 
of acrAB is the Lon protease. This is an ATP-dependent protease that degrades a 
wide range of proteins, including MarA and RamA. Thus, the overexpression of the 
Lon protease results in decreased transcription of acrAB, as the transcription 
activators are degraded (Weston et al., 2017). 
Expression of AcrAB is also controlled at a post-transcriptional level. A recent study in 
S. Typhimurium has shown that CsrA, an RNA binding protein involved in carbon 
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storage regulation, facilitates the translation of the acrAB transcript by altering the 
secondary structure of the mRNA, which in turn helps the binding of ribosomes (Ricci 
et al., 2017). 
 
1.8.2 Physiological role of AcrB 
RND efflux pumps receive their name from their role in heavy metal Resistance, 
Nodulation and cell Division (Dinh et al., 1994). In 1994, the RND superfamily was 
comprised of only six proteins: AcrF (formerly EnvD) involved in cell division in E. coli, 
NolGHI involved in formation of nodules on the roots of legumes by Rhizobium melitoli 
and the CszA and CnrA pumps from Alcaligenes eutrophus involved in resistance 
towards nickel and cobalt (Saier et al., 1994). AcrB was later included in the RND 
superfamily based on its high sequence identity to AcrF. 
The acrB gene was first identified 40 years ago as the second gene conferring 
resistance to acriflavine (Nakamura et al., 1978), an acridine dye historically used to 
cure plasmids. Nakamura (1965) showed that E. coli had chromosomal determinants 
that confer resistance to acriflavine; he also showed that strains resistant to acriflavine 
had cross-resistance to other acidic dyes such as methylene blue and crystal violet. 
In subsequent studies using the mutants obtained in 1965, he showed that acriflavine 
resistance was mediated by a gene identified as acrA (Nakamura, 1968) and that 
acriflavine-mediated plasmid curing was more efficient in these mutants (Nakamura, 
1974).  Mutations downstream of acrA were also identified at the time; however, these 
were not studied until 1978, when they led to the discovery of acrB.  
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The acrB gene was re-discovered in 1993 and named acrE by Ma et al. (1993). The 
name of the gene was rectified two years later by the same group, when they reported 
that acrAB were responsible for the intrinsic drug resistance of E. coli towards 
novobiocin, erythromycin, bile salts and sodium dodecyl sulphate (SDS, a detergent). 
They also noticed that fatty acids and bile salts induced expression of acrAB. 
Therefore, they concluded that AcrAB was a “stress-induced efflux system” (Ma et al., 
1995). 
Lacroix et al. (1996) described the gene encoding AcrB in S. Typhimurium. They 
confirmed that AcrB is required for resistance to bile salts by testing the susceptibility 
of an acrB::TnphoA mutant, where the gene was inactivated by a transposon insertion. 
Interestingly, they also observed that the acrB::TnphoA mutant was attenuated in a 
C57BL/6 murine oral infection model. The authors concluded that this was due to the 
increased susceptibility of the S. Typhimurium acrB mutant to bile salts. Overall, these 
results suggested that AcrB played an important role in survival of Enterobacteriaceae 
in the mammalian gut by conferring innate resistance to bile salts. 
Later studies focused on the role of AcrAB and other RND efflux pumps in MDR. Some 
efforts have been made towards understanding their physiological role. However, this 
has been complicated as homologous pumps serve different physiological roles in 
different bacterial species. For example, in Mycobacterium smegmatis and 
Corynebacterium glutamicum RND efflux pumps are involved in efflux of precursors 
of long-chain fatty acids called mycolic and corynomycolic acids, respectively, which 
are essential cell wall components in these species (Varela et al., 2012). In 
Enterobacteriaceae, the general consensus is that the loss of RND efflux pumps 
results in loss of virulence (Buckley et al., 2006, Bina et al., 2008, Padilla et al., 2010, 
Perez et al., 2012, Alcalde-Rico et al., 2016). This has been shown in multiple species 
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(Alcalde-Rico et al., 2016), including S. enterica, where the impact of five RND efflux 
pumps in virulence was studied. Nishino et al. (2006) tested the virulence of insertional 
inactivation mutants of acrB, acrD, acrF, mdsB and mdtB of S. Typhimurium in a 
BALB/c murine intragastric infection model. The conclusion of this study was that the 
acrB::aph mutant was the most attenuated mutant when compared to the parental 
wild-type strain. Other studies showed that the absence of either of the components 
of the AcrAB-TolC complex results in diminished ability of S. Typhimurium to adhere 
and invade intestinal epithelial cells in vitro; again the acrB mutant was the most 
affected (Buckley et al., 2006, Blair et al., 2015b). 
These early studies suggested that the loss of virulence observed in the acrB mutant 
was due to the loss of an intrinsic mechanism of resistance to host-derived 
antimicrobial compounds, such as bile salts. Apart from bile, AcrAB-TolC also effluxes 
fatty acids in E. coli (Lennen et al., 2013), which are in abundance in the human sera 
and gut (Rodríguez-Carrio et al., 2017). Additionally, this RND pump complex is 
partially involved in resistance to AMPs in E. coli. An acrB::aph mutant showed 
increased susceptibility to the cationic AMP LL-37 and human -defensin HBD-1, but 
not to α-defensin HNP-2 (Warner and Levy, 2010). 
Later studies indicate that loss of virulence may not be due exclusively to the inability 
of the acrB mutant to efflux host-derived compounds. A microarray study showed that 
inactivation of genes encoding any of the components of AcrAB-TolC in S. 
Typhimurium resulted in significant changes in the transcriptome of the mutant when 
compared against its parental wild-type strain, without exposure to the host. In the 
acrB::aph mutant, genes involved in SPI-1 expression and motility were among the 
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most downregulated, whereas genes involved in anaerobic metabolism were 
upregulated (Webber et al., 2009).  
These changes in transcription indicate that AcrB has an important role in bacterial 
physiology and virulence. Expression of virulence genes in many bacteria is controlled 
by quorum sensing (QS). QS is a cell density-dependent mechanism of cell-to-cell 
communication that relies on the production and accumulation of signalling molecules 
called autoinducers (AIs) (Whiteley et al., 2017). The concentration of extracellular AIs 
increases proportionally to the number of bacteria in the population. Once the AI 
threshold is achieved, the AIs are internalised and phosphorylated. This is the first 
step of a phosphorylation cascade, which results in expression of QS-dependent 
genes. Analogues of AcrB in Pseudomonas aeruginosa export AIs or precursors of 
AIs (Aendekerk et al., 2005, Lamarche and Déziel, 2011, Minagawa et al., 2012). It 
was also proposed that AcrB is involved in efflux of AIs in E. coli as an acrAB::aph 
mutant reached higher cell density in stationary phase than the parental strain (Yang 
et al., 2006). However, another study could not reproduce these findings (Webber et 
al., 2009) and so to date there is no evidence that AcrB or any of the RND pumps in 
Enterobacteriaceae export AIs.  
There are other studies that support the hypothesis that RND pumps directly export 
virulence factors. Studies in E. coli and V. cholerae have shown that RND pumps 
contribute towards efflux of siderophores (Horiyama and Nishino, 2014, Kunkle et al., 
2017), small iron-chelating molecules that provide ferrous iron (Fe2+) to bacteria under 
nutrient-limiting conditions. Strains that overproduce siderophores are often 
hypervirulent; whereas, strains deficient in siderophore production tend to be 
attenuated (Holden and Bachman, 2015). This suggests that the virulence attenuation 
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observed in RND pump-deficient strains could also be caused by decreased export of 
virulence factors.  
Although the contribution of AcrB and its homologous efflux pumps in virulence have 
been established, the mechanism by which this is mediated remains unclear. 
 
1.9 Project background  
Hirakata et al. (2002) showed that addition of cell-free culture supernatant from 
multicystic dysplastic kidney cells (MCDK) infected with P. aeruginosa K767 could 
restore virulence to a ∆mexAB-oprM (AcrAB-TolC homologue) triple deletion mutant. 
While reproducing this experiment in Salmonella, Blair (2010) found that adding cell-
free culture supernatant from wild-type S. Typhimurium SL1344 grown overnight in LB 
broth (conditioned medium or exometabolome) to a ∆acrB mutant restored the ability 
of the mutant to invade INT-407 embryonic intestinal epithelial cells. Based on these 
observations, it was hypothesised that AcrB is involved in the efflux of a virulence 
regulating molecule(s) or a novel virulence factor(s).  
To explore this hypothesis, experiments were designed to discover the nature and 
mechanism of action of the molecule(s). Conditioned medium from S. Typhimurium 
SL1344 was added to ∆acrB mutants during infection assays with INT-407 intestinal 
epithelial cells. This restored the invasive ability of the mutant to almost the same level 
as the parental wild-type strain when concentrated 3-fold (final concentration of 1.5-
fold). To identify the size of the factor(s) and whether it was a protein, conditioned 
medium was centrifuged using Vivaspin® (GE Healthcare Life Sciences, UK), leaving 
only molecules smaller than 5 kDa. Surprisingly, this conditioned medium retained its 
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restorative effect. However, when proteinase K was added, the restorative effect was 
lost. The virulence-restoring molecule(s) also proved to be stable after heating at 70°C 




AcrB exports bacterially derived molecules important in the virulence of Salmonella 
enterica serovar Typhimurium SL1344. 
 
1.11 Aims and objectives 
The aims of this project are:  
 To identify the molecule(s) that restore virulence to an AcrB loss-of-function 
mutant of Salmonella enterica serovar Typhimurium SL1344. 
 To discover additional physiological roles of AcrB in S. Typhimurium. 
The objectives are: 
 Construct an adequate model that allows differentiation of the effect of loss of 
AcrB efflux function from the effect of the loss of AcrB protein. 
 Determine the phenotypic and transcriptomic differences between a loss of 
efflux function mutant and the wild-type S. Typhimurium mutant. 
 Identify candidate molecules that restore virulence to a loss of AcrB function 
mutant. 
 









CHAPTER 2.  
Materials and Methods
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2.1 Bacterial strains 
All bacterial strains used in this study (Table 2.1) were grown in Lennox lysogeny 
medium (LB) (Sigma, USA, cat. no. L3022) or MOPS minimal medium (Teknova, USA, 
cat. no. M2106) at 37C, unless specified otherwise. All S. Typhimurium mutants used 
in this study are derived from SL1344, an experimental strain derived from a calf 
isolate (Wray and Sojka, 1978). SL1344 is a laboratory strain commonly used to study 
virulence of S. Typhimurium. It has a histidine autotrophy due to an ablation of the 
hisG gene. Therefore, when grown in minimal medium, histidine is required to a final 
concentration of 25M (0.4g/L). All E. coli mutants were constructed in a K-12 MG1655 
background, a well-characterised strain with “minimal genetic manipulations” when 
compared against the ancestral K-12 strain (Blattner et al., 1997). This strain has 
decreased expression of PyrE, which leads to a mild pyrimidine auxotrophy that can 
be compensated by addition of 1g/mL of thiamine (E. coli Genome Project, 2002-
2018).  
Strains were routinely checked by Gram-staining and API-20E tests (Biomerieux, 
France, cat. no. 20100). The API-20E system comprises a variety of biochemical tests 
that allow identification of Enterobacteriaceae species. To prepare the inoculum for 
the test, a bacterial suspension (OD600=0.1) was prepared in 5mL of sterile distilled 
water. The suspension was dispensed into the wells of an API-20E test strip with a 
sterile Pasteur pipette (Fisher Scientific, UK, cat. no. 12887605). Strips were incubated 
at the appropriate temperature and results were recorded according to the 
manufacturer’s instructions. Results were introduced into an online system to identify 
the microorganism. 
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Species Genotype Antibiotic resistance Origin 
L354 S. Typhimurium SL1344 Wild-type hisG- None APHA 
L110 S. Typhimurium SL1344 acrB::aph KanR Eaves et al., 2004 
L644 S. Typhimurium SL1344 ∆acrB None Eaves et al., 2004 
L1804 S. Typhimurium SL1344 acrB G1223C (AcrB D408A substitution)  None This study 
L103 S. Typhimurium SL1344 ramA::aph KanR Lawler et al., 2013 
L1351 S. Typhimurium SL1344 wild-type carrying pSIM18 HygR Constructed by Dr. Vito Ricci 
L1232 S. Typhimurium SL1344 wild-type carrying pMW82+ramAp-gfp AmpR Lawler et al., 2013 
L1353 S. Typhimurium SL1344 ∆acrB carrying pMW82+ramAp-gfp AmpR Lawler et al., 2013 
L1812 S. Typhimurium SL1344 AcrB D408A carrying pMW82+ramAp-gfp AmpR This study 
L1909 S. Typhimurium SL1344 wild-type carrying pMW82+lexAp-gfp AmpR This study 
L1910 S. Typhimurium SL1344 AcrB D408A carrying pMW82+lexAp-gfp AmpR This study 
L1407 S. Typhimurium SL1344 wild-type carrying pMW82 empty vector AmpR Lawler et al., 2013 
L1899 S. Typhimurium SL1344 ∆acrB carrying pMW82empty vector AmpR Lawler et al., 2013 
L1900 S. Typhimurium SL1344 AcrB D408A carrying pMW82 empty vector AmpR This study 
L1708 S. Typhimurium SL1344 wild-type carrying pDiGc AmpR This study 
L1897 S. Typhimurium SL1344 AcrB D408A carrying pDiGc AmpR This study 
L1706 S. Typhimurium SL1344 wild-type carrying pDiGc AmpR This study 
L1898 S. Typhimurium SL1344 AcrB D408A carrying pDiGc AmpR This study 
L828 S. Typhimurium 14028S Wild-type None ATCC 
L830 S. Typhimurium 14028S acrB::aph KanR Nishino et al., 2006 
I364 E. coli K-12 MG1655 Wild-type ilvG- rfb-50 rph-1 None Blattner et al., 1997 
I970 E. coli K-12 MG1655 acrB::aph KanR  AmpR Constructed by Dr. Vito Ricci 
I1144 E. coli K-12 MG1655 ∆acrB None This study 
I1124 E. coli K-12 MG1655 acrB A1223C (AcrB D408A substitution) None This study 
I1122 E. coli K-12 MG1655 carrying pSLTS AmpR This study 
I113 E. coli NCTC 10418 None NCTC 
 
- 45 - 
 
I448 E. coli ATCC 25922 None ATCC 
G191 Pseudomonas 
aeruginosa 
PAO1 Wild-type ATCC15692 None ATCC 
F77 Staphylococcus 
aureus 
NCTC8532 None NCTC 
V1 Vibrio harveyi TL25 ΔluxM ΔluxPQ ΔcqsS None Long et al., 2009 
V2 Vibrio harveyi TL26 ΔluxN ΔluxS ΔcqsS None Long et al., 2009 
V3 Vibrio harveyi BB170 luxN::Tn5  KanR Bassler et al., 1993 
KanR indicates resistance to 50g/mL of kanamycin, AmpR indicates resistance to ≥50g/mL of ampicillin, HygR indicates resistance to 100g/mL 
of hygromycin. APHA refers to Animal Health and Plant Agency (UK, formerly Animal Health and Veterinary Laboratories Agency). NCTC refers 
to the National Collection of Type Cultures (Public Health England, UK). ATCC refers to the American Type Culture Collection (USA). 
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All strains were stored in ProtectTM cryopreservation beads (Technical Service 
Consultants Ltd., UK, cat. no. Tn/80-GN) at -80°C. Working stocks were stored at -
20°C. Stocks were prepared from an agar plate with confluent growth of the respective 
strain. Bacteria were harvested with a sterile loop and introduced into the cryo-tube. 
Tubes were vortexed briefly to disrupt bacterial aggregates and excess of 
cryopreservation media was removed. Tubes were immediately stored at the 
appropriate temperature. 
 
2.1.1 Growth of bacterial strains 
Growth kinetics were carried out in a FLUOstar OPTIMA microplate reader (BMG 
Labtech, UK). Overnight cultures were diluted 1:1000 when LB broth was used or 
1:100 when MOPS minimal medium was used. A 10L aliquot of the diluted cultures 
was inoculated into 90L of fresh broth in a U-bottom 96-well plate (Greiner Bio-One, 
Germany, cat. no. 655098), to make a starting culture of 1X104 or 1X106 CFU/mL in 
LB broth or MOPS, respectively. Plates were incubated at 37C for 18 hours. 
Absorbance at 600nm was measured every 5 minutes from the bottom of the plate. 
An orbital adjustment of 2mm to ensure that measurements were taken from the same 
position of each well. A pathway length correction for 100L was applied to account 
for the distortion of light in liquid. 
To calculate generation times, OD600 values from the start and end of the logarithmic 
growth phase were multiplied by 1X106 to obtain an estimate of the total number of 
bacteria per well. The formula used to calculate generation time was: 
Generation time (minutes) =
Time interval from start to end of logarithmic phase(minutes)
3.3 × log( 
No.of bacteria at end of log  phase
No.bacteria at start of log phase⁄ )
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Where viable counts were required, an aliquot of 20L of culture was taken and 
transferred to 180L of sterile 1X PBS for serial dilutions. Cultures were diluted from 
1:10 to 1:1015. Dilutions were plated and viable count was carried out by the Miles and 
Misra method (Miles et al., 1938). The formula used to calculate CFU/mL was: 







2.1.2 Susceptibility of strains to AcrB substrates 
The minimum inhibitory concentration (MIC) of each AcrB substrate was determined 
as described by the British Society of Antimicrobial Chemotherapy (BSAC) (Andrews, 
2001). Doubling dilutions of the antibiotics and dyes were added to 20mL of Iso-
Sensitest agar (Oxoid, UK, cat. no. CM0471) (Appendix II). Antibiotic stocks were 
prepared using the following formula: 
The potency of the antibiotic was given by the manufacturer. The volume required was 
set to 10mL and the final concentration was 10,000g/mL. Antibiotic powder was 
weighed on an analytical balance (Denver Instrument, USA, model no. TP214). The 
powder was transferred into a 10mL volumetric flask and dissolved in the appropriate 
solvent (Table 2.2).  
An aliquot of 10µL of an overnight culture of each test strain grown in Iso-Sensitest 
broth (Oxoid, UK, cat. no. CM0473) was inoculated on to the agar surface and 
incubated for 20 to 24 hours at 37C. Escherichia coli ATCC 25922 and E. coli NCTC 
10418 were used as quality controls. The assay was validated by comparing the MICs 
of the control strains against the Piddock group internal MIC database and the 
EUCAST breakpoints (available at: http://www.eucast.org/clinical_breakpoints/). 
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Table 2.2 Plasmids used in this study. 







pUC19 Small plasmid (2.6 Kb) 
used as positive control 
for electroporations.  








pSLTS Encodes -Red 
recombinase under the 
control of an arabinose-
inducible promoter 
(araBp) and I-SceI under 
the control of a 
tetracycline-inducible 
promoter (tetAp) 
Yes AmpR Kim et al., 2014 
pCP20 Encodes the Flp 
recombinase under the 








Encodes AcrB from S. 
Typhimurium SL1344 
with the D408A 
substitution 
No AmpR Constructed by 
Dr. Vito Ricci 
pASKacrAB Encodes AcrAB from E. 
coli K-12 MG1655 
No AmpR Marshall, 2017 
pASKacrA+ 
acrBA1223C 
Contains the wild-type 
sequence of acrA from E. 
coli K-12 MG1655 plus a 
mutated acrB gene 
which encodes AcrB with 
the D408A substitution 
 
No AmpR This study 
pT2SK Template plasmid used 
for the amplification of 




Kim et al., 2014 
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pSIM18 Encodes -Red 
recombinase under the 
control of a heat-
inducible promoter (pL) 
Yes HygR Datta et al., 
2008 
pACBSCE Encodes I-SceI and -
Red recombinase under 
the control of an araBp 
Yes ChlR Lee et al., 
2009a 
pMW82 Template plasmid used 
for the construction of 
promoter-gfp reporter 
strains 




Encodes the promoter 
region of ramA from S. 
Typhimurium SL1344 
fused to gfp 




Encodes the promoter 
region of lexA from S. 
Typhimurium SL1344 
fused to gfp 
No AmpR Constructed by 
Dr. Robert 
Marshall 
pDiGc Encodes a constitutively 
expressed GFP and 
DsRed under the control 
of araBp 
No AmpR Helaine et al., 
2010 
pDiGi Encodes a IPTG-
inducible GFP and a 
arabinose-inducible 
DsRed 
No AmpR Helaine et al., 
2010 
AmpR indicates that the plasmid confers resistance to ≥50g/mL of ampicillin; ChlR, to 
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2.2 Molecular biology techniques 
2.2.1 Isolation of plasmids 
All the plasmids used in this study are listed in Table 2.3. Plasmid isolation was carried 
out with the GeneJET Plasmid Miniprep Kit (Thermo Scientific, UK, cat. no. K0502).  
Plasmid-containing strains were sub-cultured onto LB agar plates supplemented with 
the appropriate antibiotics and incubated overnight at 37C (or 30C when plasmids 
had a temperature-sensitive origin of replication, oriC) (Table 2.3). A single colony was 
used to inoculate 5mL of LB broth with antibiotic as required, followed by overnight 
incubation with aeration at the appropriate temperature. The culture was centrifuged 
at 3,600Xg for 5 minutes in a Hereaus Megafuge 40R (ThermoFisher Scientific, UK) 
and the pellet was used for plasmid extraction according to the manufacturer’s 
instructions. Plasmids were eluted with 50L of nuclease-free water (ThermoFisher 
Scientific, UK, cat. no. 10977035) and stored at -20C until use. 
 
2.2.2 DNA sequencing of plasmids and PCR amplimers 
Before sequencing, PCR amplimers were purified with the QIAquick PCR Purification 
kit (QIAGEN, Germany, cat. no. 28104) following the manufacturer’s instructions. 
Plasmids extracted as described in section 2.2.1 were used directly for DNA 
sequencing.  
The DNA concentration was quantified using a Nanodrop spectrophotometer (Thermo 
Scientific, UK). DNA (5-10 ng) was mixed with 0.32 pg/L of a forward or a reverse 
primer and made to a final volume of 10L in nuclease-free water. The 
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Table 2.3 Generic PCR cycling parameters using MyFiTM or MyTaqTM master 
mixes. 
 
Step Temperature Time Number of cycles 
Initial denaturation 95 °C 5 minutes 1 
Denaturation 95°C 30 seconds 30-35 
Primer annealing * °C 30 seconds 30-35 
Extension 72 °C 1 minute per kb of amplimer 30-35 
Final extension 72 °C 10 minutes 1 
(*) annealing temperature varies depending on the melting temperature (Tm) of the primers. 
Annealing temperatures of 5°C below the Tm of the primer with the lowest Tm were used. 
 
- 52 - 
 
primer-DNA mixture was sequenced at the Functional Genomics Laboratory (The 
University of Birmingham, UK). Samples were labelled using the BigDye Cycle 
Terminator Sequencing kit (Applied Biosystems, USA, cat. no. 4337455) and 
sequenced in an ABI 3730 Capillary sequencer (Applied Biosystems, USA).  
Sequencing results were retrieved from an online repository. Chromatograms were 
visualised in SeqScanner 2 (Nucleics, Australia). Sequences were transformed to 
FASTA format and aligned to the reference sequence using the ‘Align’ tool from MEGA 
version 6 (Research Center for Genomics and Bioinformatics, Japan).  
 
2.2.3 Preparation of electrocompetent cells 
Bacteria were rendered electrocompetent by continuous washing in 15% glycerol. The 
glycerol solution was prepared by adding 150mL of glycerol (Fisher Reagents, USA, 
cat. no. BP229-1) to 850mL of distilled water. Concentrated glycerol was prewarmed 
at 37C to facilitate pipetting. The solution was filter-sterilised through a 1L, 0.22m 
pore, Stericup® Filter Unit (Merck Millipore, UK, cat. no. SCVPU11RE). 
A 10mL aliquot of an overnight culture was used to inoculate 100mL of LB broth. 
Cultures were incubated at 37C with aeration until an OD600 of 0.6-0.8 was reached. 
Cultures were immediately transferred into two 50mL centrifuge tubes (Greiner Bio-
One, Germany, cat. no. 227261) and incubated on ice for 30 minutes. To pellet 
bacteria, tubes were centrifuged at 4,700Xg for 15 minutes, at 4C in a Hereaus 
Megafuge 40R (ThermoFisher Scientific, UK). The supernatant was discarded and the 
pellet was carefully resuspended in 20mL of ice-cold 15% glycerol to wash the 
bacteria. After three consecutive washes in 15% glycerol, pellets were resuspended 
in 1mL of 15% glycerol and transferred into two 1.5mL microcentrifuge tubes (Greiner 
 
- 53 - 
 
Bio-One, Germany, cat. no. 616201). A final centrifugation step was carried out at 
15,000 Xg in an Eppendorf® refrigerated microcentrifuge (Germany) at 4C for 3 
minutes to concentrate the bacterial cells. Pellets were resuspended in 500L of 
glycerol and aliquoted into 100L portions in ice-cold microcentrifuge tubes. Aliquots 
were stored at -80C until use.  
 
2.2.4 Electroporation 
A 50L aliquot of defrosted electrocompetent bacteria was added to an ice-cold 
electroporation cuvette (Geneflow, UK, cat. no. E6-0060). Plasmid or linear DNA was 
added to the cuvette, briefly mixed by pipetting and incubated on ice for 5 minutes 
before electroporation. Two additional cuvettes containing 5L of nuclease-free water 
or purified pUC19 plasmid were used as negative and positive controls, respectively. 
Electroporation was carried out in a Gene Pulser II electroporator (Bio-Rad, USA). An 
electric current at 2.5kV for S. Typhimurium or 1.8kV for E. coli was applied to the 
cuvette for 5 seconds. Electroporated bacteria were immediately transferred into 1mL 
of prewarmed LB broth, in a sterile universal tube (Starlabs, UK, cat. no. E1412-3010), 
and left to recover in an Innova® 44 shaking incubator (Eppendorf, Germany) at the 
appropriate temperature with aeration. Recovery time varied depending on the 
plasmid introduced. For transformation with pACBSCE, pMW82, pDiGi and pDiGc, 
electroporated bacteria were left to recover for 1 to1.5 hours at 37°C. For pSIM18 and 
pSLTS, transformants were left for 2 to 3 hours at 30°C. Conditions for introducing 
linear fragments of DNA are detailed in section 2.3. 
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After the recovery step, an aliquot of 100L of culture was plated onto LB agar with 
the appropriate antibiotic to select for transformants (Table 2.3). An additional 100L 
was plated onto LB agar without antibiotics to check that the electroporated bacteria 
were viable. The rest of the culture was concentrated by centrifugation in a Hereaus 
Megafuge 40R (2,800Xg, 10 minutes) and plated onto a second LB agar plate with the 
appropriate antibiotic to maximise recovery of transformants.  
 
2.2.5 Polymerase chain reaction (PCR) 
PCRs were carried out using premade master mixes, in a Sensoquest thermocycler 
(Geneflow, UK). MyFiTM Mix (Bioline, UK, BIO-25049), which contains a high fidelity 
polymerase, was used for the construction of chromosomal mutants and sequencing 
reactions. MyTaqTM Red Mix (Bioline, UK, cat. no. BIO-25043) was used for all other 
PCRs.  
A generic reaction mix comprised 12.5L of master mix, 0.5L of a 25M primer stock 
of each primer and 1L of template DNA. Reaction mixes were adjusted to a final 
volume of 25L with nuclease-free water. Generic PCR cycling parameters are shown 
in Table 2.4.  
Primers were ordered from Invitrogen (Table 2.5). Stock solutions of 100µM were 
prepared and diluted 1:4 in nuclease-free water to obtain a working concentration of 
25µM. Primer stocks were stored at -20C and thawed on ice when needed. 
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Table 2.4 Primers used in this study. 
 
(*) SM3 primers were used in combination with AcrB D408A Fwd primers. SM5 primers were used with AcrB D408A reverse primers.
Primer 
number Primer Sequence (5’ to 3’) Purpose 
234 Eco acrB Fwd CTGATCACCAGTGACGGCAT Amplification of the E. coli acrB gene. 
Anneal up and downstream of acrB.  235 Eco acrB Rev CGTATGAGATCCTGAGTTGG 
332 STm  acrB Fwd GGATCACACCTTATTGCCAG Amplification of the S. Typhimurium acrB 
gene. Anneal up and downstream of acrB. 333 STm acrB Rev CGGCCTTATCAACAGTGAGC 
2167 Kan pT2SK Fwd CGTATCACGAGGCCCTT Amplification of the kanamycin selection 
cassette for construction of mutation 
cassettes 2168 Kan pT2SK Rev CACATGTTCTTTCCTGCG 
2151 STm AcrB D408A Fwd GTTGTTGGGAACCTTTGCCG Amplification of the region of acrB  that has 
the A1223C mutation in S. Typhimurium 2152 STm AcrB D408A Rev CCATCGCGATACCCACCA AT 
2165 STm HRF SM3* AAGACATCTCGCCATCGGCTTGCTGGTGGA Construction of the S. Typhimurium AcrB 
D408A mutation cassette 2166 STm HRF SM5 * AAAAGGGCCCACGTTCTCGACCACCACGATGG 
2277 Eco A1223C Fwd CCACAACGATGGCGGCATCCACCAACAGG Construction of the E. coli acrB A1223C 
plasmid 2278 Eco A1223C Rev CCTGTTGGTGGATGCCGCCATCGTTGTGG 
2279 Eco AcrB D408A Fwd CTTCCCGTCGGGTCTGAAAA Amplification of the region of acrB  that has 
the A1223C mutation in E. coli 2280 Eco AcrB D408A Rev AATCGGTTTCAGCATGGTGGC 
2281 Eco HRF SM5* ACCGCTGCCACTCTTGAGATTTCTTCCGCCATAACACGC Construction of the E. coli AcrB D408A 
mutation cassette 2282 Eco HRF SM3* CTAAGCAGGGCGGGGCGTAAGTGCTCGCCATCGGCCTG 
429 ramA check-up Fwd CCGCTTCCAGTAATGCTTGT Amplification of the S. Typhimurium 
ramA::aph cassette. Anneal up and 
downstream of ramA. 430 ramA check-up Rev GAATCATTGATGACCGCTGC 
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Table 2.5 Antibiotics and dyes used in this study and their solubility. 
Antibiotic/dye Abbreviation Chemical class Catalogue number* 
Compound purity/ 
Potency (%) Solvent 
Acriflavine ACR Dye A8126 100 Water 
Ampicillin AMP β-lactam A9393 97 0.1M sodium bicarbonate 
Carbenicillin CAR β-lactam C1389 89 Water 
Ceftazidime CAZ  Cephalosporin C3809 95.9 0.1M NaOH 
Ceftriaxone CTX Cephalosporin C5793 92 Water 
Chloramphenicol CHL Chloramphenicol C0378 98 70% methanol 
Ciprofloxacin CIP Fluoroquinolone C17850 98 Water with CH3COOH 
Erythromycin ERY Macrolide E5389 95 70% ethanol 
Ethidium bromide ETBR Dye E7637 95 Water 
Fusidic acid FUS Fusidane F0881 98 Water 
Gentamicin GEN Aminoglycoside G1397 59 Water 
Hygromycin B HYG Aminoglycoside H7772 98 70% methanol 
Kanamycin KAN Aminoglycoside K1876 65 Water 
Minocycline MIN Tetracycline M9511 89-95 Water 
Nalidixic acid NAL Quinolone N8878 98 Water 
Novobiocin NOV Aminocoumarin N6160 85 Water 
Oxacillin OXA β-lactam O1002 81.5 Water 
Rhodamine 6G RHO Dye R4127 95 Water 
Tetracycline TET Tetracycline T3383 95 Water 
(*) all compounds were purchased from Sigma, UK  
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2.2.6 PCR amplimer visualisation 
To visualise PCR amplimers, an agarose (Fisher Bioeagents, Belgium, BP1356-500) 
gel was prepared in 1X Tris-Borate-EDTA (TBE) buffer (Sigma, USA, cat. no. T445). 
For amplimers with a size between 200bp to 10kb, a 1% agarose gel and a 1kb 
Hyperladder™ (Bioline, UK, cat. no. BIO-33053) were used; for amplimers smaller 
than 200bp, a 2% agarose gel and a 100bp Hyperladder™ (Bioline, UK, cat. no. BIO-
33056) were used. To stain double-stranded (ds) DNA, Midori Green Advance (Nippon 
Genetics, Japan, cat. no. MG04) was added to the gel to a final concentration of 
0.05L/mL. Where needed, PCR amplimers were mixed with a 5X DNA Loading Buffer 
(Bioline, UK, cat. no. BIO-37045). Loading buffer was diluted 1:5 with amplimer. 
Gels were electrophoresed at 100V for approximately 50 minutes in a horizontal gel 
electrophoresis tank (Cleaver Scientific, UK). Electrophoresed gels were transferred 
to a G:BOX gel documentation system (Syngene, UK), which uses a blue light 
transilluminator to visualise stained nucleic acids.  
 
2.3 Construction of an E. coli K-12 MG1655 acrB mutant 
The acrB::aph cassette was PCR-amplified from a previously constructed E. coli 
acrB::aph mutant that was resistant to kanamycin but also had an additional ampicillin 
selection marker (Table 2.1). A colony lysate of this strain (1L) was used as template 
DNA; the MyFi™ Master Mix and primers 234 and 235 (Table 2.5) were used for this 
PCR. A DpnI (NEB, USA, cat. no. R0176S) digestion was carried out to remove any 
template DNA. 
To introduce the acrB::aph cassette into wild-type E. coli MG1655, a -Red helper 
plasmid, pSLTS, was transformed into MG1655 by electroporation. Transformants 
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were selected by plating onto LB agar with 100g/mL of ampicillin (AMP100) (Table 
2.2) at 30C. Three colonies were restreaked on to LB AMP100 agar plates. 
Transformants were confirmed to be E. coli by Gram-staining and API-20E test and 
prepared for cryopreservation. 
To induce expression of the -Red recombinase, a 5mL culture in LB AMP100 broth 
was prepared from a single colony of MG1655 carrying pSLTS.  The culture was 
incubated overnight at 30C with aeration. The overnight culture (1mL) was used to 
inoculate 100mL of fresh LB AMP100 broth. This culture was incubated in a shaking 
incubator for 1 hour at 30C, 200rpm.  To induce expression of the recombinase, L-
arabinose (Sigma, USA, cat. no. A3256) was added to a final concentration of 2mM 
(200L of a 1M arabinose solution). The culture was incubated for another 2 hours 
until an OD600 of 0.7-0.9 was reached. Bacteria were prepared for electroporation as 
indicated in section 2.2.3.  
The acrB::aph cassette (50-100ng) was electroporated into the electrocompetent 
cells. Electroporated bacteria were incubated in a shaking incubator for 3 hours at 
30C, 200rpm, and plated onto LB agar with 50g/mL of kanamycin (KAN50). Insertion 
of the acrB::aph cassette into the chromosome of MG1655 was confirmed by PCR 
with primers 234 and 235 (Table 2.4). In the wild-type, an amplimer of 3600bp was 
expected; whereas a 1500bp amplimer was expected in an acrB::aph mutant.  
Removal of the selection marker was carried out as described by Datsenko and 
Wanner (2000). pCP20, an FLP helper plasmid, was transformed into the MG1655 
acrB::aph mutant by electroporation. Transformants were selected on LB AMP50 agar 
plates and incubated at 30°C overnight. Ten colonies were restreaked on to LB AMP50 
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agar to confirm insertion of the plasmid. A single colony from each restreak was used 
to start an overnight culture in LB AMP50 broth. Overnight cultures were incubated in 
a shaking incubator at 43°C, 200rpm, to induce the expression of the flippase.  A 
loopful of each culture was streaked onto LB agar plates without antibiotics and the 
plates incubated at 37°C for 24 hours. Two single colonies from each plate were 
replica-plated onto LB, LB AMP50 and LB KAN50 agar to confirm loss of pCP20 and 
excision of the aph gene. Colonies that grew on LB agar but not on agar containing 
antibiotics were screened by PCR (primers 234 and 235). A 600bp amplimer was 
expected from the ∆acrB mutant. 
 
2.4 Construction of an AcrB D408A chromosomal mutant 
A modified version of the method described by Kim et al. (2014) was used for the 
construction of the chromosomal mutant. The method consists of two steps: 1) 
insertion of a mutation cassette into the chromosome of the target organism mediated 
by a plasmid encoded -Red recombinase, followed by 2) the excision of the selection 
marker from the inserted cassette by a plasmid-encoded I-SceI meganuclease and 
the repair of the double strand break by the bacterial RecA system.  
The mutation cassette comprises a selection cassette and two homologous 
recombination fragments (HRFs). The selection cassette is formed of an I-SceI 
restriction site followed by the aph kanamycin resistance gene, which served as the 
selection marker during the first step of the procedure. HRFs are two fragments of the 
target gene carrying the single nucleotide substitution, located at the 5’-end and 3’-
end of the selection cassette, respectively. To facilitate the repair of the double strand 
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break during the second step of the procedure, the 5’- HRF contained 20 bp of 
homology to the 3’- HRF and vice versa.  
 
2.4.1 Construction of a plasmid encoding AcrB D408A  
To obtain the HRFs, a plasmid carrying the mutated acrB gene was required. The 
plasmid encoding the S. Typhimurium AcrB D408A substitution was previously 
constructed by Dr. Vito Ricci using a pWSK30 backbone. The QuikChange® Lightning 
Site-Directed Mutagenesis kit (Agilent Technologies, USA, cat. no. 210518) was used 
for its construction.  
To construct the plasmid encoding the E. coli AcrB D408A, a pASK plasmid carrying 
wild-type acrAB was used (donated by Dr. Robert Marshall). Primers were designed 
using the QuikChange® Primer Design Program (available at: 
https://www.genomics.agilent.com/primerDesignProgram.jsp). The sequence of acrB 
from E. coli K-12 MG1655 was introduced into the program and the A at position 1223 
was chosen to be substituted by C, this mutation translated into the AcrB D408A 
substitution. As acrB is encoded in the reverse strand, the A1223C mutation appears 
as a TG substitution in whole genome sequencing.   
The kit was used according to the manufacturer’s instructions. In brief, 75ng of plasmid 
was added to a reaction mix containing 125ng of each primer plus the other 
components in the kit. Nuclease-free water was added to make a final volume of 50L. 
A PCR was carried out to introduce the A1223C mutation into the plasmid, followed 
by DpnI (provided with kit) digestion to remove the template plasmid. Plasmids 
carrying the mutation were transformed into XL10-Gold Ultracompetent Cells (Agilent 
Technologies, USA, cat. no. 200315).  
 
- 61 - 
 
Transformants were plated onto LB AMP100 agar. Ten colonies were picked randomly 
for plasmid extraction and DNA-sequenced to confirm that the A1223C mutation had 
been introduced. Plasmids carrying the mutated acrB sequence were stored at -20 C 
until use. 
 
2.4.2 Construction of the mutation cassette 
The construction of the mutation cassette was carried out as described previously (Kim 
et al., 2014). The same procedure was used to construct the S. Typhimurium and E. 
coli AcrB D408A mutation cassettes. 
The kanamycin-resistance selection cassette was amplified from pT2SK (Addgene, 
USA, cat. num. 59383). Plasmids expressing AcrB D408A (section 2.4.1) were used 
as templates for amplification of the region of acrB containing the point mutation. Two 
fragments of ~150bp were amplified and used HRFs. The acrB A1223C mutation was 
located within the 20 bp of homology between the two HRFs to maximise chances of 
retaining the single nucleotide polymorphism (SNP) after activation of the bacterial 
RecA system. 
Amplimers were cleaned and quantified as described in section 2.2.2. Selection 
cassette (75fmol) plus 125fmol of each one of the HRFs were made up to 10L in 
nuclease-free water. Gibson assembly Master Mix (NEB, UK, cat. num. E5510S) 
(10L) was added to the mixture and incubated for 1 hour at 50C in a Sensoquest 
thermocycler.  
A 4L aliquot of the assembled product was mixed with 1L of 5X loading buffer and 
electrophoresed in a 1% agarose gel to confirm the correct assembly of the mutation 
 
- 62 - 
 
cassette. The selection cassette (5L) was electrophoresed next to the assembly mix 
to detect traces of selection cassette that was not assembled. When residual, 
unassembled, selection cassette was observed, the assembled cassette was gel-
purified. In brief, the total volume of the Gibson assembly product (16L) was 
electrophosed in a 1% agarose gel for 1 hour at 80V and the mutation cassette band 
was cut out from the gel using a clean scalpel (Swann-Morton, UK) and an UltraSlim 
LED transilluminator (Syngene, UK).  DNA was recovered from excised gel fragments 
with the QIAquick Gel Extraction kit (QIAGEN, Germany, cat. no. 28704) and the 
purified product was eluted in 35L of nuclease-free water. To confirm its correct 
assembly, the assembled mutation cassette was sent for sequencing at the Functional 
Genomics Facility (University of Birmingham, UK) (section 2.2.2). The final assembled 
mutation cassette was amplified by PCR and stored at -20C until use. 
 
2.4.3 Insertion of the mutation cassette into the chromosome 
2.4.3.1 In S. Typhimurium  
A previously constructed S. Typhimurium SL1344 transformant harbouring pSIM18 
was used for this step. pSIM18 is a -Red helper plasmid that expresses the -phage 
recombinase under the control of a heat activated promoter.  
S. Typhimurium SL1344 + pSIM18 was streaked onto a LB agar plate with 100g/mL 
of hygromycin (HYG100) and incubated overnight at 30C. A single isolated colony 
was used to inoculate 5mL of LB HYG100 broth, incubated overnight at 30C, shaking 
at 200 rpm.  The overnight culture was used to inoculate 100mL of LB HYG100 broth, 
which was incubated under the same conditions as the overnight culture until an OD600 
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of 0.3 was reached. The culture was transferred into two 50mL centrifuge tubes and 
incubated in a 42C water bath for 15 minutes to induce the expression of -Red 
recombinase. Cultures were incubated on ice for 10 minutes and rendered 
electrocompetent as described in section 2.2.3. Electrocompetent bacteria were 
resuspended in a final volume of 100L. 
The mutation cassette (50-100ng) was added to 40L of electrocompetent bacteria in 
a pre-chilled electroporation cuvette. Additionally, 75-100ng of a ramA::aph cassette, 
amplified from a previously constructed SL1344 acrB::aph, was added to a second 
electroporation cuvette and used as positive control for recombination. Electroporated 
bacteria were immediately recovered in 400L of SOC (Appendix I) and transferred 
into a universal tube. Recombinants were incubated at 37C for 2 hours, with aeration. 
Bacteria were concentrated by centrifuging at 2,800Xg for 10 minutes, the supernatant 
was discarded and the pellet was resuspended in 100L of LB. The total amount of 
bacteria was plated on to an LB KAN50 agar plate and incubated at 37C for 24 hours. 
Five colonies were re-streaked onto a LB KAN50 plate and a colony PCR was carried 
out to determine whether the mutation cassette had inserted correctly. 
2.4.3.2 In E. coli 
Insertion of the mutation cassette into the chromosome of E. coli MG1655 was carried 
out as described in section 2.3. Recombinants were plated on to LB AMP50 KAN50 
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2.4.4 Deletion of the selection marker  
2.4.4.1 In S. Typhimurium 
Excision of the kanamycin selection cassette from the chromosome of S. Typhimuruim 
SL1344 was carried out with pACBSCE as described by Lee et al. (2009a). pACBSCE 
encodes the I-SceI meganuclease and -Red recombinase under the control of an 
arabinose-inducible promoter. The plasmid also contains the I-SceI restriction site 
near its origin of replication. Therefore, expression of I-SceI will cure the plasmid from 
the carrier strain. 
The strain containing the mutation cassette was rendered electrocompetent and 
transformed with pACBSCE as described in sections 2.2.3 and 2.2.4. Transformants 
were selected by plating onto LB agar supplemented with 20g/mL of chloramphenicol 
(CHL20). 
The transformed strain was re-streaked onto LB CHL20 agar and a single isolated 
colony was used to inoculate 5mL of LB CHL20 KAN50 broth. To avoid leaky 
expression of I-SceI, glucose (Teknova, USA, cat. no. G0521) was added at a final 
concentration of 0.5%. The culture was incubated overnight at 37C with aeration and 
a 10L aliquot was used to inoculate 1mL of LB CHL20 KAN50 broth. The culture was 
incubated in a shaking incubator at 37C, 200 rpm, for 2 hours, followed by 
centrifugation for 5 minutes at 3,500Xg to remove antibiotics from the medium. The 
pellet was resuspended in LB broth without antibiotics and the centrifugation was 
repeated to ensure removal of antibiotics. Finally, the pellet was resuspended in LB 
supplemented with 0.5% of arabinose and the culture was incubated for 3 hours at 
37C, with aeration. A 20L aliquot was used to prepare serial dilutions from 1:10 to 
1:108, in 180L of 1X PBS.  One hundred L of each dilution was plated onto LB agar 
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plates without antibiotics. The dilution that contained between 50 to 100 colonies was 
chosen for negative selection.  
All colonies were replica-plated on to LB, LB KAN50 and LB CHL20 to select mutants 
that have lost the selection marker (did not grow on KAN50) and pACBSCE (did not 
grow on CHL20). Colonies that only grew on LB were screened by PCR for loss of the 
mutation cassette and PCR amplimers were sequenced at the Functional Genomics 
Laboratory (University of Birmingham, UK) to confirm correct insertion of the acrB 
A1223C mutation. 
To confirm that mutant candidates were not contaminated, an API-20E strip was 
inoculated with a suspension made from each candidate. The strip was filled according 
to manufacturer’s instructions and interpreted and incubated at 37C. 
2.4.4.2 In E. coli 
Five recombinants carrying pSLTS were streaked on to LB AMP50 KAN50 agar plates 
and incubated overnight at 30°C. One colony from each plate was resuspended in 
500L of sterile 1X PBS in a 1.5mL microcentrifuge tube. The suspension was 
vortexed briefly and 100L of each suspension was plated on to LB AMP50 
supplemented with 100ng/mL of anhydrotetracycline (aTET100) (Acros Organics, 
USA, cat. no. 233131000) to induce expression of I-SceI.   An additional 100L was 
platted onto LB AMP100 agar plates as a culture viability control.  
Plates were incubated at 30C for up to 48 hours. Only a few colonies were expected 
in the LB AMP100 aTET100 plates as the I-SceI endonuclease induces a lethal 
double-stranded break with a very low efficiency of recovery (Kim et al., 2014).   
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Four colonies per plate were replica-plated onto LB and LB KAN50 plates to check for 
loss of kanamycin resistance. Plates were incubated overnight at 37C to allow 
plasmid curing. Colonies that only grew on LB agar were screened for loss of the 
selection marker by amplifying the acrB gene. The wild-type acrB is 3.6Kb, whereas 
acrB with the selection marker is 5.1Kb. Colonies in which acrB was the correct size 
were streaked onto LB, LB AMP50 and XLD agar plates to check for loss of pSLTS 
and loss of AcrB efflux function, respectively. Plates were incubated overnight at 37C. 
Mutants that did not grow on LB AMP50 and grew poorly on XLD agar were confirmed 
to be E. coli by Gram-staining and API-20E. acrB was amplified from the candidate E. 
coli mutants and DNA-sequenced to confirm insertion of the SNP into acrB. 
 
2.5 Whole genome sequencing (WGS) and data analysis 
The S. Typhimurium SL1344 and AcrB D408A chromosomal mutants were sent to 
Microbes NG (University of Birmingham, UK) for WGS. The E. coli K-12 and acrB 
mutants were sent to the Beijing Genomics Institute (BGI) (Hong Kong) for 
sequencing. 
Bioinformatics analyses were carried out on the Galaxy online platform. Raw reads 
were trimmed using Trimmomatic. Twenty bp was trimmed from the start of the 
sequence to remove linkers. Quality of the trimmed sequences were assessed by 
FASTQC. Where required, an additional 10bp was removed from the end of the 
sequence where the quality of the reads start to decrease. On average, trimmed reads 
were approximately 100bp. Reference genomes and annotations were download from 
either EnsemblBacteria or the Genbank. The assemblies used were FQ312003.1 and 
U00096.3 for S. Typhimurium SL1344 and E. coli K-12 MG1655, respectively.  
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For S. Typhimurium, reads were aligned and mapped to the reference genome using 
Bowtie2, which generates a BAM file of the assembled genome. The BAM file was run 
through BamLeftAlign to align indels in order to detect insertions or deletions. Finally, 
variant calling was carried out using MPileup, which compares two assemblies and 
generates a list of all differences and their locations in the genome. The wild-type 
strain was compared against the reference genome, while the mutant was compared 
against the assembled wild-type genome and the reference genome, separately.  
To validate any SNPs, deletions and insertions, BAM files were viewed on Artemis 
(Sanger Institute, UK). The location of the variant was identified and the sequence of 
the mapped reads was verified manually. 
For E. coli, variant calling was carried out using Snippy on the Cloud Infrastructure for 
Microbial Bioinformatics (CLIMB) portal. Snippy comprises all the steps up to variant 
calling in one program and provides the list of variants and BAM files. As with S. 
Typhimurium assemblies, all variants were confirmed manually on Artemis.  
acrB is encoded in the reverse strand; therefore, the A1223C mutation appears as a 
TG substitution in WGS. 
 
2.6 Western blot of AcrB 
Protein samples from S. Typhimurium SL1344, E. coli MG1655 and their respective 
∆acrB and chromosomal AcrB D408A mutants were prepared from exponential phase 
cultures (OD600=0.6). To prepare the cultures, 5mL of LB broth was inoculated with a 
single colony of the respective strain. The overnight culture was used to inoculate fresh 
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LB broth. Cultures were incubated in a shaking incubator at 37C, 200 rpm, until an 
OD of 0.6 was reached.  
Bacteria were harvested by centrifuging at 3,500Xg for 10 minutes, at 4C in a 
Hereaus Megafuge 40R. Pellets were resuspended in 1mL of 10mM Tris-EDTA buffer 
(Fluka, USA, cat. no. 93283) with 100g/mL of lysozyme (Sigma, USA, cat. no. 
L6876). Resuspended pellets were incubated on ice for 30 minutes.  
Sonication was carried out using a SoniPrep 150 sonicator (SANYO, Japan). To lyse 
bacteria, four cycles of 30 seconds sonication plus 30 seconds rest were carried out. 
Protein preparations were centrifuged at 3,500Xg for 10 minutes, at 4C, to remove 
cellular debris. The supernatant was recovered and stored at -20C until use. 
The protein concentration was quantified using the QubitTM Protein Assay Kit 
(Invitrogen, UK, cat. no. Q33221) according to the manufacturer’s instructions. This kit 
provides a fluorescent dye that stains proteins and allows their quantification using a 
specialised fluorometer. In brief, a working solution was prepared by diluting the dye 
1:200 in the provided buffer. The protein preparation (1L) was added to 199 L of 
working solution in a Qubit assay tube (Invitrogen, UK, cat. no. 32856). Standards 
were prepared by adding 10L of each standard to 190L of working solution. All 
samples were incubated for 30 minutes at room temperature and read in a Qubit 3 
Fluorometer (Invitrogen, UK). 
Protein samples (10µg) were electrophoresed on a 4-12% NuPAGE® Bis-Tris gel (Life 
Technologies, USA, cat. no. NP0321BOX) and transferred onto a nitrocellulose 
membrane using the iBlot® system (Thermo Fisher Scientific, UK) for 7 minutes. The 
membrane was washed 3 times in 1X TBS pH 7.6 buffer (Appendix I) and blocked by 
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incubating for 1 hour at room temperature with a 5% skim milk (Sigma-Aldrich, UK, 
cat. no. 70166) solution in TBS buffer. The blocked membrane was washed three 
times with TBS 1X and incubated with rabbit anti-AcrB primary antibody (donated by 
Dr. Helen Zgurskaya, The University of Oklahoma, USA) for 1 hour, followed by a one 
hour incubation with anti-rabbit IgG secondary antibody linked to horseradish 
peroxidase (HRP) (Cell Signaling Technology, USA, cat. no. 7074S). The blot 
developed with the Westar Supernova chemiluminescent substrate kit (Cyanagen, 
Italy, cat. no. XLS3,0100).  
A second blot, prepared at the same time, was incubated with a mouse anti-
Enterobacteriaceae RNA polymerase -subunit primary antibody (BioLegend, USA, 
cat. no. 664602), followed by an HRP-linked anti-mouse IgG secondary antibody (Cell 
Signaling Technology, USA, cat. no. 7076S).  This blot was used to normalise the 
amount of AcrB to the amount of total protein per sample, as RNA polymerase is 
constitutively expressed and its expression levels are not affected by changes in AcrB.  
Blots were analysed with the GeneSys program (Syngene, USA); the concentration of 
AcrB was determined by the intensity of the band given by the number of pixels. 
  
2.7 Accumulation and efflux assays of two AcrB substrates 
2.7.1 Hoescht 33342 (bis-benzimide) accumulation assay 
Hoescht 33342 (H33342) is a dye that fluoresces when intercalated with DNA. 
Accumulation of H33342 in bacteria can be measured by monitoring fluorescence over 
time, which gives an indication of membrane permeability (Blair and Piddock, 2016). 
The assay was carried out as described by (Coldham et al., 2010). A 4% inoculum of 
an overnight culture was added to 10mL of prewarmed LB broth. Cultures were 
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incubated at 37C, under aeration until an OD600 of 0.5 was reached. Bacteria were 
immediately pelleted by centrifugation at 3,500Xg for 10 minutes and resuspended in 
sterile Dulbecco’s PBS (DPBS) (Sigma, USA, cat. no. D8537). The OD600 of the 
resuspended cultures was measured and all cultures were adjusted to a starting OD600 
of 0.1 in 1X PBS. Aliquots of 180L of each adjusted culture were added in triplicate 
into a black 96-well plate (Corning, USA, cat. no. 3991). Three wells each containing 
either sterile PBS or heat treated (boiled) bacteria were used as blank and positive 
control, respectively. The initial fluorescence of the aliquots was measured every 
minute for three minutes; subsequently, 20L of a 25µM solution of H33342 (Sigma-
Aldrich, UK, cat. no. B2261) was injected into each well to make a final concentration 
of 2.5L. Fluorescence was measured every minute for 100 minutes in a FLUOstar 
Optima microplate reader. An excitation wavelength of 350-10nm with a 460nm 
emission filter were used. The gain was adjusted to 2315.  
 
2.7.2 Ethidium bromide efflux assay 
This method consists of preloading bacteria with ethidium bromide (ETBR), followed 
by activation of efflux via addition of glucose. Efflux is then monitored by a decrease 
in fluorescence. Cultures were incubated in the same way as described in section 
2.7.1. Bacteria were harvested at an OD600 of 0.4, washed in 0.1M PPB (Annex I) by 
centrifugation (3,500Xg for 10 minutes) and resuspended in 10mL PPB with 50µg/mL 
of ethidium bromide ETBR (Sigma, USA, cat. no. E8637) and 100mM of carbonyl 
cyanide m-chlorophenyl hydrazone (CCCP) (Alfa Aesar, UK, cat. no. L06932). 
Resuspended cultures were incubated for 1 hour at room temperature (~22°C) to allow 
ETBR to accumulate intracellularly. ETBR and CCCP were removed by centrifugation 
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(2,500Xg for 10 minutes at room temperature); cultures were resuspended in 3mL of 
0.1M PPB and an aliquot of 180L was added to a black 96-well plate. Three wells 
each containing PPB or boiled bacteria were used as blank and positive control, 
respectively. The initial fluorescence was measured for three minutes, followed by 
injection of 20L of a 100mM glucose solution (Sigma, USA, cat. no. G8270) (final 
concentration of 25mM) to energise the bacteria and activate efflux. Fluorescence was 
measured every minute for 60 minutes in a FLUOstar Optima microplate reader. An 
excitation wavelength of 545-10nm with a 600-10nm emission filter were used. The 
gain was adjusted to 1460. 
 
2.8 Transcriptomic analysis 
2.8.1 RNA extraction  
A total of six overnight cultures of each test strain were prepared by inoculating 5 mL 
of MOPS or LB broth with a single colony of the respective strain. Each colony 
represented a biological replicate. Overnight cultures (4% for MOPS or 0.1% for LB) 
were used to inoculate 10mL of fresh, prewarmed media. Cultures were incubated at 
37 °C, shaking at 200 rpm, in a shaking incubator until an OD600 of 0.6 was reached 
in MOPS, or for 10 hours when RNA was extracted from stationary phase cultures 
(LB).  
Aliquots of 2 mL of each culture were quenched by snap-freezing in liquid nitrogen or 
by pipetting a 2:5 proportion into a 95% ethanol:5% phenol mixture. For snap-freezing, 
cultures were aliquoted into a 2mL microcentrifuge tube (Thermo Scientific, UK, cat. 
no. 69720) and centrifuged for one minute at 13,000Xg at 4°C. Supernatants were 
removed and pellets were transferred into liquid nitrogen. Cultures quenched with 
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phenol:ethanol were incubated on ice for 30 minutes, followed by centrifugation at 
3,500Xg for 10 minutes to pellet bacteria and remove the quenching solution. 
Quenched cultures were immediately stored at -80°C until use.  
For cultures grown in MOPS to an OD600 of 0.6, RNA was extracted from samples 
quenched by snap-freezing. The SV Total RNA kit (PROMEGA, UK, cat. no. Z3100) 
was used. Bacterial pellets were resuspended in 200L of Ambion® TE buffer 
(Invitrogen, UK, AM9849) with 50g/mL of lysozyme (Sigma, USA, cat. no. L6876). 
Resuspended pellets were incubated in a heat block at 25°C for 5 minutes to lyse 
bacteria.  
Extraction of good quality RNA from stationary phase cultures grown in LB was carried 
out using the RNeasy mini kit (QIAGEN, Germany, cat. no. 74104) due to 
complications obtaining good quality RNA with other kits. RNA was quenched and 
extracted as described by Kröger et al. (2013).   
The concentration of RNA and DNA in the samples was assessed using the Qubit™ 
High Sensitivity RNA and dsDNA kits (Invitrogen, UK, cat. no. Q32852 and Q32854), 
respectively. Working solutions and standards were prepared as described in section 
2.6 for the protein samples. A minimum of two consecutive DNase treatments with the 
TURBO DNA-free™ kit (Invitrogen, UK, cat. no. AM2238) were carried out to remove 
residual DNA. Concentration of DNA in samples was monitored after each DNase 
treatment until the concentration of DNA did not decrease further. To confirm that DNA 
was successfully removed, a PCR was carried out using primers 938 and 939 (Table 
2.6) for S. Typhimurium samples or primers 2432 and 2433 for E. coli samples. 
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2.8.2 RNA quality assessment 
The quality of the extracted RNA was assessed using a NanoDrop spectrophotometer 
(Thermo Scientific, UK). This provides an indication of the purity of the RNA by 
measuring absorbance of RNA at 260 nm, proteins at 280 nm and of any chemical 
contaminants such as carbohydrates and phenol at 230 nm. The 260/280 ratio 
indicates contamination by proteins; whereas the 260/230 ratio provides an indication 
of chemical contamination. A value ≥1.8 for both ratios indicates that the RNA is pure.  
A preliminary test to assess the integrity of the extracted RNA, samples were 
electrophoresed in a 1% agarose gel to visualise the 16S and 23S rRNA bands. 
Smearing of the bands was used as an indication of RNA degradation. RNA integrity 
was further assessed using the Agilent 2100 Bioanalyzer (Agilent Genomics, USA), a 
microfluidics system that provided a chromatogram of the RNA samples. The Agilent 
RNA 6000 Nano kit (Agilent Genomics, USA, cat. no. 5067-1511) was used. The kit 
provides a gel and a fluorescent dye that allows to quantify and determine the integrity 
of the RNA. Gel, dye and marker were prepared and loaded according to the 
manufacturer’s instructions. Twelve samples were loaded on to each RNA Nano chip. 
The Bioanalyzer provides a 16S/23S ratio based on the size of the 16S and 23S peaks. 
A ratio ≥1.0 indicates high RNA integrity. The system also calculates an RNA Integrity 
Number (RIN) using a built-in algorithm. A RIN ≥7.0 and a flat baseline are 
indicative of high RNA integrity. In S. Typhimurium, the 16S/23S ratio and RIN were 
disregarded and a flat baseline was used as the only indication of non-degraded RNA. 
This is due to the system being unable to properly recognise S. Typhimurium SL1344 
rRNA peaks due to multiple rRNA peaks, thus providing inaccurate 16S/23S ratios 
and RINs (Bhagwat et al., 2013).  
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2.8.3 RNA-sequencing (RNA-seq) library assembly 
Good quality RNA samples were sent to the Beijing Genomics Institute (BGI, Hong 
Kong) for library construction and quantification of total RNA.   
rRNA depletion, RNA fragmentation and cDNA synthesis were carried out by BGI 
according to their standard operation procedures. An aliquot of 1g of each RNA 
sample was used. Library construction was validated by measuring the average length 
of cDNA in the constructed library in an Agilent 2100 Bioanalyzer, using the Agilent 
DNA 1000 kit (Agilent Technologies, USA, cat. no. 5067-1504). Quantification of cDNA 
by real-time quantitative PCR (qPCR) was also carried out with a TaqMan Probe 
according to BGI standard procedures. 
Finally, libraries that passed validation were pair-end sequenced in an Illumina HiSeq 
4000 System by BGI. 
 
2.8.4 Bioinformatics to determine differential gene transcription between 
wild-type and mutants 
Analysis of the RNA-seq data for the wild-type strains and their AcrB D408A mutants 
was carried out in collaboration with Dr. Alasdair Ivens (The University of Edinburgh, 
UK). Quality of the raw RNA-seq data was analysed by FASTQC. Cutadapt software 
version 1.9 was used to remove poly-A tails. Bowtie2 was used to map trimmed 
sequences on to reference genomes. Accession numbers of genomes used were 
F1312003.1, HE654724, HE654725 and HE654726 for S. Typhimurium SL1344 and 
its three plasmids. For E. coli MG1655, the reference genome used was U00096.3. All 
references were downloaded from the European Nucleotide Archive (ENA) at the 
European Bioinformatics Institute (EBI). Data normalisation was carried out by scale-
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normalising all datasets to the one with the lowest number of mapped reads (counts), 
counts per gene were converted to log2 and quantile normalised to make datasets 
comparable. Gene transcription comparisons were carried out using normalised data 
with the Bioconductor limma package. The limma package integrates linear modelling 
and a variety of statistical principles, including the empirical Bayes method, to assess 
differential gene expression between two RNA-seq datasets (Ritchie et al., 2015).  
At Birmingham, differentially transcribed genes per species were classified into 
functional groups using the Clusters of Orthologous Groups (COG) database. COG 
functional annotations were downloaded from the MicroScope Microbial Genome 
Annotation and Analysis Platform 
(http://www.genoscope.cns.fr/agc/microscope/home/index.php).   
 
2.8.5 Validation of RNA-seq data 
Significant changes in transcription were validated by quantitative real-time PCR (qRT-
PCR) and GFP transcriptional fusion reporters. 
2.8.5.1 cDNA synthesis  
For experiments carried out with exponential phase cultures (OD600 of 0.6), cDNA was 
synthesised using the SuperScript™ II Reverse Transcriptase. A mixture of 1g of 
RNA, 50ng of random hexamers (Thermo Scientific, UK, cat. no. S0142) and 10mM 
of a dNTP mix (Invitrogen, UK, cat. no. 10297-018) was prepared. The RNA mixture 
was heated at 65C for 5 minutes to allow alignment of random hexamers to RNA, 
followed by 5 minutes incubation on ice. First strand buffer (4L), 2L of DTT 
(dithiothreitol) and 1L of RiboLock RNase inhibitor (Thermo Scientific, UK, EO0381) 
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were added to the RNA mix. The reaction mix was incubated for 2 minutes at 23C 
before adding 1L of reverse transcriptase. The final reaction mixture (20L) was 
incubated at 42C for 50 minutes, then 70C for 15 minutes. 
For experiments carried out with stationary phase cultures, cDNA was synthesised 
with SuperScript™ IV Reverse Transcriptase (Invitrogen, UK, cat. no. 18090010). This 
enzyme was used instead of SuperScript™ II due to its higher sensitivity. The amount 
of RNA available in stationary phase cultures was considerably lower than in 
exponential phase cultures; therefore, a highly sensitive reverse transcriptase was 
required to obtain cDNA from all transcripts. This was not necessary for RNA-seq as 
an enrichment step was used.  
The RNA mixture was prepared by adding 1g of RNA to 50M of random hexamers 
and 10mM of a dNTP mix. The RNA mixture was heated at 65C for 5 minutes and 
incubated on ice for 5 minutes. Next, 4L of the 5X SSIV buffer was added alongside 
1L of DTT, 1L of RNase inhibitor and 1L of reverse transcriptase. The reaction 
mixture was incubated at 23C for 10 minutes, followed by 10 minutes at 52.5C and 
10 minutes at 80C to inactivate the enzyme. 
Synthesis of cDNA was confirmed by using 1L of cDNA as template for a PCR with 
primers 2406 and 2407 (Table 2.6) for S. Typhimurium samples or primers 2432 and 
2433 for E. coli samples. Aliquots of 5L of cDNA were prepared and frozen at -20C 
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2.8.5.2 Quantitative real-time reverse transcription PCR (qRT-PCR) 
The normalised expression (CT) method was used to determine transcription levels 
by qRT-PCR (Pfaffl, 2001). This method calculates transcription levels of a gene of 
interest by normalising against the number of transcripts of one or more housekeeping 
genes. To decrease chances of erroneous normalisation, two housekeeping genes 
were used in all qRT-PCRs. Housekeeping genes were chosen from a list of previously 
validated genes (Rocha et al., 2015), based on the differential gene transcription 
profile obtained from the RNA-seq data. For cDNA obtained from mid-logarithmic S. 
Typhimurium cultures and stationary phase E. coli cultures, gyrB and 16S rRNA were 
used as housekeeping genes. For stationary phase cultures of S. Typhimurium, rpoD 
and rho were used. 
qRT-PCR reactions were prepared with iQTM SYBR Green Supermix (BIO-RAD, 
Singapore, cat. no. 170-8882). cDNA (1L) was mixed with 12.5L of supermix, 
500nM of each primer and 9.5L of nuclease-free water to make a 25L reaction. 
Reactions were prepared in a 96-well plate (Starlabs, USA, E1403-0209), covered 
with a sealing film (Starlabs, USA, cat. no. E2796-9793) to avoid evaporation of the 
reaction mixture. qRT-PCRs were carried out in a CFX96 Real-Time thermocycler 
(Bio-rad, USA).  The transcription levels of genes of interest were measured using a 
minimum of three biological replicates with two technical replicates each, per strain. 
Data was analysed on the CFX manager software (Bio-Rad, USA).  
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Table 2.6 qRT-PCR primers used in this study. 
Primer number Primer Sequence (5’ to 3’) Target gene Organism 
324 16srRNA Fwd CCTCAGCACATTGACGTTAC 16S rRNA S. Typhimurium and E. coli 325 16srRNA Rev TTCCTCCA ATCTCTACGCA 
1992 gyrB STm RT Fwd  GTATCGGCGTGGAAGTAG gyrB S. Typhimurium 1993 gyrB  STm RT Rev  TGCGGAATGTTGTTGGTA 
1057 acrB STm RT Fwd GTCCTCAAGTAGCTTCCT acrB S. Typhimurium 1058 acrB STm RT Rev GTAATCCGAAATATCCTCCTG 
1059 acrF STm RT Fwd GTTCCTGTCGTGTTGCTA acrF S. Typhimurium 1060 acrF STm RT Rev CAAACATCGTCAGGGTATTG 
1055 acrD STm RT Fwd CCTTTGTCAAAGCCTCGATTATC acrD S. Typhimurium 1056 acrD STm RT Rev CAGGAACAGATACATCACCAG 
1053 rob STm RT Fwd AGTGCTTTATGGGCTTAATGAAA rob S. Typhimurium 1054 rob STm RT Rev AAGTATTCTATACCACCGCACT 
1672 acrR STm RT Fwd GTCGGATTTATTCAGTGA acrR S. Typhimurium 1673 acrR RT RT R CTCTTAATACAGATAGTGGAT 
2058 envR STm RT Fwd ATAATGGTATGATATCGGAACAG envR S. Typhimurium 2059 envR STm RT Rev TATGACATCCAGATCAAGACT 
934 marA STm RT Fwd CAACACTGACGCTATTACTA marA S. Typhimurium 935 marA STm RT Rev CAGGTGCCATTTGGAA 
938 ramA STm RT Fwd TGAATCAGCCGTTACG ramA S. Typhimurium 939 ramA STm RT Rev AGACTCTCCCCTTTGTA 
1792 emrA STm RT Fwd GCTACTTCTTACCTTGCTCTT emrA S. Typhimurium 1793 emrA STm RT Rev GCATCATCTGTCTCTTCAATATG 
956 livJ STm RT Fwd CAACGGCGGCAAAGTATA ilvJ S. Typhimurium 957 livJ STm RT Rev CGTACTGCTGCTTATCGT 
964 trpA STm RT Fwd CAGCCATTGTCAAGATTATCG trpA S. Typhimurium 965 trpA STm RT Rev CTGAGACAAAGGACCTGAG 
752 flgC STm RT Fwd CCGGAAAAGCTGGTTTATGA flgC S. Typhimurium 753 flgC STm RT Rev GCTGACATCGTGTTGACCAT 
2295 fliA STm RT Fwd ATACCAACAACAGCCAACT fliA S. Typhimurium 2296 fliA STm RT Rev ATCGCATCCATTACCCGC 
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924 glnP STm RT Fwd CCATCCGCCATGTTAT glnP S. Typhimurium 925 glnp STm RT Rev AACAATAAACAACGAGGT 
956 nirC STm RT Fwd TAACTGGCTGGTTTGTCT nirC S. Typhimurium 927 nirC STm RT Rev CACCACCAGATAGCAAGA 
2293 pipC STm RT Fwd ATTGATGATGGGATACAGGTT pipC S. Typhimurium 2294 pipC STm RT Rev GCAAAGTCAGGATGTCGT 
1761 rpoD STm RT Fwd CACTGTTGAACTGTTGAC rpoD S. Typhimurium 1762 rpoD STm RT Rev CATTGAACCTGGTTGATC 
2450 rho STm RT Fwd GGTTGAACACAAGAAAGACG rho S. Typhimurium 2451 rho STm RT Rev TCAATACTTTACCGGAAGCC 
2398 CsrB STm RT Fwd TTACAAGGAAAGGCTTCAGG CsrB sRNA S. Typhimurium 2399 CsrB STm RT Rev CCCGATGTGATAGCTTCTTC 
2400 fliC STm RT Fwd TGGCACAAGTAATCAACACT fliC S. Typhimurium 2401 fliC STm RT Rev GATACGCAGACCAGAAGAC 
2402 SL0699 STm RT Fwd TCACTACAGACATCGCCTTA SL0699 S. Typhimurium  2403 SL0699 STm RT Rev CCTGACAACAGTAATCCCAG 
2404 pduE STm RT Fwd TGAAATCTACAACGCCCTTC  pduE S. Typhimurium 2405 pduE STm RT Rev AATCTTTGCCTGATAACGGT  
2406 dnaB STm RT Fwd CTATCGACCTGATTACGCTC dnaB S. Typhimurium 2407 dnaB STm RT Rev CTTGGCGTGTTTTTAGACAG 
2408 pabC STm RT Fwd TTAAAACATCTGAACCGCCT pabC S. Typhimurium 2409 pabC STm RT Rev GTACGCCAGAACAAATTAGC 
2410 sseE STm RT Fwd TGGTGCAAGAAATAGAGCAA sseE S. Typhimurium 2411 sseE STm RT Rev ATAAACTGCTGCCCAAGTAA 
2412 pagC STm RT Fwd TGTTGAGCCTGAAGGTATTC pagC S. Typhimurium 2413 pagC STm RT Rev CAGCGCGTATAACGAAAAAT 
2414 siiD STm RT Fwd TCAGGGCGTTATCACTACTA siiD S. Typhimurium 2415 siiD STm RT Rev TATCACCCTCGGCTACATAA 
2416 nucD2 STm RT Fwd ATAAATGTGTGGTACAGCCG nucD2 S. Typhimurium 2417 nucD2 STm RT Rev ACCTTTGACATATACCCAGC 
2418 StyR44 STm RT Fwd GAAACACAGAACAACGAAAGT StyR-44 sRNA S. Typhimurium 2419 StyR44 STm RT Rev TAACCTCACAACCCGAAGAT 
2420 gyrB Eco RT Fwd ATGGACAAAGAAGGCTACAG gyrB E. coli 
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2421 gyrB Eco RT Rev TCACCTCAGAAGAAACCAGT 
2422 ibpB Eco RT Fwd TCAATGGATCGGTTTTGACA ibpB E. coli 2423 ibpB Eco RT Rev TAATGCGGTAGTGGTTATCG 
2424 paaA Eco RT Fwd GGCAGGAGTTTAACGAAGTA paaA E. coli 2425 paaA Eco RT Rev CTTACGGGCATGTTGTTTTT 
2426 nrdG Eco RT Fwd GTATCAAACGCCAGGGTATT nrdG E. coli 2427 nrdG Eco RT Rev AGTTCGTCGAGTTTATAGCC 
2428 hipB Eco RT Fwd AATTGGTATTAAGCAGGCGA hipB E. coli 2429 hipB Eco RT Rev GAGAGTTCAAGCGACTGTAA 
2430 patA Eco RT Fwd AATCGGCTATAACTTTGCCA patA E. coli 2431 patA Eco RT Rev TTCACACTGTTCAATGGTCA 
2432 dnaJ Eco RT Fwd GCTTATGAAGTTCTGACCGA dnaJ E. coli 2433 dnaJ Eco RT Rev CCGAAAACGTCACCAAAAAT 
2434 tisB Eco RT Fwd TCCTGAACCACAGGAGAC tisB E. coli 2435 tisB Eco RT Rev TATAAAAGGGGAGCGGTTTC 
2436 norV Eco RT Fwd GCATGATGACTTACCTGACA norV E. coli 2437 norV Eco RT Rev GTCTGATCCACTTCATCGTT 
2438 rcnB Eco RT Fwd TACAACATTAAGCAGTGGCA rcnB E. coli 2439 rcnB Eco RT Rev AAAAATCTCACCGTCGTAGG 
2440 yjiY Eco RT Fwd TCACTTCGGTATTCTGTTCG yjiY E. coli 2441 yjiY Eco RT Rev TTTTTCAGGAACGGGATGAA 
2442 gatD Eco RT Fwd ACCCTGTTTTACTTGTCCAG gatD E. coli 2443 gatD Eco RT Rev ATTCAGCAAATCCACCATCA 
2444 plsY Eco RT Fwd GTTACTGACCGTGCTATTGA plsY E. coli 2445 plsY Eco RT Rev GGAAGGTGAATTGTGGCTTA 
2446 eutQ Eco RT Fwd AACTCATCACAGCGAATGAT eutQ E. coli 2447 eutQ Eco RT Rev GGTAAAACCCAGTAGATCCG 
2448 lldP Eco RT Fwd TACCGTAACACTGTGGAGTA lldP E. coli 2449 lldP Eco RT Rev GCAACCAGTTTATCGAGGTA 
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2.8.6 GFP reporter assays 
To make the reporter plasmid containing an unstable GFP, the promoter of ramA or 
lexA was fused with gfp in a pMW82 plasmid backbone (Table 2.2). Plasmids were 
transformed into S. Typhimurium SL1344 and its AcrB D408A mutant by 
electroporation.  
ramA reporter assays were carried out as described previously (Lawler et al., 2013). 
In brief, strains carrying the reporter plasmid were grown to an OD600 of 0.6 in MOPS.  
Three technical replicates of 100L each were aliquoted into a clear-bottom, black, 
96-well plate (Greiner Bio-One, Germany, cat. no. 655090). Chlorpromazine (Sigma, 
USA, cat. no. C8138) at a final concentration of 25g/mL was used as positive control 
of ramA induction (Lawler et al., 2013). Wild-type and mutant strains harbouring a 
pMW82 empty vector were used as negative controls. The plate was loaded onto a 
FLUOstar Optima microplate reader (BMG Labtech, UK). Fold-changes in ramA 
induction were calculated at 1.5 hours, where maximum level of ramA induction was 
observed. 
lexA induction assays were carried out in the same way as the ramA assays. Nalidixic 
acid at a final concentration of 1.6g/mL was used as a positive control of lexA 
induction (Dowd et al., 2007). Additionally, fluorescence of the lexA reporter strains 
grown to an OD600 of 0.6 were measured in an Attune NxT Flow Cytometer 
(ThermoFisher Scientific, UK). Cultures were diluted 1:100 in filter-sterilised 1X PBS 
(Sigma, UK, cat. no. D8537). Bacteria were gated using the positive control. GFP 
fluorescence was measured in channel BL1 (excitation wavelength=448nm, emission 
filter=530/30nm). The fluorescence of the control samples was measured at 520V, 
whereas samples without nalidixic acid were measured at 700V (due to low levels of 
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basal induction of lexA). The GFP fluorescence of 20,000 events acquired in the 
‘bacteria’ gate was determined. The median fluorescence intensity per sample was 
used for statistical analysis. 
 
2.9 Preparation of conditioned media (exometabolome) 
To prepare cell-free culture supernatants or conditioned media, 10mL of LB, MOPS or 
EZ Rich Defined Medium (EZ) (TEKNOVA, USA, cat. no. M2105) was inoculated with 
three colonies of SL1344 or its AcrB D408A mutant. Overnight cultures were grown at 
37C under aeration and diluted to an OD600 of 1.5. The diluted culture (30L) was 
used to inoculate 30mL of the respective medium (1:1000 dilution). Cultures were 
grown for 17.5 hours at 37C, shaking at 200rpm. Bacteria were pelleted by 
centrifuging at 3,500Xg in a Hereaus Megafuge 40R for 25 minutes. Pellets were 
retained to check the purity of the culture by streaking onto LB and XLD agar plates. 
PCR of acrB and amplimer-sequencing were carried out to confirm the identity of the 
strains.  
Culture supernatant was filter-sterilised using a 0.22m pore, Stericup Filter Unit and 
aliquoted into 50mL centrifuge tubes (21mL per tube maximum) for storing up to a 
month or into 500mL freeze-drying glass vials for immediate use. Aliquots were frozen 
at -80C for a minimum of two hours and freeze-dried in a K4 Modulyo Freeze Dryer 
(Edwards, UK) for 24 hours or until all the water was removed. Freeze-dried 
conditioned media was resuspended in 1/3 of its original volume in UltraPure™ 
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2.9.1 Fractionation of conditioned media 
Conditioned medium (1X) produced from cultures grown in LB was incubated with 
Diaion HP-20 resin (SUPELCO, USA, cat. no. 13606). HP-20 is a polymeric resin 
formed of styrene chains interlinked with divinylbenzene. It is used to adsorb 
hydrophobic compounds.  
Fractionation with HP-20 was carried out as described by Jauffrais et al. (2012). 
Twenty-five grams of resin was used per litre of conditioned media. The resin was pre-
treated by washing three times with 50mL of HPLC-grade methanol (Fisher Scientific, 
UK, cat. no. A452-1) in a 250mL PVDF membrane, 0.22m pore, Stericup Filter Unit 
(Merck Millipore, UK, cat. no. SCGVU02RE). A final wash with sterile-distilled water 
was carried out to remove residual methanol. Pre-treated resin was added to the 
conditioned medium. Medium with resin was subsequently transferred into a 250mL 
sterile flask and incubated for 24 hours with constant shaking at 200rpm, at 37C, in a 
shaking incubator. After incubation, media and resin were transferred into a Büchner 
funnel covered with filter paper, attached to a Büchner flask. Media was filtered 
through the funnel under vacuum. Recovered media or hydrophilic fraction (HF) was 
frozen and freeze-dried as described in section 2.9. 
After elution of the hydrophilic fraction, the resin was washed three times with 50mL 
of acetone (Fisher Scientific, UK, cat. no. 10417440) (Act CM), followed by three 
washes with 50mL of methanol each (MeOH CM) and another three times with distilled 
water (H2O CM). Acetone and methanol fractions were transferred into a round bottom 
borosilicate flask and dried for 30 minutes in a rotary evaporator (Büchi, Switzerland) 
at 45°C, with a vacuum pressure of 150mmHg. Dry fractions were dissolved in 
dimethyl sulfoxide (DMSO) (Sigma, UK, cat. no. D4540) and used in infection assays 
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(section 2.10.2). The water fraction was freeze-dried and prepared as described in 
section 2.9. 
 
2.10 Tissue culture  
To study the interaction of S. Typhimurium with non-polarised and polarised intestinal 
epithelial cells, the cell lines used were INT-407 embryonic intestinal epithelial cells 
and Caco-2 colorectal epithelial cells. J774A.1 murine macrophages were used to 
study the interaction of S. Typhimurium with macrophages.   
All cell lines were routinely cultured in T75 tissue culture flasks (Falcon, USA, cat. no. 
353136). Cells were incubated at 37°C, with 5% CO2 in a Galaxy® 170S incubator 
(Eppendorf, Germany). INT-407 cells were grown in Eagle’s Minimum Essential 
Medium (EMEM) (Sigma, USA, cat. no. M2279); whereas, Caco-2 and J774A.1 cells 
were grown in Dulbecco’s Modified Eagle’s Medium (Sigma, USA, cat. no. M6546). All 
media were supplemented with 1% of non-essential amino acids (NEAA) (Sigma, 
USA, cat. no. M7145), 1% of L-glutamine (Sigma, USA, cat. no. G7513), 10% heat-
inactivated foetal bovine serum (Invitrogen, UK, cat. no. 10108-165) and 50µg/mL of 
gentamicin (Sigma, USA, cat. no. G1397).  
 
2.10.1 Trypan blue exclusion assays 
Trypan blue exclusion assays were routinely carried out to assess the viability of the 
eukaryotic cells. Trypan blue is a viability dye as it cannot traverse the membrane of 
healthy, intact cells. The dye can only penetrate cells with a damaged membrane. 
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Therefore, live cells will be colourless and damaged/dying cells will be stained blue 
(Strober, 2001).  
Monolayers were disrupted with trypsin, followed by inactivation of the enzyme by 
addition of fresh media. Trypsin was removed and cells were concentrated by 
centrifuging at 1,500Xg in a Hereaus Megafuge 40R, for 5 minutes at room 
temperature. When cells were recovered from 24-well plates, the pellet was 
resuspended in 200L of fresh, prewarmed media. When T75 flasks were used, the 
pellet was resuspended in 5 to 8mL of media, depending on the size of the pellet. An 
aliquot of 10L of resuspended cells were mixed with 1L of 0.4% trypan blue (Sigma, 
USA, cat. no. T8154) and immediately transferred into a Neubauer chamber for cell 
counting. All cells were counted in the central grid. Number of live and damaged cells 
per grid were recorded and concentration of live cells was calculated using the 
following formula: 
Cells mL⁄ =




2.10.2 Infection assays 
The ability of S. Typhimurium to colonise, invade and replicate inside the host cell is 
often studied using cell culture experiments. A common experiment is the gentamicin 
protection assay. Gentamicin cannot penetrate eukaryotic cells, killing only 
extracellular bacteria. Therefore, internalised bacteria are not exposed to the antibiotic 
and can be recovered by viable counting as an indication of the ability of a strain to 
invade (Lobo and Mandell, 1973, Dandekar et al., 2014). 
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Gentamicin protection assays were carried out as described previously (Buckley et al., 
2006, Blair et al., 2009). Association of S. Typhimurium to eukaryotic cells was 
measured at 2 hours post-infection and invasion was measured at 4 hours post-
infection. To prepare eukaryotic cells for the infection assays, two 24-well plates 
(Costar, USA, cat. no. 3524) per assay were seeded with 1.8X105 cells/mL of Caco-2 
or 2X105 cells/mL of INT-407 cells or J774A.1 cells. INT-407 and J774A.1 cells were 
incubated at 37°C, with 5% CO2 for 48 hours to allow formation of a confluent 
monolayer. Caco-2 cells were incubated for two weeks to allow polarisation of the 
epithelial cells; media was replaced with fresh media every 48 hours.  
Confluent monolayers were washed with pre-warmed Hank’s Balanced Salt Solution 
(HBSS) (Gibco, UK, cat. no. 24020-091) three times before proceeding to infect with 
1mL of a wild-type or mutant S. Typhimurium suspension adjusted to a final 
concentration of 7.6X107 CFU/mL. Where conditioned media was required, 3X 
concentrated media was added to the wells in a 1:2 proportion. One plate was used 
to assess the ability of S. Typhimurium to associate to eukaryotic cells, whilst the other 
one was be used to determine the ability to invade. 
To prepare the bacterial suspension, a 10mL overnight culture of S. Typhimurium, 
grown in LB was washed twice in 10mL of sterile DPBS, by centrifuging at 2,800Xg 
for 10 minutes in a Hereaus Megafuge 40R. Bacteria were resuspended in 8mL of 
sterile DPBS and OD540 of the washed culture diluted 1:10 in DPBS was recorded. 
The OD540 value was multiplied by a factor of 1.4 to obtain an estimate of the CFU/mL, 




× 1.4 = CFU × 109 per mL 
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At 2 hours post-infection, wells were washed three times with pre-warmed HBSS. 
EMEM or DMEM (2mL) with 100µg/mL of gentamicin was added to the ‘invasion’ plate 
and incubated for another 2 hours. The ‘association’ plate was processed by adding 
500µL of 1% Triton X-100 (Sigma, USA, cat. no. T8787) and one magnetic stirrer per 
well. To release the bacteria from eukaryotic cells, monolayers were mechanically 
disrupted on a magnetic stirring plate for 10 minutes. Serial dilutions from 1:10 to 1:105 
were carried out by adding 20µL of the Triton-treated bacteria suspension to 180µL of 
sterile 1X PBS. To determine viable counts, a modified version of the Miles and Misra 
method (Miles et al., 1938) was used, in which 20µL of each dilution was plated in 
triplicate onto LB agar plates. 
At 4 hours post-infection, media with gentamicin was removed from the ‘invasion’ 
plate. The plate was washed three times with pre-warmed HBSS to remove residual 
gentamicin and the same procedure as above was carried out to release bacteria from 
cells and do viable counting. 
 All agar plates were incubated for 24 hours at 37°C. Colonies were counted and 
reported as CFU/well. The formula used to calculate CFU/well was: 







Where the aliquot is 0.02mL (20L) and the dilution is presented as 0.0001 for a 1:104 
dilution for example. 
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2.11 Murine infection assays 
Mouse infection assays were carried out by Dr. Barbara Chirullo from the Istituto 
Superiore di Sanità (Italy). Six groups of 6-8 week old female BALB/c mice with five 
mice each were used. Three groups were used for oral inoculation and three for 
intraperitoneal (IP) inoculation. Each group were inoculated with an overnight culture 
of S. Typhimurium SL1344 wild-type or AcrB D408A mutant diluted in sterile PBS. A 
control group was inoculated with sterile PBS. 
Inocula were prepared from overnight cultures incubated at 37°C under aeration. 
Cultures were washed in sterile PBS by centrifuging at 2,800Xg for 10 minutes. For 
oral infection, a 200L suspension containing 5X107 CFU was administered 
intragastrically to the mice (Kingsley et al., 2003). For intraperitoneal infection, a 200L 
suspension containing 3.3X107 CFU was injected into the peritoneum of the mice (Gil-
Cruz et al., 2009). Mice were constantly monitored for four days and spleen and liver 
were recovered on the fifth day post-infection to determine the bacterial load by viable 
counting. Organs were harvested under aseptic conditions, weighed and disrupted to 
determine the total number of CFU per mg of organ. 
The research protocol, approved by the Service for Biotechnology and Animal Welfare 
of the Istituto Superiore di Sanità and authorized by the Italian Ministry of Health, 
adhered to the guidelines contained in Italian Legislative Decree 116/92, based on 
European Directive 86/609/EEC on Laboratory Animal Protection (decree numbers 
84/12.B and 255/2012.B). 
 
- 89 - 
 
2.12 Determination of changes in bacterial replication dynamics 
Plasmid pDiGi (Table 2.2) was transformed into SL1344 and its AcrB D408A mutant 
by electroporation. Strains were grown on LB agar with 50g/mL of carbenicillin to 
maintain the plasmid.  
Bacteria harbouring the plasmid were grown in MgMES minimal medium pH 5 
(Appendix I) at 37C. This medium simulates the conditions that Salmonella encounter 
inside the Salmonella containing vacuole and is ideal for expression of DsRed (Helaine 
et al., 2010). Gates for bacteria, GFP and DsRed were set up using an overnight 
culture of SL1344 grown in MgMES supplemented with the appropriate inducers. In 
bacteria carrying pDiGi, expression of DsRed and GFP was induced with 0.2% 
arabinose and 0.5mM of IPTG (Sigma, USA, cat. no. I5502), respectively. 
Compensation was manually adjusted to avoid false detection of GFP or DsRed due 
to overlap of the emission spectra of the two fluorescent proteins.  
This assay relies on both strains having the same growth rates; therefore, growth 
kinetics, as described in section 2.1.1, with SL1344 and the AcrB D408A mutant were 
carried out in MgMES pH 5.0 supplemented with 0.2% glucose or arabinose.  
 To determine the number of potential persister cells, bacteria carrying pDiGi were 
grown overnight in MgMES with 0.2% arabinose, under aeration at 37C, to induce 
expression of DsRed. A 1% inoculum was added to 10mL of prewarmed MgMES 
containing 0.2% glucose and 0.5mM IPTG. Cultures were incubated in a shaking 
incubator at 37C, at 200rpm. Samples of 10L were taken every 2 hours and diluted 
1:100 in 1X PBS. Diluted samples were vortexed briefly and loaded on to an Attune 
NxT Flow Cytometer. GFP fluorescence was measured in channel BL1 (excitation 
wavelength=448nm, emission filter=530/30nm) at 440V; whereas, DsRed 
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fluorescence was measured in channel YL1 (excitation wavelength=561nm, emission 
filter= 585/16nm) at 600V. The total number of bacteria expressing DsRed was 
obtained by counting the number of bacteria in the DsRed gate (+/-) and expressing 
DsRed and GFP (+/+). The total number of bacteria expressing GFP was measured 
in the GFP gate (-/+) (Appendix V). A total of 30,000 gated events were acquired due 
to the sensitivity of the assay. 
 
2.13 Quantification of autoinducer-2 (AI-2)  
Cell-free culture supernatants from S. Typhimurium SL1344 and its AcrB D408A 
mutant grown in LB broth, LB supplemented with 0.5% glucose, MOPS and 
autoinducer bioassay (AB) medium (Appendix I) were used. Supernatants were 
harvested from cultures grown to an OD600 of 0.1, 0.3, 0.6 and 1.0 as described in 
section 2.9. Culture supernatant from overnight cultures was also harvested. Syringe 
filters (Starlabs, UK, cat. no. E4780-1226) and 10mL syringes (Becton Dickinson, 
Spain, cat. no. 302188) were used to filter-sterilise culture supernatants. Supernatants 
were stored at -20°C until use. 
For the AI-2 quantification assay, an overnight culture of Vibrio harveyi BB170 AI-2 
reporter strain was grown in AB medium at 30°C, shaking at 200rpm (Surette and 
Bassler, 1998). V. harveyi is a bioluminescent marine bacterium that luminesces in 
presence of autoinducers (Greenberg et al., 1979, Bassler et al., 1997). Strain BB170 
has a transposon insertion that interrupts luxN, which encodes the sensor of 
autoinducer-1; therefore, this strain can only respond to AI-2.  
An overnight culture of V. harveyi BB170 was diluted 1:5000 in AB medium and 
aliquoted (90L) into each well of a clear bottom, black, 96-well plate. Culture 
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supernatants of S. Typhimurium (10L) were added to the diluted reporter strain. 
Culture supernatants from V. harveyi TL25, TL26 and BB170 were used as positive 
control, negative control and blank, respectively. The plate was loaded on to a 
FLUOstar OMEGA plate reader (BMG Labtech, UK). Luminescence and OD600 were 
measured every 10 minutes for 18 hours. Luminescence was divided by OD600 to 
obtain relative luminescence units (RLU).  
 
2.14 Motility assays 
The inoculum for motility assays was prepared by diluting an overnight culture of the 
test strains to an OD600 of 0.5 in LB broth or MOPS minimal medium. This culture was 
used to inoculate LB and MOPS plates containing 0.3% or 0.5% of Difco® Bacto agar 
(Becton Dickinson, USA, cat. no. 214530) to study swimming or swarming, 
respectively (Li et al., 2014).  Plates with 0.3% of agar (swimming plates) were 
inoculated using a straight loop and stabbing the inoculum into the agar, while plates 
with 0.5% of agar (swarming plates) were inoculated by spotting 5µL of the inoculum 
on the surface of the agar (Li et al., 2014). 
Plates were incubated at 37°C facing up. The best incubation time to obtain an halo 
of motility that was measurable and did not occupy the whole surface of the agar was 
determined. In LB, swimming plates were read after 7 hours of incubation, whereas 
swarming plates were read at 12 hours. In MOPS, swimming plates were read after 
24 hours and swarming plates were discarded after 7 days as S. Typhimurium did not 
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2.15 Curli production in congo red agar 
Expression of curli proteins was visualised on Congo red agar (Baugh, 2014). Congo 
red dye (Sigma, USA, cat. no. C6277) was added to a final concentration of 40g/mL 
in 25mL of LB or MOPS agar. Plates were inoculated with an overnight culture of the 
respective test strain, grown in the appropriate medium (LB or MOPS depending on 
the agar used), adjusted to an OD600 of 0.1. An aliquot of 5L was spotted on top of 
the agar plates. 
Plates were incubated for 48 hours at 30 or 37°C and colonies were visualised in a 
stereoscopic microscope (Nikon, Japan, model no. C-DSS230). Photos were taken 
with a camera control unit (Nikon, Japan, model no. DS-L2). Strains producing curli 
gave red, dry and rough colonies; whereas colonies from non-producers had a pink 
and smooth phenotype (Baugh, 2014).  
 
2.16 Metabolomics 
2.16.1 Preparation of exometabolome (ExM or conditioned media) 
ExM was prepared in the same way as described in section 2.9. Ten overnight cultures 
from single colonies were prepared and used to inoculate one universal tube 
containing 10mL of fresh, prewarmed LB broth each. Cultures were incubated for 17.5 
hours at 37C, shaking at 200rpm. A control sample, which contained sterile LB broth, 
was also prepared. Cell-free culture supernatants were obtained by filter-sterilising 
through a 0.22m pore, PVDF membrane syringe filter (Starlabs, UK, cat. no. E4780-
1221), using a 20mL syringe (Becton Dickinson, Spain, cat. no. 300613). Aliquots of 
1mL were stored at -80°C, in 1.5mL microcentrifuge tubes (Eppendorf, Germany, cat. 
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no. 0030125.150). The remaining culture supernatant was freeze-dried and used in 
infection assays to test for biological activity. 
 
2.16.2 Analysis of the composition of the ExM 
Frozen ExM were delivered to Dr. Warwick Dunn (Phenome Centre Birmingham, UK) 
for analysis by UHPLC-MS (ultra-high performance liquid chromatography-mass 
spectrometry) as described previously (Winder et al., 2008). In brief, ExM samples 
were diluted in 2/3 of methanol and processed in an UltiMate™ 3000 RSLCnano 
UHPLC system coupled to a Q Exactive™ Focus Mass Spectrometer (Thermo 
Scientific, UK). Metabolites in samples were separated via a HILIC column to analyse 
polar metabolites, or a C18 reversed phase column to analyse lipids and other non-
polar metabolites. Assays were carried out in positive and negative modes to 
maximise metabolite detection.   
Data was processed on the XCMS platform, using univariate data analysis approaches 
to identify metabolites that were in a higher concentration in the wild-type ExM when 
compared against the mutant ExM and the sterile LB broth control. Detected features 
were given putative identities. Where more than one putative identity was given, 
literature research was carried out to determine which metabolite was most likely to 
be synthesised by the strain from which the ExM had been obtained. Pathways and 
processes in which the identified metabolite participated were identified in the KEGG 
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2.17 Determination of metabolic constraints in the S. Typhimurim SL1344 
AcrB D408A mutant using the Metabolic Transformation Algorithm 
(MTA)  
MTA is a mathematical model that identifies genes that are essential for the 
maintenance of the metabolic state of a wild-type strain compared to a mutant and 
vice versa (Yizhak et al., 2013). The aim of using this model was to define metabolic 
constraints that could account for the loss of virulence in the S. Typhimurium SL1344 
AcrB D408A mutant. The analysis was done by Dr. Daniel D. Dwyer and Sean Mack 
(The University of Maryland, USA) using RNA-seq data generated in this project as an 
input. Differential gene transcription data was run through an integrative metabolic 
analysis tool (iMAT), which maps genes to reactions or pathways and predicts the rate 
at which metabolites go through them (flux). Next, pathways or reactions in which 
fluxes are significantly changed were identified and reactions were classified into 
‘changed’ and ‘unchanged’ groups.  The MTA was applied to identify perturbations 
that could push the flux of reactions from the changed group to the target 
state, without affecting the flux of the unchanged reactions. This produced a list of the 
best “transforming” deletion reactions, which were linked back to genes in specific 
pathways. The effect of each individual gene-deletion on the metabolic network 
was modelled. The simulation assigned a transformation score to each gene with 
which the knockout was ranked. Genes with the highest scores are the most likely to 
generate a flux change in the right direction (wild-type to mutant metabolic state or 
mutant to wild-type state) when deleted. 
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2.18 Statistical analyses 
All experiments were repeated at least three times. When curves such as growth 
kinetic curves were required, the mean of all experiments was plotted. GraphPad 
Prism version 7 (GraphPad Software, USA) was used for data analyses and 
construction of plots. A Student’s t-test with Welch’s correction was used for statistical 
analysis for all experiments unless specified otherwise. An unpaired Student’s t-test 
was used to compare means of two independent groups, where data is normally 
distributed and have equal variances. A Welch’s correction allowed comparison 
between datasets with unequal variances and was used to minimise false positives. 
For mouse infection experiments, a Mann-Whitney U test was used. This test is the 
equivalent to a Student’s t-test for non-parametric datasets. All analyses were 
performed on raw data even when plots have a logarithmic scale. 
For RNA-seq data analysis, Bayesian approaches integrated in the Bioconductor 
limma package were used (Ritchie et al., 2015). Bayesian statistics use probabilities 
to infer the chance of an event being significant or not, it accounts for differences in 
sampling sizes and provides a more stringent analysis when compared to Student’s t-
tests and ANOVAs. 
In metabolomics studies, a one-way analysis of variances (ANOVA) with Bonferroni 
correction was used. A one-way ANOVA allows comparison of means between 
multiple independent groups; it is used to analyse large datasets as doing multiple t-
tests increases the chance of Type 1 error that leads to false positives. A Bonferroni 
correction was applied to further reduce false discovery rates.  
A P<0.05 was considered statistically significant for all tests.  
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To validate that values obtained from infection assays were normally distributed and 
that a Student’s t-test was the best statistical test to use, all wild-type and mutant 
invasion data were tested for normality using the D'Agostino-Pearson omnibus test. 
This test determines the symmetry and shape of data distribution and compares it 
against a Gaussian distribution. It produces a P-value, where the null hypothesis is 
that all values belong to a Gaussian distribution; therefore, a P>0.05 indicates a normal 
distribution. 
 







CHAPTER 3.  
Construction and characterisation of a loss of 
AcrB efflux function mutant 
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3.1 Background 
AcrAB-TolC is formed of three proteins: AcrB, the transporter; TolC, the outer 
membrane protein and AcrA, the periplasmic adapter protein that binds AcrB to TolC 
(Seeger et al., 2008, Symmons et al., 2009).  Deletion of Salmonella Typhimurium 
acrB increases susceptibility of the strain to antibiotics (Eaves et al., 2004, Buckley et 
al., 2006) and causes physiological changes such as decreased motility and 
attenuation of virulence (Buckley et al., 2006, Webber et al., 2009). Deletion of acrB 
has also been associated with increased transcription of homologous RND pumps 
acrD and acrF in S. Typhimurium (Blair et al., 2015b). However, AcrB is a 114 kDa 
transmembrane protein, the deletion of which might produce pleiotropic phenotypes 
unrelated to loss of efflux function. To differentiate between the effects of loss of AcrB 
protein from loss of efflux function, a mutant that expresses an inactive form of AcrB 
is required. 
AcrB functions as a drug-proton antiporter, where the proton motive force (PMF) is 
generated by translocation of protons within the protein. The PMF is used by AcrB to 
undergo the conformational changes required to transport drugs. Five amino acids are 
essential for proton translocation in Escherichia coli AcrB: D407, D408, K940, R971 
and T978 (Su et al., 2006, Yao et al., 2010). Substitution of either of these amino acids 
with a non-charged amino acid, such as alanine, produced multidrug hyper-
susceptibility in Escherichia coli (Takatsuka and Nikaido, 2006, Seeger et al., 2009). 
Of these five amino acids, D407 and D408 are the most conserved amongst different 
bacterial species (Guan and Nakae, 2001, Hou et al., 2010).   
Due to the high sequence similarity between AcrB in E. coli and S. enterica and since 
a mutation in either of the proton translocation residues was predicted to produce the 
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same phenotype, D408 was chosen to be mutated in AcrB of S. Typhimurium SL1344 
to generate an AcrB mutant suitable for physiological studies.  
The majority of structural studies of AcrB have been carried out using the E. coli K-12 
protein. For comparative purposes, E. coli K-12 MG1655 AcrB D408A and acrB 
mutants were constructed. 
 
3.2 Aims 
 To construct a loss-of-efflux-function AcrB chromosomal mutant of Salmonella 
Typhimurium SL1344 and Escherichia coli MG1655, by substituting the aspartate 
(D) at position 408 for an alanine (A).  
 To characterise the phenotype of the constructed AcrB D408A mutants. 
 
3.3 Hypothesis 
 The D408A substitution in AcrB confers loss of efflux function in E. coli and S. 
Typhimurium. 
 
3.4 Construction of the S. Typhimurium SL1344 chromosomal AcrB 
D408A mutant 
The AcrB D408A chromosomal mutant was constructed using the method described 
by Kim et al. (2014). This method relies on pSLTS, a low copy number plasmid which 
encodes the -Red recombinase system and the I-SceI meganuclease under the 
control of an arabinose-inducible promoter and the tetA tetracycline-inducible 
promoter, respectively. Some modifications were made to the method as pSLTS did 
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not work and none of the enzymes could be induced, these modifications are 
explained in the following sections. 
 
3.4.1 Construction of the mutation cassette 
Two approaches were tested for constructing the mutation cassette. The first approach 
was to ligate the selection cassette to the homologous recombination fragments 
(HRF). The selection cassette and HRF were digested with PciI and EcoO109I. The 
assembly of the fragments was attempted using a T4 DNA ligase. However, this 
approach did not work. 
The second approach was to construct the mutation cassette using a commercial 
Gibson assembly master mix as described by Kim et al. (2014). The Gibson assembly 
master mix is a mixture of exonuclease, DNA polymerase and DNA ligase optimised 
to work at 50 C in a single reaction. The exonuclease generates 3’-end sticky ends 
on all the fragments; the polymerase fills in the gaps and the ligase seals the nicks to 
generate the assembled construct (Gibson et al., 2009). The commercial master mix 
requires between 20 to 50 bp of homology between the fragments to be assembled, 
so new primers were designed to add 20 bp of homology to the HRF.  
The mutation cassette was assembled successfully at the first attempt. However, there 
was residual selection cassette after the assembly; this required an extra gel-
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Ligation and Gibson assembly products were electrophoresed on a 1% agarose gel. The 
mutation cassette was assembled with Gibson assembly master mix as ligation did not work; 
however, there was residual selection cassette.  
Mutation cassette (1.5kb)
Residual selection cassette (1.2kb)
Lane Sample
1 Bioline 1kb ladder
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3.4.2 Insertion of the mutation cassette into the chromosome of S. 
Typhimurium SL1344 
For the insertion of the mutation cassette into the chromosome, two approaches were 
tested. The first approach was to use pSLTS as described by Kim et al. (2014) (Figure 
3.2). However, this approach did not work since the recombinase could not be induced 
from pSLTS. This was shown by the absence of recombination in the positive control 
experiment with ramA::aph carried out in the same way as the insertion of the mutation 
cassette. The ramA::aph gene-disruption is a 1kb fragment that is easily introduced 
into the chromosome (Bailey et al., 2010). 
As the recombinase could not be induced from pSLTS in S. Typhimurium SL1344, the 
plasmid was substituted with pSim18 for the recombination process. pSim18 is a low 
copy number plasmid with a temperature-sensitive origin of replication, which has 
been used previously as a -Red helper plasmid in S. Typhimurium SL1344 (Baugh, 
2014). This plasmid encodes -Red proteins under the control of the pL inducer (Lee 
et al., 2009b). pL is a transcription factor repressed by CI857; the repressor protein is 
inactivated at 42°C allowing the expression of the pL operon. The temperature-
sensitive origin of replication stops the plasmid from being transferred vertically at 
temperatures higher than 30°C, thus ‘curing’ the plasmid from the bacterial cell without 
any further procedures. The plasmid also encodes hygromycin resistance to facilitate 
monitoring the insertion and loss of the plasmid. 
The insertion of the mutation cassette was successful using pSim18, resulting in 72 
recombinant colonies at the first attempt. The recombinant strain was also successfully 
‘cured’ from the plasmid after growing at 37°C, as demonstrated by the absence of 
growth on LB agar plates supplemented with 100g/mL of hygromicin.  
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Figure 3.2 Diagram of the method used for genome editing.  
 
From Kim et al., 2014. To edit the genome of S. Typhimurium, pSLTS was replaced with 
pSim18 for the insertion of the mutation cassette and pACBSCE for the induction of I-SceI. 
For E. coli, the procedure was followed as shown here. 
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3.4.3 Deletion of selection marker 
pSLTS was initially used to delete the selection marker from the genome of the 
recombinants. However, no mutants were selected in three attempts; therefore, 
pACBSCE was used instead. pACBSCE was engineered by Lee et al. (2009a) to 
include the I-SceI restriction site and express the I-SceI meganuclease under the 
control of an arabinose-inducible promoter. This allows the plasmid to be ‘cured’ once 
the restriction enzyme is induced, without further procedures. pACBSCE confers 
chloramphenicol resistance to the transformants to facilitate monitoring the insertion 
and loss of the plasmid. 
I-SceI uses negative selection, thus colonies were replica plated onto LB agar and LB 
agar supplemented with 50g/mL of kanamycin; only those colonies that grew in LB 
alone were selected as candidates. Fifty-two colonies were screened from a 1:108 
dilution of bacterial cells, of which four colonies did not grow in LB supplemented with 
kanamycin. The loss of the selection marker was confirmed in these by PCR (Figure 
3.3). 
 
3.5 Construction of the E. coli MG1655 chromosomal AcrB D408A mutant 
3.5.1 Construction of the mutation cassette 
The mutation cassette was constructed using Gibson assembly as described in 
section 3.4.1. A difficulty encountered with the E. coli acrB mutation cassette was that 
the two HFR fragments assembled to each other. Therefore, a two-step approach was 
used to facilitate the assembly of the cassette. First, the selection cassette was 
assembled with either the 5’-HRF or the 3’-HRF. This initial assembly was PCR-
amplified and sequenced before proceeding to do a second assembly to attach the 
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remaining HFR (Figure 3.4). The assembled mutation cassette was gel purified, 
amplified by PCR and sequenced to confirm its correct assembly. 
 
3.5.2 Insertion of the mutation cassette into the chromosome of E. coli 
MG1655 
The initial strategy was to use the same helper plasmids as in the construction of the 
S. Typhimurium SL1344 AcrB D408A mutant. An acrB::aph cassette was used as 
positive control for recombination. Recombination using the pSIM18 -Red helper 
plasmid was tested; however, no recombinants were obtained after multiple attempts. 
Therefore, an alternative -Red helper plasmid was sought after. 
Kim et al. (2014) reported that pSLTS worked in E. coli MG1655. Surprisingly, despite 
pSLTS failing in S. Typhimurium, fourteen recombinant colonies were obtained on the 
first attempt, all of them had the mutation cassette inserted in the chromosome.  
 
3.5.3 Deletion of selection marker 
As pSLTS worked for the recombination step, the plasmid was kept for the expression 
of I-SceI. Expression of I-SceI was induced by plating 100L of an emulsion of a single 
colony in PBS on to agar plates containing 100ng/L of anhydrotetracycline 
(aTET100) and AMP50. Of five colonies tested, I-SceI was successfully induced in 
three, as shown by a significant decrease in the total number of bacteria that grew on 
aTET100 plates (fifty colonies per plate on average) when compared against the ‘lawn’ 
that grew when the emulsion was plated on to LB plates without aTET.  
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A fragment of acrB was amplified with primers 2151 and 2152. In the wild-type and AcrB 
D408A strain, a ~200bp amplimer was observed; whereas, in the acrB mutant harbouring the 
mutation cassette, a 1.5kb amplimer was observed. Due to the size of the amplimers, a 2% 
agarose gel was used. 
 
1 2 3 4 5
Lane Sample
1 Bioline 100bp ladder
2 Wild-type acrB fragment 
(~200bp)
3 acrB fragment when MC is 
inserted (~1.5kb)
4 Fragment of acrB in the AcrB 
D408A mutant (~200bp)





















- 107 - 
 
 




Assembly products were electrophoresed on a 1% agarose gel. An arrow indicates the 
assembled mutation cassette (~1.8kb). Each assembly was electrophoresed next to its 
preceding assembly for size comparison purposes. 
Lane Sample
1 Bioline 1kb ladder
2 Assembly of 5’-HFR-selection
cassette + 3’-HFR
3 5’-HFR-selection cassette 
assembly (~1.5kb)
4 Assembly of 3’-HFR-selection
cassette + 5’-HFR
5 3’-HFR-selection cassette 
assembly (~1.5kb)














1 2 3 4 5 6
Assembled mutation cassette ~1.8kb
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Ten colonies from each plate were selected for further characterisation. Of 30 colonies 
tested, 27 lost the selection cassette as shown by lack of growth on LB KAN50. Ten 
mutant candidates were restreaked on to LB agar and incubated 37C to ‘cure’ the 
plasmid. Two colonies from each plate were streaked on to LB AMP50 and LB and 
incubated at 30 and 37C, respectively. All 20 colonies were ‘cured’ from pSLTS as 
shown by lack of growth on AMP50 plates. 
 
3.6 Construction of the E. coli MG1655 acrB mutant 
For the construction of the E. coli acrB mutant, an aliquot of 100ng of an E. coli 
acrB::aph cassette was electroporated into wild-type MG1655 carrying pSLTS. Fifty 
mutant candidates were selected on LB KAN50 plates incubated overnight at 37C to 
‘cure’ pSLTS. Seven colonies were restreaked on to LB KAN50 and LB AMP50 to 
confirm loss of the helper plasmid. 
acrB was PCR-amplified from all seven candidates. The size of the wild-type amplimer 
was 3.6kb; when acrB was replaced with the aph gene, a 2kb amplimer was observed, 
indicating the successful construction of the acrB::aph mutant. One of the seven 
acrB::aph mutants was selected for further genome editing. 
The aph gene was deleted using the pCP20 plasmid, which encodes a flippase. 
pCP20 was introduced into the acrB::aph mutant by electroporation. Twenty L of 
plasmid yielded 20 colonies of acrB::aph with pCP20 on LB AMP50 plates. Six 
colonies were inoculated into LB broth and incubated overnight at 43C to induce 
expression of the flippase. A loopful of each overnight was streaked on to LB agar and 
incubated at 37C. A single colony from each plate was streaked on to LB AMP50 and 
 
- 109 - 
 
KAN50 to select for mutants that had ‘cured’ pCP20 and lost the aph genes, 
respectively. None of the mutant candidates grew on AMP50 or KAN50 indicating that 
pCP20 had been ‘cured’ and that the aph gene had been removed from the genome 
of the mutant. To confirm the later, acrB was amplified from each mutant. A 600bp 
amplimer was observed in each one of the six candidates, confirming the removal of 
the acrB gene from the chromosome of E. coli MG1655 (Figure 3.5). acrB mutants 
were confirmed to be E. coli by API-20E tests. 
 
3.7 Confirmation of correct insertion of mutation into the chromosome of 
S. Typhimurium SL1344 and E. coli MG1655 
3.7.1 Preliminary tests 
Several experiments were carried out to determine the correct insertion of the mutation 
into the chromosome of S. Typhimurium SL1344. Initial tests consisted of sequencing 
acrB and growth on xylose-lysine-deoxycholate (XLD) agar. XLD is a highly selective 
medium designed for isolation of Salmonella spp.and Shigella spp. from clinical 
samples (Zajc-Satler and Gragas, 1977), it contains deoxycholate to inhibit growth of 
Gram-positive bacteria, xylose, sucrose and lactose as carbon sources and phenol 
red as pH indicator. Other Enterobacteriaceae, such as Escherichia spp., also grow in 
this medium. E. coli colonies are easily distinguishable from Salmonella and Shigella 
due to fermentation of lactose, which acidifies the medium and changes the colour of 
the pH indicator. AcrB-mediated efflux confers innate resistance to deoxycholate in 
Enterobactericeae; as a consequence, strains with an inactivated AcrB or deleted acrB 
gene grow poorly in this medium, making XLD an ideal medium for fast screening for 
acrB mutants. 
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A Salmonella strain with a functional AcrB grew within 24 hours to form translucent 
colonies with a black centre due to production of sulphydric acid, and a bright pink halo 
due to decarboxylation of lysine, which results in production of cadaverine that 
alcalinises the medium. E. coli strains with a functional AcrB formed pale yellow 
colonies with a yellow halo due to fermentation of lactose and production of organic 
acids that acidify the medium (Appendix III).  
Genera and species of mutant candidates were confirmed using the API-20E test 
system. This system allows the identification of bacterial species from the 
Enterobacteriaceae family, by using simplified biochemical tests. 
 
3.6.1.1 Selection of AcrB D408A mutant candidates in S. Typhimurium 
SL1344 
Four mutant candidates of S. Typhimurium were streaked onto XLD agar. Two 
candidates grew well on XLD agar; thus they were discarded. Sequencing of acrB was 
carried out for the remaining two candidates that did not grow on XLD agar. 
Sequencing results showed that one of the mutants had the target mutation, whereas 
the other one did not. Therefore, one S. Typhimurium SL1344 mutant candidate was 
selected. The API-20E test identified the mutant candidate as Salmonella spp. 
confirming the identity of the strain. 
 
 
- 111 - 
 
 




Seven mutant candidates were screened by colony-PCR. Strains with an intact acrB have a ~3.6kb amplimer, when acrB is interrupted with the 





















5 acrB candidate 1
6 acrB candidate 2
7 acrB candidate 3
8 acrB candidate 4
9 acrB candidate 5
10 acrB candidate 6
11 acrB candidate 7
12 Contamination control
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3.6.1.2 Selection of AcrB D408A mutant candidates in E. coli MG1655 
Ten candidates of each acrB mutant were replica-plated onto XLD agar. Eight colonies 
grew on XLD suggesting that the mutation had not been inserted. acrB was PCR-
amplified and sequence from the two colonies that did not grow on XLD. Both mutant 
candidates had the GACGCC substitution that translates into D408A and were 
confirmed to be E. coli by API-20E test. Therefore, one mutant was selected for further 
characterisation. 
 
3.7.2 Confirmation of acrB mutants by whole genome sequencing (WGS) 
WGS was carried out to confirm that mutations did not occur on unintended targets 
during the genetic modification procedure. When compared against the S. 
Typhimurium SL1344 reference genome FQ312003, WGS of the mutant revealed five 
SNPs. These SNPs were confirmed by checking the mapped reads on Artemis; only 
those SNPs consistent in all the reads were considered true. The remainder were 
disregarded as sequencing errors. Previous data  showed that the parental SL1344 in 
our laboratory contained four of the five SNPs (Ricci et al., 2012). The only SNP 
exclusive to the mutant was located at position 530662 in its chromosome; this 
mutation corresponds to the TG substitution in acrB, which translates into the AcrB 
D408A mutation (Figure 3.6). This confirmed that the chromosomal AcrB D408A 
mutant was correctly constructed and had no additional mutations that could affect its 
phenotype. 
The same procedure was carried out with E. coli MG1655 WGS. Reads from wild-type 
and acrB mutants were mapped against the MG1655 reference genome U00096.3. 
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Figure 3.6 WGS of the S. Typhimurium SL1344 AcrB D408A mutant. 
 
An asterisk at the end of the “Mutation” column denotes the SNPs present in SL1344. Marked in yellow is the acrB SNP corresponding to the 
AcrB D408A mutation. This SNP is shown in the Artemis plot where each one of the blue lines represents a mapped read and the vertical red 
lines indicates SNPs; only red lines that go across all the reads can be considered true SNPs. 
Amino acid sequence
Nucleotide sequence
SNPs in AcrB D408A mutant
Gene Position in chromosome Mutation
caiB 84505 T  C*
acrB 530662 T  G 
manX 635606 T  A*
rlpA 699519 A  C*
menC 2411272 T  C*
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The parental wild-type strain had two SNPs, one insertion and one deletion when 
compared against the reference genome. These mutations were present in both acrB 
mutants. The AcrB D408A mutant had an additional TG substitution at position 
483181 in the chromosome, which corresponds to the AcrB D408A mutation. The 
acrB mutant had no reads mapped to the acrB gene as the gene is not present in the 
chromosome of the mutant (Figure 3.7). 
 
3.7.3 Quantification of expression of AcrB by Western Blot  
Western Blotting of AcrB was carried out to confirm the expression of the protein in 
the mutants. Protein preparations from the parental strain and its ∆acrB mutant were 
used as positive and negative controls, respectively, for expression of AcrB.  
In S. Typhimurium AcrB expression of AcrB in the D408A mutant were 100% of the 
wild-type strain (Figure 3.8). As expected, the ∆acrB mutant did not express AcrB. To 
validate that the results observed were due to changes in amount of AcrB expressed 
and not to a difference in amount of total protein loaded, the amount of RNA 
polymerase β-subunit was quantified in parallel. This protein is constitutively 
expressed and its expression is not affected by acrB; therefore, it was used as an 
indicator of how much total protein was loaded into each well.  
Similar results were observed with the E. coli acrB mutants. The E. coli AcrB D408A 
mutant expressed on average 97.43% of the wild-type levels of AcrB; the acrB 
mutant did not express AcrB. The small difference in AcrB expression between the 
wild-type and AcrB D408A was due to a difference in total protein loaded as shown by 
the RNA polymerase blot (Figure 3.8). 
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Figure 3.7 WGS of the E. coli MG1655 acrB mutants. 
 
Mutations and their position in the chromosome of the MG1655 wild-type strain used in the 
laboratory are shown. WGS results are shown in the Artemis plot, where all reads mapped to 
the acrB gene are highlighted in red. Each blue and green horizontal line represents a mapped 
read. The SNP that translates into the D408A substitution in the AcrB protein is shown as a 
red vertical line that goes across all mapped reads. 
Mutations in the MG1655 wild-type strain
Gene Position in chromosome Mutation
ybhJ 803662 CA
mntP 1905761 GA
b2092 (pseudogene) 2173360 ACCCAC
b3423
(pseudogene) 3560455 CCCGC
Intergenic region 4296380 ACACGC
AcrB D408A
TG at position 483181 in the chromosome
∆acrB
No reads mapped to the acrB gene
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Bands corresponding to AcrB are shown in the figure. Band intensity was determined using GeneSys, this information was used to assign a 






Wild-type ∆acrB AcrB D408A
Relative [AcrB] 100% 0% 100 %
Relative [RNA pol]
100% 97.43%0%
Wild-type ∆acrB AcrB D408A
S. Typhimurium SL1344 E. coli K-12 MG1655
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These results confirmed that AcrB was expressed in the S. Typhimurium and E. coli 
chromosomal AcrB D408A mutants. 
 
3.8 Phenotype of Salmonella Typhimurium and E. coli acrB mutants 
3.8.1 Growth kinetics 
The growth of the AcrB D408A mutants, ∆acrB mutants and their respective parental 
wild-type strains was monitored by optical density at 600nm (OD600), over time. 
The growth curve and generation times of mutants in rich and minimal media were 
similar to those of the respective wild-type strains, with no statistically significant 
difference between them (Figure 3.9).  
 
3.8.2 Antimicrobial susceptibility of acrB mutants 
As the mutation had no effect on growth, the minimum inhibitory concentrations (MIC) 
of several AcrB substrates were determined in order to assess the activity of the 
AcrAB-TolC efflux pump. AcrB substrates were selected from the literature. The 
inclusion criterion for dyes and antibiotics was that MICs of these were decreased 
following inactivation or deletion of the acrB gene (Buckley et al., 2006, Seeger et al., 
2009, Takatsuka et al., 2010), or increased when the acrB gene was overexpressed 
(Nishino and Yamaguchi, 2001). The MIC values of all of the compounds tested were 
at least two two-fold dilutions lower for all acrB mutants when compared to those of 
the parental wild-type strain (Table 3.1). 
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Figure 3.9 Growth curves and generation times of S. Typhimurium SL1344, E. 
coli MG1655 and their respective acrB mutants. 
 
 
Growth curve and generation times ± standard deviation of A) S. Typhimurium and C) E. coli 
strains in LB broth are presented. Growth curve and generation times ± standard deviation of 
B) S. Typhimurium and D) E. coli strains in MOPS minimal medium are shown. Growth curves 
represent the mean of three biological replicates. 
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Table 3.1 Minimum inhibitory concentrations of AcrB substrates for S. Typhimurium SL1344, E. coli MG1655 and their 
respective acrB mutants. 
 




Wild-type 0.03 4 512 8 2 2 >1024 0.5 512 256 512 >2048 512 
∆acrB 0.008 1 8 2 0.5 0.25 32 <0.008 16 8 64 32 8 
AcrB D408A 0.008 1 8 2 0.5 0.25 16 <0.008 16 8 32 32 8 
E. coli 
MG1655 
Wild-type 0.01 8 1024 4 4 4 >1024 0.06 512 256 128 512 512 
∆acrB <0.008 2 16 1 1 0.5 1024 0.03 4 64 8 32 8 
AcrB D408A <0.008 2 16 1 1 0.5 1024 0.03 4 64 8 32 8 
 
CIP, ciprofloxacin; NAL, nalidixic acid; NOV, novobiocin; CHL, chloramphenicol; TET, tetracycline; MIN, minocycline; FUS, fusidic acid; CAZ, 
ceftazidime; CTX, cefoxitin; OX, oxacillin; ERY, erythromycin; ACR, acriflavine; ETBR, ethidium bromide; RHO, rhodamine 6G. Agar dilution 
MICs were determined 4 times. Mode values are shown. Black font, MIC values for wild-type strains and values that are one dilution lower than 
wild-type; blue font, MIC values ≥2 dilutions lower than the respective wild-type. 
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3.8.3 Accumulation and efflux of AcrB substrates by acrB mutants 
As the MIC data suggested that the efflux activity of the chromosomal AcrB D408A 
mutants was compromised, efflux activity of all the strains was measured with the 
Hoescht 33342 (H33342) accumulation and the ethidium bromide (ETBR) efflux 
assays (Coldham et al., 2010, Blair and Piddock, 2016). Both dyes are multi-drug 
resistance (MDR) efflux pump substrates that fluoresce when bound to double-
stranded nucleic acids (Olmsted and Kearns, 1977). 
A time-dependent increase in fluorescence was observed when the H33342 dye 
accumulated inside the bacterial cells; this reached stasis when the amount of dye 
accumulated reached an equilibrium or steady state. The acrB mutants reached an 
equilibrium concentration faster than their respective parental strains and accumulated 
a significantly higher amount of dye, observed as a higher level of fluorescence at the 
end of the assay (Figure 3.10). In E. coli, the AcrB D408A mutant accumulated more 
H33342 than the acrB strain, although the difference was not statistically significant. 
In contrast, there was no difference in H33342 accumulation between the S. 
Typhimurium acrB mutants. 
To measure efflux, bacteria were preloaded with ETBR by temporarily inhibiting 
oxidative phosphorylation with carbonyl cyanide m-chlorophenyl hydrazone (CCCP). 
CCCP acts as a proton (H+) ionophore, binding irreversibly to H+. This causes the 
periplasmic H+ gradient to dissipate, eventually resulting in loss of protonmotive force 
(PMF) and decreased ATP synthesis. Preloaded bacteria are subsequently energised 
with 25mM of glucose, at which point a decrease in ETBR fluorescence over time is 
observed due to active efflux of the dye (Figure 3.11). In S. Typhimurium, the acrB 
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Figure 3.10 Accumulation of Hoescht 33342 in S. Typhimurium SL1344, E. coli 





A) shows accumulation kinetics and final fold-change in accumulation of H33342 in S. 
Typhimurium SL1344. B) shows results in E. coli MG1655. One and three asterisks denote a 
significant difference of P<0.05 and P<0.0001, respectively, between two groups, compared 
by Student’s t-test with Welch’s correction. 
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Figure 3.11 Efflux of ethidium bromide in S. Typhimurium SL1344, E. coli 





A) shows efflux kinetics and final fold-change in efflux of ethidium bromide in S. Typhimurium 
SL1344. B) shows results in E. coli MG1655. Two asterisks denote a significant difference of 
P<0.001 between two groups, compared by Student’s t-test with Welch’s correction. 
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mutants reached the steady state concentration faster than SL1344 and effluxed 
significantly less dye than SL1344. However, surprisingly in E. coli, inactivation of AcrB 
and deletion of the gene had no effect on ETBR efflux (Figure 3.11B). 
These data show that the efflux and accumulation kinetics of the chromosomal AcrB 
D408A mutant are the same as a ∆acrB mutant. 
 
3.9 Changes in transcription of RND pumps in S. Typhimurium SL1344 
AcrB D408A mutant 
It was previously reported that the transcription levels of other RND efflux pump genes, 
acrD and acrF was significantly increased when the acrB gene was deleted in S. 
Typhimurium SL1344 (Blair et al., 2015b, Eaves et al., 2004). To determine whether 
increased transcription of these RND pump genes is a consequence of loss of AcrB 
efflux function or loss of protein, qRT-PCRs were carried out to measure the amount 
of the acrD and acrF mRNA in the SL1344 AcrB D408A mutant. Data obtained was 
compared against published data from the SL1344 ∆acrB (Blair et al., 2015b). In the 
AcrB D408A mutant, mRNA levels of acrB were the same as in the wild-type parental 
strain (Table 3.2). Interestingly, inactivation of AcrB did not increase transcription of 
acrD and acrF.  
 
 




Table 3.2 Relative fold-change in transcription of acrBDF pumps in S. 
Typhimurium SL1344 and its acrB mutants. 
 
Strain 
Fold change in gene transcription 
acrB  acrD  acrF  
Wild-type 1.0 1.0 1.0 
∆acrB  
- a 3.6 a*  7.6 a 
- b 13.4 b* 16.0 b* 
AcrB D408A 1.3 1.2 1.0 
 
a Data taken from Eaves et al. (2004). b Data taken from Blair et al. (2015b). An asterisk 
(*) denotes significantly increased transcription (P<0.05) when compared against wild-
type. 
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3.10 Discussion 
Several studies have been published showing a role for AcrB in the virulence of 
Salmonella Typhimurium (Buckley et al., 2006, Nishino et al., 2006, Webber et al., 
2009) or its homologues in other species (Bina et al., 2008, Padilla et al., 2010, Perez 
et al., 2012, Spaniol et al., 2015, Alcalde-Rico et al., 2016). However, all previous 
research have used gene inactivated or deletion mutants, which has caused some 
scepticism regarding the phenotype observed. To determine whether the phenotypes 
observed in Salmonella are due to loss of efflux function or loss of a transmembrane 
protein, an acrB mutant incapable of efflux activity was constructed in the present 
study. 
The AcrB efflux pump is a trimer that translocates protons through residues D407, 
D408, K940, R971 and T978 to generate protonmotive force (PMF). The PMF allows 
AcrB to change its conformation and efflux a variety of compounds including 
antibiotics, dyes and detergents. Previous studies have suggested that mutating these 
residues to non-charged amino acid residues such as alanine, will ‘lock’ the pump in 
one conformation rendering it incapable to efflux (Su et al., 2006, Takatsuka and 
Nikaido, 2006). In silico studies have shown that substitution of the proton 
translocation residues with alanine does not  significantly alter the structure of the 
protein (Su et al., 2006). Furthermore, E. coli ∆acrB mutants complemented with a 
plasmid expressing AcrB with substitutions in any of the proton translocation residues 
have been demonstrated to be hyper-susceptible to AcrAB-TolC substrates, indicating 
that AcrB was inactive in these mutants (Takatsuka and Nikaido, 2006, Seeger et al., 
2009).  
Residues essential for substrate binding of AcrB have also been described (Vargiu 
and Nikaido, 2012). However, modifying the binding pocket residues to inactivate AcrB 
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is not recommended as mutations in binding pockets occur naturally and can increase 
as well as decrease efflux of substrates (Blair et al., 2015a, Soparkar et al., 2015). 
Unlike the binding pocket, it is thought unlikely that mutations will occur naturally in 
residues involved in the proton translocation pathway as any changes will partially or 
totally inactivate the pump. Total inactivation of the pump happens when D407, D408 
or K940 are mutated to alanine (Seeger et al., 2009). D407 and D408 are the first 
residues in the proton translocation pathway. As a consequence, mutating D408 to 
A408 should abolish proton translocation completely making it an ideal target for 
genetic modification. 
The easiest way to introduce a genetically modified protein into a bacterium is by 
deleting the target gene from the bacterial chromosome and inserting the modified 
gene in an expression vector, producing a plasmid complementation mutant. However, 
complementation mutants require constant addition of antibiotics to maintain the 
plasmid vector and do not always replicate native levels of protein expression. 
Moreover, addition of antibiotics can interfere with the phenotype of a strain, for 
example, -lactams increase elongation in bacteria, which interferes with OD600 
readings (Catlin, 1975). Chromosomal mutants are better for physiological studies as 
they do not require addition of selective agents that could interfere with the phenotypes 
observed. Additionally, having a chromosomal mutant ensures that any changes 
observed in protein expression are due to changes in the native regulatory network 
and not due to changes caused by differences in number of complement plasmids. 
Consequently, in this study an AcrB D408A chromosomal mutant was constructed. 
The chromosomal point mutation was carried out in S. Typhimurium SL1344 and E. 
coli MG1655, two well-recognised laboratory strains used by many researchers across 
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the world. Slight variations between genomes of well-established laboratory strains 
occur frequently due to the multiple passages the strain has undergone since it was 
first isolated, allowing laboratory strains to divergently evolve (Mikkola and Kurland, 
1992, Fux et al., 2005, Klockgether et al., 2010). To account for possible variations in 
the phenotype of the acrB mutants, the mutants were constructed in an isogenic 
background and consistently compared against their respective parental wild-type 
strain. The AcrB D408A mutants constructed in this study contained the same SNPs 
as their respective parental strains plus the TG substitution in acrB; confirming that 
the only difference between mutant and parent was a single nucleotide in the genome 
of the mutant. It is important to note that acrB is encoded in the reverse strand of the 
chromosome; therefore, the mutation inserted in acrB is A1223C, the codon was 
changed from GACGCC. 
A few difficulties were encountered during the construction of the mutants. The major 
problem was selecting helper plasmids that worked in each background. Interestingly, 
pSLTS worked perfectly in E. coli MG1655 when it failed in S. Typhimurium SL1344. 
Similarly, pSim18 worked in SL1344 and not in MG1655. In both cases, plasmids were 
successfully introduced into target bacteria as shown by selection of transformants 
resistant to the antibiotic the plasmid confers resistance to. However, the recombinase 
could not be induced from these plasmids as shown by lack of insertion of the positive 
control DNA. It is unclear why this happened. It is hypothesised that the degree of 
general DNA supercoiling is different between E. coli and S. enterica (Cameron et al., 
2011), which could affect gene expression. This is particularly important for pSim18, 
which expresses recombinase under the control of pL promoter, previously shown to 
be affected by the degree of DNA supercoiling (Kincade and deHaseth, 1991). 
Interestingly, pSim18 has been used successfully in E. coli K-12 strains DH10B and 
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BW25113 to introduce linear DNA fragments into their chromosome (Storek et al., 
2018, Li et al., 2013); however, no reports were found where pSim18 was used in 
MG1655. In one article, the authors used pSim18 to introduce a mutation into DH10B 
to then transduce the mutation into MG1655 using a P1 phage (Li et al., 2013). The 
rationale behind this procedure was not explained; however, it is plausible that 
recombinases could not be induced from pSim18 in E. coli MG1655. It is important to 
note that E. coli DH10B has a 13.5-fold-higher mutation rate than MG1655 associated 
with the large number of insertion sequence transpositions in its chromosome (Durfee 
et al., 2008), which could also facilitate insertion of linear DNA into the chromosome.  
Regarding I-SceI expression, two plasmids were tested in the different bacterial 
strains. Both plasmids were highly inefficient as only one colony was obtained with 
pACBSCE in S. Typhimurium and two colonies with pSLTS in E. coli. Kim et al. (2014) 
mentioned that the efficiency of I-SceI encoded in pSLTS was very low in highly 
transcribed genes as the restriction enzyme could not bind to its target site due to 
constant transcription of the gene where the selection cassette had been introduced. 
To address this, two terminator sequences were added upstream of the I-SceI 
restriction site in the selection cassette to facilitate binding of the enzyme to its target. 
This improved the efficiency of the double-stranded break; however, a minimum of 12 
colonies had to be screened (Kim et al., 2014). Compared to genes such as rpoD, 
which has 215 transcripts per million (TPM) in mid-logarithmic phase in S. 
Typhimurium, acrB is not highly transcribed (123 TPM in mid-logarithmic phase); 
however, the absolute number of transcripts of acrB is still relatively high when 
compared to metabolic genes such as trpA, which only produces eight TPM (Kröger 
et al., 2013). The relatively high transcription levels of acrB could account for the low 
efficiency of I-SceI induced double-stranded break. 
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Expression of AcrB in the mutants was compared against the parental wild-type strain. 
In both E. coli and S. Typhimurium, the inactive AcrB was expressed to the same level 
as the wild-type strain and there was no expression of AcrB in the ∆acrB mutants. In 
S. Typhimurium, this was further confirmed by qRT-PCRs, where the amount of acrB 
mRNA in the AcrB D408A mutant was the same as in the parental strain.  
Yang et al. (2006) reported that the absence of acrB in E. coli caused the mutant to 
reach stationary phase later than the wild-type strain. In this study, none of the acrB 
mutants tested showed any significant changes in growth either in rich or minimal 
media, in E. coli and S. Typhimurium. This is in accordance with a previous study in 
which no differences were observed between the growth kinetics of an acrB::aph 
mutant and the wild-type strain as measured by OD600 and viable counts (Webber et 
al., 2009). AcrB is required for contact-dependent inhibition of growth in E. coli. 
However, this is specific to strain EC93, an isolate from rat intestines that is similar to 
K-12, and has not been shown to occur naturally in any other strain of E. coli to date 
(Ruhe et al., 2013a, Ruhe et al., 2013b). 
MICs of AcrB substrates were significantly lower for the acrB mutants when compared 
to those for the parental strains. Interestingly, the MICs of the AcrB substrates for the 
AcrB D408A mutant were the same as those for the ∆acrB mutant, which suggested 
that the D408A substitution abolished efflux activity to the same degree a gene-
deletion mutant in S. Typhimurium and E. coli. In accordance with the MICs, in S. 
Typhimurium, assays measuring H33342 accumulation and ETBR efflux indicated that 
both acrB mutants accumulated more H33342 and effluxed less ETBR than the 
parental SL1344 strain, confirming that the D408A substitution renders the AcrB efflux 
pump inactive. In contrast, in E. coli, the accumulation and efflux kinetics did not reflect 
the MIC results. Upon initial analysis, the AcrB D408A mutant accumulated more 
 
- 130 - 
 
H33342 than the ∆acrB mutant; however, the difference in H33342 accumulation 
between the two acrB mutants was not significant. It is possible that a difference exists 
between the two mutants but there is not sufficient statistical power to show a 
difference due to the large standard deviation between each experiment. Regardless 
of the possible difference in H33342 accumulation between the two E. coli acrB 
mutants, both mutants accumulated significantly more dye than the parental MG1655 
strain; however, the fold-change difference in final accumulation between wild-type 
and mutant E. coli strains was smaller (average fold-change of <2) when compared 
against data obtained for S. Typhimurium (average fold-change of 2.5). Furthermore, 
no significant differences were observed between the acrB mutants and the wild-type 
E. coli MG1655 when ETBR efflux was measured. It is possible that in E. coli 
alternative pumps play an important role in active efflux of ETBR in the absence of 
AcrB function. However, the MIC data indicated that inactivation of AcrB/acrB confers 
multidrug hyper-susceptibility to E. coli, suggesting that the alternative pump(s) either 
do not bind all of the AcrB substrates or are not expressed at a high enough 
concentration to have a significant effect on drug susceptibility.  
A comparison between E. coli MG1655 and S. Typhimurium SL1344 transporters 
showed that there are a total of 601 transporters in MG1655 versus 631 in SL1344. 
However, in terms of RND transporters, MG1655 has ten whereas SL1344 has nine 
(Elbourne et al., 2017) (Appendix IV). Of the MDR RND pumps, MG1655 does not 
express MdsB and SL1344 does not express MdtF. MdsB contributes to virulence in 
S. Typhimurium but does not contribute to the overall drug susceptibility phenotype as 
shown with a mdsB::aph mutant (Nishino et al., 2006). MdtF, when deleted, does not 
affect the drug susceptibility phenotype in E. coli (Sulavik et al., 2001); however, it 
slightly increases the MIC of ETBR when it is overexpressed (Nishino and Yamaguchi, 
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2001). Another RND pump that can slightly increase the MIC of ETBR when 
overexpressed is AcrF (Nishino and Yamaguchi, 2001), which is expressed in both E. 
coli and S. Typhimurium; therefore, AcrF is unlikely to be responsible for the ETBR 
efflux phenotype. Consequently, it is hypothesised that MdtF rid the cell of non-
inhibitory concentrations of ETBR (MIC of ETBR is 512g/mL, concentration of ETBR 
used in efflux assay is 50g/mL) in the absence of AcrB-mediated efflux in E. coli, by 
actively effluxing the dye.  
Under the current hypothesis, as E. coli MG1655 has more RND efflux pumps that can 
export ETBR than SL1344, a higher MIC of ETBR would have been expected for 
MG1655. However, the MIC of ETBR for E. coli is lower (512g/mL) to that for S. 
Typhimurium (2048g/mL). An alternative hypothesis is that there are major 
differences in membrane permeability between E. coli and S. Typhimurium. 
Differences in membrane permeability accounts for differential influx of antibiotics into 
the bacterial cell, which would explain the difference in MIC, but could potentially affect 
efflux assays as it dictates the amount of dye that diffuses in and out of the cell. This 
hypothesis and the MdtF-mediated efflux are not mutually exclusive.  
The AcrB-loss-of-function mutant was constructed to investigate whether deletion of 
the gene/loss of protein had pleiotropic effects on the physiology of S. Typhimurium. 
A phenotype caused by deletion of acrB is the increased transcription of alternative 
RND pumps acrD and acrF (Eaves et al., 2004, Blair et al., 2015b). To determine if 
this was a general effect of loss of efflux function or loss of protein, qRT-PCRs were 
carried out. Interestingly, neither acrD nor acrF were significantly upregulated in the 
AcrD D408A mutants, suggesting that this is a consequence of loss of AcrB protein. It 
is hypothesised that acrDF are overexpressed in the acrB mutant because loss of a 
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highly expressed large transmembrane protein destabilises the membrane; therefore, 
to re-stabilise the membrane, the bacterium overexpresses proteins that are similar to 
AcrB. As AcrB is expressed to the same level as the wild-type in the AcrB D408A 
mutant, there is no space in the membrane to insert additional RND pump proteins; 
accordingly, acrDF cannot be overexpressed.  
 
3.11 Key findings 
 In S. Typhimurium SL1344 and E. coli MG1655, the AcrB D408A substitution 
confers a multidrug hyper-susceptible phenotype to the mutant. 
 The D408A substitution in AcrB increases accumulation of H33342 in S. 
Typhimurium SL1344 and E. coli MG1655.  
 Loss of AcrB-mediated efflux reduces efflux of ethidium bromide in S. Typhimurium 
but not in E. coli MG1655. 
 The substitution does not affect growth of the mutant or expression of the AcrB.  
 Increased transcription of acrDF is a consequence of loss of AcrB protein and not 
of loss of efflux function. 
 
3.12 Future work 
 More experiments with E. coli MG1655 are desirable to determine whether there is 
a significant difference in H33342 accumulation between the AcrB D408A mutant 
and the acrB mutant. 
 Determine if increased MdtF expression occurs in the E. coli AcrB D408A mutant 
and if it is responsible for the phenotype observed in ETBR efflux assays. 
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 Determine if there are membrane permeability differences between S. Typhimurium 
SL1344 and E. coli MG1655 and their AcrB D408A mutants. 
 
 










Physiological changes caused by loss of AcrB 
efflux function in S. Typhimurium
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4.1 Background 
The AcrAB-TolC multidrug resistance efflux complex has been thoroughly studied as 
a mechanism of innate and acquired resistance to antibiotics. However, few studies 
have focused on the biological role of the complex. Most efflux pumps such as AcrD 
and AcrF have low basal expression under laboratory conditions and their expression 
is only induced after addition of antibiotics. Unlike other pumps, AcrB is constitutively 
expressed at a high concentration (Nishino et al., 2009), suggesting that the pump has 
a general physiological role.  In S. Typhimurium, the role of AcrB in virulence is well-
established. Nishino et al. (2006) analysed the effect of all RND-HAE pumps on 
virulence of S. Typhimurium and found that deletion of acrB caused a significant 
attenuation of virulence in a BALB/c mouse model. This observation has been 
reproduced in multiple infection models including 1-year old chicks and INT-407 
human embryonic intestinal epithelial cells (Buckley et al., 2006, Blair et al., 2009). 
Further studies suggested that this was due to decreased transcription of Salmonella 
Pathogenicity Island (SPI) genes (Webber et al., 2009); however, the reason behind 
this significant decrease in transcription remains unknown.  
Apart from virulence, AcrB also has a role in motility and biofilm formation of S. 
Typhimurium (Webber et al., 2009, Baugh, 2014). An acrB::aph mutant produced less 
biofilm and curli when compared against the isogenic wild-type strain (Baugh, 2014). 
In Pseudomonas aeruginosa, the AcrAB-TolC homologue, MexAB-OprM, is involved 
in export of quorum sensing (QS) signalling molecules, which regulate the expression 
of virulence and other genes in a cell-density dependent manner (Evans et al., 1998, 
Minagawa et al., 2012). 
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All previous studies have been carried out using an acrB::aph or a acrB mutant, so it 
is unclear whether the phenotypes observed are caused by loss of AcrB protein or 
AcrB-mediated efflux. In this chapter, some of the previously described phenotypes 
were interrogated using the AcrB D408A mutant and the physiological role of AcrB in 
S. Typhimurium was explored by RNA-sequencing (RNA-seq).  
 
4.2 Aims 
 To explore transcriptome changes caused by loss of function of AcrB in S. 
Typhimurium by RNA-seq. 
 To identify phenotypes associated with loss of AcrB efflux function. 
 
4.3 Hypotheses 
 Loss of AcrB efflux function causes significant changes in the transcriptome of the 
S. Typhimurium AcrB D408A mutant. 
 AcrB efflux function is required for virulence and multiple other physiological 
processes in S. Typhimurium. 
 
4.4 Impact of the D408A substitution in AcrB upon the transcriptome of S. 
Typhimurium SL1344 
RNA-seq was carried out to study the impact of the D408A substitution in AcrB on the 
biology of S. Typhimurium. Six cultures per strain were grown in parallel in MOPS 
minimal medium to an OD600 of 0.6 under the conditions described in section 2.8.1. 
Cultures were quenched by snap-freezing before RNA-extraction. Two sets of cultures 
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were grown in different days and the three RNA samples with the best quality were 
selected for RNA-sequencing, each sample representing a biological replicate. No 
pooling of the RNA-samples was carried out.  
Significant changes in the transcriptome of the mutant were observed. Of the 5031 
genes in the genome of Salmonella, 741 were significantly changed in the mutant 
when compared to wild-type (14.35% of the genome). Of these, 374 and 365 genes 
had increased and decreased transcription, respectively. 
Phage islands, flagellar genes, heat shock proteins A and B (hslTS), threonine (tcd 
operon) and nitrogen metabolism genes (nir and nap) were among the genes with 
increased transcription. csgB involved in curli biosynthesis was the most upregulated 
gene, followed by gtgF, a phage virulence protein (Figure 4.1).  
Genes with decreased transcription included SPIs required for host cell invasion; 
genes encoding ABC transporters, such as the lsrABCD operon involved in import of 
quorum sensing autoinducer-2 (AI-2); genes involved in cysteine biosynthesis (cys) 
and ethanolamine utilisation (eut), as well as genes from the aroPLMQDF 
supraoperon for biosynthesis of aromatic amino acids (Figure 4.1). There was also a 
significant decrease in transcription of several omp genes, such as ompA, which 
encodes an outer membrane porin required for pathogenesis. The most 
underexpressed gene was a methionine charging tRNA (tRNAMet). 
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Figure 4.1 Transcriptional landscape of the SL1344 AcrB D408A mutant. 
 
Transcriptome of the mutant was compared to parental SL1344. Significantly upregulated genes in the mutant are marked in red and 
significantly downregulated genes are marked in blue. Black crosses denote genes with no significant changes between the two 
strains. The orange dotted line indicates the end of the chromosomal genes and start of the plasmid genes. 
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4.4.1 RNA-seq data analysis on Clusters of Orthologous Groups (COG) 
To facilitate the biological interpretation of data, significantly differentially transcribed 
genes (hereafter referred to as differentially transcribed genes) were assigned to 
Clusters of Orthologous Groups (COG) classes (Figure 4.2). The COG database is 
formed of four process groups; each one of them comprised of several classes of 
genes that encode proteins that have a similar physiological role. The SL1344 COG 
database only includes 4615 genes, since sRNA, rRNA, tRNA and plasmid encoded 
genes are not included in the database. 
Most of the differentially transcribed genes were involved in metabolism (33%) and 
cellular processes and signalling (28%). A large percentage of genes were poorly 
characterised (24%) (Figure 4.2). 
Analysis of COG classes revealed that the transcription of genes involved in cell 
motility was predominantly increased. Other classes that followed the same trend were 
“Cell cycle control, cell division, chromosome portioning”; “Replication, recombination 
and repair”; “Posttranslational modification, protein turnover, chaperones” and 
“Defence mechanisms” (Figure 4.3). The last COG class encompassed transcriptional 
activators, hypothetical exported proteins and transporters such as the MDR efflux 
pump emrAB.  
COG classes in which gene-transcription was predominantly decreased, belonged to 
the Metabolism process. These classes included genes involved in amino acid, 
carbohydrate, lipid and nucleotide transport and metabolism. Additionally, genes in the 
“Intracellular trafficking, secretion and vesicular transport” class, which includes SPI 
genes, were also predominantly downregulated. Fifty percent of the genes in the 
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Figure 4.2 Classification of differentially transcribed genes into COG groups and 
classes. 
 
Each COG group is comprised of different classes. The percentage of differentially expressed 
genes in each class was calculated by dividing the number genes changed per class by the 
total number of genes in the class. Therefore, the percentage shown is that of the number of 
differentially transcribed gene within each class. 
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Figure 4.3  Percentage of differentially transcribed genes in each COG class. 
 
COG classes are shown on the left side of the chart, the total number of genes in this class are indicated in brackets. Percentage of 
up- and downregulated genes in each class are denoted with red and blue bars, respectively. 
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“Extracellular structures” COG class had decreased transcription. However, this class 
only contains two genes: the SPI-1 sipC and sadA, which encodes an autotransporter. 
As sipC transcription was decreased and sadA was not differentially transcribed, a 
large percentage of the genes in the class was downregulated (Figure 4.3).  
 
4.4.2  Validation of RNA-seq data 
To validate the RNA-seq results, significantly up- and downregulated genes, as well 
as genes that were not differentially transcribed were chosen randomly and their 
transcription was quantified using quantitative reverse-transcription PCR (qRT-PCR). 
16s rRNA and gyrB DNA gyrase were used as housekeeping genes as they were not 
significantly up- or downregulated in the present or previous transcriptomics studies 
of SL1344 acrB mutants (Webber et al., 2009). 
Transcription values of the target gene in the wild-type and AcrB D408A mutant were 
normalised against the housekeeping genes. Values were transformed to log2 fold-
change, plotted against the log2 fold-change in transcription obtained from RNA-seq 
and fitted by linear regression (Figure 4.4). A positive slope was observed, indicating 
that genes were changed in the same direction; that is, upregulated genes in RNA-
seq had increased transcription as measured by qRT-PCR and genes with decreased 
transcription in RNA-seq were also transcribed less when measured by qRT-PCR. A 
R2 of 0.88 was observed. 
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Log2 fold-change in gene transcription between the AcrB D408A mutant and the wild-
type S. Typhimurium SL1344 strains are shown. Gene transcription was measured by 
RNA-seq and qRT-PCR. 
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4.5 Correlation of differentially transcribed genes in an acrB::aph mutant 
with the AcrB D408A mutant 
A S. Typhimurium SL1344 acrB::aph mutant was previously constructed in the 
Piddock group and its transcriptome was studied by microarray (Webber et al., 2009) 
(ArrayExpress accession number E-MEXP-1981). The microarray study was carried 
out with cultures grown in MOPS minimal medium to an OD600 of 0.6, which were the 
 same conditions used for RNA-seq of the AcrB D408A mutant. Results from the 
comparison of each mutant transcriptome against its parental wild-type strain 
(differential gene transcription profiles) were used to determine differences and 
similarities between the two mutants. The acrB::aph mutant was reported to have 
significant changes in the transcription of 569 genes; in the AcrB D408A mutant, 741 
genes were significantly changed. When the significantly changed genes in the 
acrB::aph mutant were compared against those of the AcrB D408A mutant, only 190 
genes matched. Of these, 85 genes were changed in the same direction; that is, 44.7% 
of differentially transcribed genes were equally up- or downregulated. The rest of the 
genes (55.3%) were changed in opposite directions. In accordance with this, when 
log2 fold-change values obtained from RNA-seq of the AcrB D408A mutant were 
plotted against those from microarray data of the acrB::aph mutant,  a slightly negative 
slope was observed (Figure 4.5). R2 was used to find the correlation between the two 
datasets, the correlation between the two datasets was very weak and did not follow 
any trendline as shown by a R2 of 0.06 (Figure 4.5).  
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Figure 4.5 Correlation between the transcriptome of a S. Typhimurium SL1344 acrB::aph mutant and the AcrB D408A 
mutant. 
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Comparison of COGs revealed that genes involved in cell motility were primarily 
upregulated in the AcrB D408A mutant, whereas they were downregulated in the 
acrB::aph mutant. Similar patterns were observed in three other COG classes: 
nucleotide transport and metabolism; post-translational modification, protein turn over 
and chaperones; and replication, recombination and repair. Only three COG classes 
had a similar percentage of down and upregulated genes in both mutant strains, these 
were: cell wall/membrane/envelope biogenesis; secondary metabolites biosynthesis, 
transport and catabolism; and transcription (Figure 4.6). 
 
4.6 Comparison of motility phenotypes between an acrB::aph, ∆acrB and 
AcrB D408A mutants 
The “Cell motility” COG class was one of the COG classes with the most differentially 
transcribed genes in the acrB::aph and AcrB D408A mutants. Genes were also 
transcribed in opposite directions between the two mutants. To explore changes in the 
motility phenotype, motility assays in semisolid agar were carried out. A acrB mutant 
was included as it was expected to have the same phenotype as either the acrB::aph 
mutant or the AcrB D408A mutant. 
To measure swimming, S. Typhimurium SL1344 and its acrB mutants were stabbed 
into MOPS minimal medium with 0.3% of agar to allow movement of bacteria through 
the pores of the agar. Consistent with the transcriptome analysis, the acrB::aph mutant 
was significantly less motile than the wild-type strain, whereas the acrB and the AcrB 
D408A mutants were significantly more motile (Figure 4.7).  
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Figure 4.6 Comparison of COGs between an SL1344 acrB::aph mutant and the AcrB D408A mutant. 
 
COG classes are shown on the left side of the chart, the total number of genes in this class are indicated in brackets. Orange bars 
show results for the acrB::aph mutant, orange bars indicate results for the AcrB D408A mutant. Percentage of downregulated genes 
in each class are denoted with dark-coloured bars, whereas percentage of upregulated genes are shown with light-coloured bars. 
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Figure 4.7 Swimming of S. Typhimurium SL1344 and its acrB mutants in MOPs minimal medium with 0.3% agar. 
  
A) shows motility halos formed by swimming S. Typhimurium. The inoculum was stabbed into the middle of the plate and S. 
Typhimurium swam to form concentric circles around the inoculum. B) shows area of the motility halos as measured in mm2 in ImageJ. 
Each dot represents a biological replicate and the line in the middle represents the mean of each dataset. A Student’s t-test with 
Welch’s correction was carried out between the wild-type strain and each mutant to determine statistical significance. Two asterisks 
(**) indicate a significant difference with a P<0.01, three asterisks (***) denote a significant difference with a P<0.001. 
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Swarming motility was also measured. Swarming consists of the movement of bacteria 
across the surface of semisolid agar (0.6% agar in this case). Assays were attempted 
using MOPS minimal agar; however, no swarming was observed after five days of 
incubation. Therefore, LB semisolid agar supplemented with 4g/L of glucose was used 
(Harshey and Matsuyama, 1994). Similar to what was observed with swimming, the 
acrB::aph mutant swarmed significantly less than the other acrB mutants. Interestingly, 
no significant increase in motility was observed in the AcrB D408A and the acrB 
mutants (Figure 4.8).  
To test whether the loss of the hyper-motility phenotype in the AcrB D408A and the 
acrB mutants were due to changes in media composition, swimming assays were 
carried out in LB semisolid agar. As LB medium is richer in nutrients than MOPS, S. 
Typhimurium grew faster and, consequently, swam faster through the agar. Therefore, 
incubation times were reduced to seven hours to obtain a good measurement of the 
halo of motility. In LB medium, no significant differences in swimming were observed 
between the wild-type and its acrB mutants (Figure 4.9), suggesting that the motility 
phenotype is specific to minimal media. 
 
4.7 Changes in the transcription of the acrAB transcription regulator ramA 
and the SOS response regulator lexA in the AcrB D408A mutant 
4.7.1 Differential transcription of ramA  
The global transcription regulator ramA is known to control the expression of AcrAB in 
S. Typhimurium. Previous studies have shown that the transcription of this gene is 
significantly increased in an acrB::aph mutant and a acrB mutant, and also when 
efflux inhibitors, such as phenyl-alanine -naphtylamide (PAN) and chlorpromazine 
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Figure 4.8 Swarming motility of S. Typhimurium SL1344 and its acrB mutants in LB medium supplemented with glucose 
with 0.5% agar. 
  
A) shows motility patterns formed by swarming of S. Typhimurium. The inoculum was spotted onto the agar, in the middle of the 
plate. B) shows area of motility as measured in mm2 in ImageJ. Each dot represents a biological replicate and the line in the middle 
represents the mean of each dataset. A Mann-Whitney U test was carried out between the wild-type strain and each mutant to 
determine statistical significance. This test was used as data did not pass the normality test. Three asterisks (***) denote a significant 
difference with a P<0.001. 
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Figure 4.9 Swimming motility of S. Typhimurium SL1344 and its acrB mutants in LB medium with 0.3% agar. 
  
A) shows motility halos formed by swimming S. Typhimurium. The inoculum was stabbed into the middle of the plate. S. Typhimurium 
swam in concentric circles around the inoculum. B) shows area of the motility halos as measured in mm2 in ImageJ. Each dot 
represents a biological replicate and the line in the middle represents the mean of each dataset. A Mann-Whitney U test was carried 
out between the wild-type strain and each mutant to determine statistical significance. This test was used as data did not pass the 
normality test. 
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(CPZ), were added S. Typhimurium. Therefore, it was expected that ramA would be 
upregulated in the AcrB D408A mutant. However, RNA-seq revealed that this gene 
was not differentially transcribed in the mutant. To validate this result, a ramA induction 
assay was carried out using a ramA-GFP reporter plasmid. The plasmid was 
constructed by fusing the ramA promoter region to a gene encoding a green 
fluorescent protein (GFP) in a pMW82 background (Lawler et al., 2013). Induction of 
the transcription of ramA resulted in expression of GFP, the fluorescence intensity of 
which was measured and normalised against the OD600 of the culture to assess the 
induction of ramA transcription relative to number of bacteria. CPZ was used as 
positive control for ramA induction and a promoterless pMW82-gfp was used to detect 
leaky expression of GFP.  In accordance with previous studies, ramA was overinduced 
in an acrB mutant (fold-change of 5.75±1.61); however, no significant changes in 
ramA induction were observed in the AcrB D408A mutant (fold-change of 1.68±0.82) 
(Figure 4.10).  
 
4.7.2 Differential transcription of lexA  
The lexA gene, involved in regulation of the SOS DNA repair response, was 
significantly upregulated in the AcrB D408A mutant as shown by the RNA-seq results. 
To validate this finding, induction of transcription of lexA was assessed using a lexA-
GFP reporter construct (plexA). The construct was tested using varying concentrations 
of nalidixic acid (NAL) as this antibiotic is known to induce expression of the SOS 
response by inhibiting bacterial DNA gyrase. This in turn causes DNA damage and 
activation of the SOS response, characterised by increased transcription of recA and 
 
 










Fold-change in gene induction was calculated by dividing the relative fluorescence of 
the acrB mutant by the relative fluorescence of the wild-type. Each dot represents an 
independent experiment. The line in the middle represents the mean of each dataset. 
A Student’s t-test with Welch’s correction was carried out between the parental strain 
and the acrB mutants to determine statistical significance. An asterisk indicates a 
significant difference (P<0.05). 
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lexA response regulators and response effectors. A concentration of NAL of 
≥1.6g/mL was required to cause a significant induction of lexA when compared 
against the control (0g/mL of NAL). Maximum induction of lexA was observed at 
10g/mL, after which, the relative fluorescence started to decrease; although induction 
of lexA was still significant up to 80g/mL of NAL (Figure 4.11A). As a positive control 
for the lexA induction assay, 1.6g/mL was chosen since it did not affect growth of the 
AcrB D408A mutant and simultaneously induced transcription of lexA. Unfortunately, 
the reporter strain was not suitable for assessing native levels of lexA induction as 
SL1344+plexA emitted the same amount of fluorescence as the SL1344+pMW82 
empty vector (fold-change of 0.91±0.46) (Figure 4.11B). Since the aim of this 
experiment was to validate the RNA-seq results, which showed an increase in the 
native levels of lexA transcription in the AcrB D408A mutant; the measurements 
obtained from the fluorescence reader could not be used as it could not differentiate 
between the empty vector and reporter strain. Therefore, a more sensitive instrument 
was required. The experiment was repeated in a flow cytometer. A voltage of 520V 
was used to differentiate fluorescent from non-fluorescent bacteria in the positive 
control; that is, SL1344+plexA and AcrB D408A+plexA exposed to 1.6g/mL of NAL. 
The positive control sample separated into two peaks, one of relative GFP intensity 
(GFP-expressing) and the other with lower relative intensity (non-fluorescent). 
However, when S. Typhimurium without exposure to NAL was analysed, no high 
fluorescence peaks were observed, but a shift in fluorescence between the strains 
carrying plexA to those carrying the empty vector was seen (Appendix V). The voltage 
was increased to 700V in order to try to separate the fluorescent from the non-
fluorescent subpopulation, yet fluorescence intensity patterns remained the same. 
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Figure 4.11 Induction of lexA in S. Typhimurium SL1344 exposed to nalidixic acid. 
 
 
A) shows the induction of lexA in S. Typhimurium SL1344 during exposure to varying concentrations of NAL. B) shows the native 
induction of lexA in the wild-type SL1344 and its AcrB D408A mutant in the absence of inducers. Fold-changes in induction were 
calculated by dividing the relative fluorescence of the S. Typhimurium in the presence of NAL by the relative fluorescence of S. 
Typhimurium grown without NAL. Each dot represents an independent experiment. The line in the middle represents the mean of 
each dataset. A Student’s t-test with Welch’s correction was carried out between the control without NAL and each concentration of 
NAL to determine statistical significance. An asterisk indicates a significant difference (P<0.05) at the given concentration of NAL 
when compared against the control without NAL. 
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Nonetheless, there was a slight difference in fluorescence intensity between 
SL1344+plexA and AcrB D408A+plexA (Figure 4.12). 
Median fluorescence intensity was used to determine whether lexA was significantly 
induced in the AcrB D408A mutant when compared against the parental SL1344 
strain. The median was used as the fluorescence intensity histograms did not follow a 
normal distribution (Figure 4.12). In the AcrB D408A mutant, lexA was induced 0.314-
fold (31.4%) more than in the wild-type strain (Figure 4.13). The difference was 
statistically significant with P<0.05. 
 
4.8 Attenuation of virulence of S. Typhimurium as a consequence of loss 
of AcrB efflux function 
4.8.1 Infection of human intestinal epithelial cells and murine 
macrophages by the AcrB D408A mutant 
The transcriptomics results indicated that many SPI genes were significantly 
downregulated in the acrB mutant compared to its parental SL1344 strain. SPI genes 
are essential for invasion and survival of Salmonella spp. in host cells. The decreased 
transcription of these genes suggested that the ability of the AcrB D408A mutant to 
invade intestinal cells and macrophages was compromised. To test this hypothesis, 
association and invasion of the mutant into intestinal epithelial cells and macrophages 
was measured in gentamicin protection assays and compared against the parental 
SL1344 and a previously constructed ∆acrB mutant.  
INT-407 and Caco2 are human intestinal epithelial cell lines. INT-407 cells are derived 
from human embryonic intestinal tissue, whereas Caco2 cells derived from a human 
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Figure 4.12 Induction of lexA in S. Typhimurium SL1344 as measured in an 




Induction of transcription was lexA, as given by GFP fluorescence intensity, was 
measured in a flow cytometer. GFP fluorescence intensity, measured in the BL1 
channel (X axis), was plotted against the number of bacteria detected and normalised 
to percentage (Y axis) to allow comparison between strains. A) shows the 
fluorescence intensity of SL1344 and its AcrB D408A mutant carrying the reporter 
plasmid (plexA) or the empty vector, after exposure to 1.6g/mL of nalidixic acid (NAL). 
B) shows the fluorescence intensity of test strains and negative controls without 
exposure to NAL, measured at 540V. C) shows the fluorescence intensity of test 




AcrB D408A + plexA
SL1344 + pMW82 empty vector
AcrB D408A + pMW82 empty vector
 











The fold-change induction of lexA in the AcrB D408A mutant when compared against 
its parental wild-type strain is shown. Each dot represents an independent experiment. 
The line in the middle represents the mean of each dataset. Two asterisks (**) indicate 
a statistically significant difference with a P<0.01 as calculated with a Student’s t-test 
with Welch’s correction.  
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colorectal adenocarcinoma. The main difference between these two cell lines is that 
Caco2 cells form polarised monolayers with well-differentiated apices and bottoms, 
whereas INT-407 cells can only form plain, undifferentiated, monolayers. In INT-407 
cells, the acrB mutants associated and invaded epithelial cells less than 2% of that 
seen with SL1344. In Caco2 cells, invasion was decreased to 12-17%. The loss of 
virulence phenotype was stronger during invasion than association (Figure 4.14). 
The J774A.1 cell line derives from blood macrophages of BALB/c mice. Infection 
assays with this macrophage lineage showed similar results to those observed with 
epithelial cells. None of the acrB mutants were able to associate or invade the 
macrophages resulting in invasion levels as low as 1% of those seen with the parental 
strains SL1344 (Figure 4.15). 
 
4.8.2 Infection of BALB/c mice by the AcrB D408A mutant 
To validate that the decreased invasion of intestinal epithelial cells and macrophages 
happened in vivo, groups of five BALB/c mice were inoculated orally or 
intraperitoneally with the wild-type and the AcrB D408A mutant. Mice were sacrificed 
at five days post-infection and liver and spleen were recovered to assess the degree 
of systemic infection. In general, mice infected with the AcrB D408A mutant had less 
CFU/mg of organ than when infected with the parental SL1344 strain. The difference 
was significant, except in the liver of mice inoculated orally, where the P-value 
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Figure 4.14 Infection assays with SL1344 and its acrB mutants in A) INT-407 and 





Association and invasion of a S. Typhimurium SL1344 ∆acrB and AcrB D408A mutant 
in A) INT-407 and B) Caco2 cells is shown. Each dot represents an independent 
experiment. The line in the middle represents the mean of each dataset. An asterisk 
denotes a significant difference of P<0.05 between two groups, compared by 
Student’s t-test with Welch’s correction. 
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Association and uptake of a S. Typhimurium SL1344 ∆acrB and AcrB D408A mutant 
in J774A.1 murine macrophage cell-line is shown. Each dot represents an 
independent experiment. The line in the middle represents the mean of each dataset. 
An asterisk denotes a significant difference of P<0.05 between two groups, compared 
by Student’s t-test with Welch’s correction. 
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Figure 4.16 Assessment of systemic infection of BALB/c mice inoculated with SL1344 and its AcrB D408A mutant. 
 
Groups of five 6-8-week old female BALB/c mice were infected A) orally with 5X107 CFU/mL or B) intraperitoneally (IP) with 3X103 
CFU/mLof wild-type or mutant S. Typhimurium. Bacterial burden in spleen and liver was assessed by viable counting. Each dot 
represents a mouse. The line in the middle represents the mean of each dataset. A Mann-Whitney-U test was used to determine 
significant differences between the wild-type and mutant. A significant difference (P<0.05) is represented by an asterisk. 
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4.9 Loss of AcrB efflux function and its effect on the replication dynamics 
of S. Typhimurium SL1344 
RNA-seq of the AcrB D408A mutant showed that expression of tRNAMet was 
significantly decreased. Literature research revealed that tRNAfMet in Salmonella 
enterica is cleaved by the vapC toxin, which led to formation of persisters, a 
subpopulation of slow-growing or transiently non-replicating bacteria (Winther and 
Gerdes, 2011). 
Toxin-antitoxin modules (TA) are not correctly annotated in FQ312003, the reference 
genome used in the analysis of RNA-seq data. Therefore, a list of all toxin-antitoxin 
modules was obtained from a recently published study and modules were identified 
manually (Lobato-Marquez et al., 2015). The vapBC TA was significantly upregulated 
in the AcrB D408A mutant when compared against its parental SL1344 strain; 
whereas, the T4-A4 module was significantly downregulated. Interestingly, the sehA 
toxin, from the sehAB TA, was significantly upregulated, but the sehA antitoxin was 
not (Table 4.1). 
Changes in TA and tRNAMet suggested that the AcrB D408A mutant was more 
susceptible to entering a persister state than the parental wild-type strain. To explore 
this hypothesis, replication dynamics of SL1344 and its isogenic AcrB D408A mutant 
were measured using the pDiGi plasmid. This plasmid encodes an IPTG-inducible 
GFP and an arabinose-inducible DsRed. The fluorescent proteins are best expressed 
in MgMES minimal medium, which simulates the conditions S. enterica encounters 
within a macrophage (Helaine et al., 2010). Therefore, experiments were carried out 
in this medium.  
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Table 4.1 Differential transcription of toxin-antitoxin modules identified in S. 








SL1344_1479 1583418 1583702 - 0.15 0.46 
SL1344_1480 1583692 1583940 - 0.1 0.7 
SL1344_2379 2527069 2527431 yfeC 0.059 0.75 
SL1344_2380 2527433 2527825 yfeD -0.058 0.75 
SL1344_2658 2836766 2837056 rnfH -0.011 0.95 
SL1344_2659 2837046 2837501 yfjG 0.18 0.17 
SL1344_2935 3123641 3123898 - -0.16 0.45 
SL1344_2936 3123903 3124178 - -0.2 0.22 
SL1344_3011 3215876 3216274 vapC# 0.46 0.019* 
SL1344_3012 3216274 3216501 vapB# 0.62 0.0082* 
SL1344_3437 3641837 3642439 fic 0.16 0.57 
SL1344_3438 3642429 3642596 yhfG 0.58 0.19 
SL1344_3483 3701215 3701490 - 0.27 0.2 
SL1344_3484 3701493 3701753 - 0.43 0.13 
SL1344_3524 3749258 3749626 kil -0.68 0.28 
SL1344_3525 3749623 3749850 phd -0.73 0.43 
SL1344_3617 3859051 3859536 T4# -0.56 0.011* 
SL1344_3618 3859524 3859811 A4# -0.55 0.023* 
SL1344_3743 4000107 4000466 - -0.062 0.76 
SL1344_3744 4000450 4000773 - -0.064 0.63 
SL1344_3866 4137213 4137530 - 0.19 0.46 
SL1344_3867 4137527 4137868 - 0.062 0.81 
SL1344_3976 4261087 4261515 sehB# 0.14 0.39 
SL1344_3977 4261530 4261841 sehA# 0.54 0.022* 
SL1344_3979 4263074 4263385 - 0.21 0.45 
SL1344_3980 4263386 4263676 - 0.018 0.95 
SL1344_4253 4583140 4583433 - 0.18 0.28 
SL1344_4254 4583430 4583921 - 0.1 0.54 
SL1344_4379 4712031 4712273 relB -0.063 0.79 
SL1344_4380 4712263 4712547 relE -0.14 0.6 
SL1344_4459 4806232 4806519 - 0.13 0.56 
SL1344_4460 4806506 4806808 - 0.0082 0.97 
 
Toxin-antitoxin (TA) modules are shown in pairs. The location of the gene in the 
chromosome of SL1344, in sequence FQ312003, is indicated in the start and end of 
the gene columns. Gene annotations are shown, an (#) at the end of the gene name 
indicates that the gene name was introduced manually. Log2 fold-change in 
transcription between the mutant and the wild-type is presented as well as the P-value, 
which was calculated using Bayesian approaches. An (*) at the end of each P-value 
indicates statistical significance (P<0.05). Significantly upregulated and 
downregulated genes are highlighted in red and blue, respectively.  
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An overnight culture of S. Typhimurium SL1344 and its AcrB D408A mutant carrying 
the plasmid was prepared in MgMES with arabinose to produce an inoculum that only 
expressed DsRed. This culture was diluted in MgMES supplemented with glucose, to 
‘wake up’ potential persisters from the inoculum, and IPTG to induce the expression 
of GFP (Appendix V, Figure A). Growth of S. Typhimurium was monitored by viable 
counting and OD600 measurements every 2 hours for the first 10 hours, then every 24 
hours until 72 hours. Bacterial replication at a single-cell level was measured by flow 
cytometry (gating strategy is shown in Appendix V, Figure B) and changes in 
replication dynamics were assessed by quantifying the number of bacteria that 
retained DsRed and the number of bacteria that only expressed GFP. No significant 
differences were observed between growth of the wild-type and mutant at a population 
level (Figure 4.17A, B). Viable counting showed that both strains grew equally during 
exponential growth phase and that the death phase started after 24 hours post-
inoculation. Interestingly, the AcrB D408A mutant maintained consistently higher 
viable counts than the wild-type after 24 hours post-inoculation. At a single-cell level, 
a larger subpopulation of DsRed-retaining bacteria was observed in the AcrB D408A 
mutant when compared against the wild-type and the proportion of GFP-expressing 
AcrB D408A mutant was significantly lower than in the wild-type (Figure 4.17C, D). 
However, results were unclear and no conclusions can be drawn from this experiment. 
 
4.10 Effect of loss of AcrB-mediated efflux on quorum sensing (QS) 
QS is mechanism of cell-to-cell communication used by bacteria to regulate the 
expression of genes in a population density-dependent manner. In S. Typhimurium, 
the QS signalling molecule, autoinducer-2 (AI-2), is imported into the bacterium via an 
 
 




Figure 4.17 Replication dynamics of S. Typhimurium SL1344 and its AcrB D408A 





Replication dynamics at a population level were measured by A) viable counting using 
the Miles-Misra method and B) OD600 measurements. At a single-cell level, 
fluorescence dilution was measured in a flow cytometer. C) shows the proportion of 
bacteria that retain DsRed and D) shows the proportion of bacteria that have diluted 
DsRed and only express GFP as measured in a flow cytometer. The number of 
bacteria/µL was determined using the number of events counted in the ‘Bacteria’ gate, 
divided by the number of µL that were processed. The average of three experiments 
± standard deviation is shown. A two-way ANOVA was used to determine statistical 
significance between replication dynamics of the wild-type and the mutant, a P<0.05 
was considered statistically significant. 
Disappearance of DsRed 
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ABC-type transporter, encoded by lsrABCD. AI-2 is then phosphorylated by LsrK, 
encoded in the lsrKR operon adjacent to the lsrABCD. Differential gene transcription 
analysis of the AcrB D408A mutant revealed a significant downregulation of the lsr 
operon, including the accessory genes lsrKR. As the lsr operon does not export nor 
synthesise AI-2, it was hypothesised that import of AI-2 is decreased in the AcrB 
D408A mutant; therefore, more AI-2 would be present in the culture supernatant. 
To test this hypothesis, the bioluminescent Vibrio harveyi strain BB170 was used. This 
strain is considered a bio-reporter of AI-2 as it contains a Tn5 transposon insertion in 
the luxN gene, making it unable to respond to other types of autoinducers (Bassler et 
al., 1997). The reporter strain was exposed to cell-free culture supernatants from 
SL1344 and its AcrB D408A mutant collected from various growth phases in different 
media. Luminescence and OD600 readings were taken every 10 minutes to determine 
the point of maximum luminescence. For three of the four media tested (MOPS, AB 
and LB), maximum luminescence was detected at 10 hours, for LB supplemented with 
glucose, maximum luminescence was detected at 10.5 hours. Therefore, these 
timepoints were used for data analysis. 
No significant differences were observed between the effect of the wild-type and the 
mutant supernatant in MOPS, AB and LB medium. However, in LB supplemented with 
glucose, the supernatant from the AcrB D408A mutant caused a significant increase 
in relative luminescence of the reporter strain when compared to the parental strain 
(Figure 4.18). This suggested that in LB with glucose, the loss of AcrB-mediated efflux 
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Figure 4.18 Relative luminescence of Vibrio harveyi BB170 exposed to cell-free culture supernatants from S. Typhimurium 
SL1344 and its AcrB D408A mutant. 
 
V. harveyi BB170 was exposed to cell-free culture supernatant of S. Typhimurium SL1344 and its AcrB D408A mutant collected from 
multiple timepoints in different media. Relative luminescence units were obtained at 10 hours for MOPS, AB and LB medium; whereas 
10.5 hours was used for LB with glucose. An average of four experiments ± standard deviation is shown. A two-way ANOVA was 
used to determine statistical significance between replication dynamics of the wild-type and the mutant, a P<0.05 was considered 
statistically significant. 
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4.11 Changes in curli production in the AcrB D408A mutant 
Curli is an amyloid fibre produced by multiple bacteria that has been associated with 
biofilm formation. A gene essential for curli production is csgB, which was significantly 
upregulated in the AcrB D408A mutant when compared against the parental wild-type 
strain. This was surprising as a previous study showed that curli was significantly 
downregulated in an acrB::aph mutant with a corresponding phenotypic effect (Baugh, 
2014). 
To determine if curli production was affected by loss of AcrB efflux function, S. 
Typhimurium SL1344 and its acrB mutants were grown on Congo red agar. Bacteria 
that produce curli form red colonies with a rough and dry appearance due to the 
staining of curli proteins on the outer membrane of Gram-negative bacteria. Bacteria 
that do not produce curli form pink or white colonies with a smooth appearance.  
Previous studies were carried out with S. Typhimurium 14028S wild-type and its 
acrB::aph mutant (Baugh, 2014). These strains were used as controls for the assay. 
In accordance with the previous report, the 14028S acrB::aph mutant formed smooth, 
pink colonies on LB agar at 37C; whereas, the wild-type 14028S strain formed rough, 
red colonies, suggesting a lack of curli production in the mutant. However, in SL1344, 
there were no visible changes in phenotype between the wild-type and the acrB 
mutants (Figure 4.19). 
The experiment was repeated on MOPS minimal agar with Congo red to simulate the 
conditions under which RNA-seq was carried out. Curli-producing phenotypes were 
not observed on this agar in any of the strains used (Figure 4.20). 
 
 
- 170 - 
 




Curli-producing bacteria form red colonies with a rough appearance. Non-curli producing bacteria form colonies with a pale pink 
colour and a smooth appearance. A representative figure from four assays is shown. 











- 171 - 
 





Curli-producing bacteria form red colonies with a rough appearance. Non-curli producing bacteria form colonies with a pale pink 
colour and a smooth appearance. A representative figure from four assays is shown. 
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Baugh (2014) previously reported that curli production was better observed when S. 
Typhimurium was incubated at 30C. Therefore, experiments in LB and MOPS agar 
were repeated at 30C. Similar to what was observed at 37C, the curli production 
phenotype was only observed on LB agar when 14028S wild-type strain was used, 
with its acrB::aph mutant forming a pink, smooth colony. Interestingly, at 30C, the 
wild-type SL1344 colony had a slightly rougher appearance than the colonies formed 
by acrB mutants. However, the phenotype was not clear (Figure 4.21). On MOPS agar, 
in accordance with the results obtained at 37C, the curli-producing phenotype was 
not observed in any of the strains used (Figure 4.22).  
 
4.12 Metabolic implications of loss of AcrB efflux function 
The transcription of multiple genes involved in metabolism was significantly changed 
in the AcrB D408A mutant, suggesting a general change in metabolism. To determine 
which genes were responsible for the metabolic shift in the AcrB D408A mutant, 
Metabolic Transformation Algorithm (MTA) was applied (Yizhak et al., 2013). The 
algorithm uses differential gene transcription data to model the metabolism of S. 
Typhimurium. In this case, the same differential gene transcription data shown in 
section 4.4 was used as input for the analysis. Differential gene transcription data was 
run through an integrative metabolic analysis tool (iMAT), which maps genes to 
reactions or pathways and predicts the rate at which metabolites go through them 
(flux), generating a reconstructed metabolic network. MTA uses the iMAT networks to 
identify perturbations that could push the flux of reactions from the changed group to 
the target state, without affecting the flux of the unchanged reactions. This generates 
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Curli-producing bacteria form red colonies with a rough appearance. Non-curli producing bacteria form colonies with a pale pink 
colour and a smooth appearance. A representative figure from four assays is shown. 
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Curli-producing bacteria form red colonies with a rough appearance. Non-curli producing bacteria form colonies with a pale pink 
colour and a smooth appearance. A representative figure from four assays is shown.
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a list of reactions/genes that, when deleted, are likely to cause a metabolic shift in the 
‘right direction’. These genes can also be interpreted as those that are essential in the 
maintenance of the metabolic state of the source state (Figure 4.23). In this study, the 
two directions of interest were 1) AcrB D408A mutant to the wild-type metabolic state 
(hereafter referred to as Direction 1) and 2) wild-type to the AcrB D408A metabolic 
state (referred to as Direction 2). 
For each direction, the algorithm produced a list with genes scored in order of 
relevance. MTA uses a cut-off value of 1, where the higher the score, the most likely 
the gene deletion was to cause a metabolic shift in the right direction. The gene with 
the highest score in the Direction 1 list was fadB (score=7.15), which encodes a protein 
essential for β-oxidation of fatty acids (Table 4.2). For Direction 2, the top two genes 
had similar scores, differing only by 0.12 (Table 4.3). These genes were glpK 




AcrB and its homologues have different physiological roles in different bacteria. In S. 
Typhimurium, the most frequently described phenotype is the attenuation of virulence 
(Buckley et al., 2006, Nishino et al., 2006, Webber et al., 2009), but it is not the only 
phenotype associated to absence of AcrB. In a previous study, it was shown that 
genetic inactivation of either of the components of the AcrAB-TolC complex in S. 
Typhimurium SL1344 led to significant changes in the transcriptome of the respective 
mutant as measured by microarray. Interestingly, of all three mutants, the acrB::aph 
mutant was the most affected. In the present study, the transcriptome of a SL1344 
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Figure 4.23 Schematic representation of the workflow used to find genes 
implicated in maintenance of the metabolic state of the SL1344 AcrB D408A 
mutant using MTA. 
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Table 4.2 List of genes that are predicted to shift the AcrB D408A mutant 
metabolic state to the same as the wild-type SL1344. 
Protein 
code* Gene Description Score 
STM3983 fadB Fatty acid oxidation complex subunit alpha 7.1500 
STM3010 aas Bifunctional protein Aas 3.6417 
STM3330 gltB Glutamate synthase, large subunit 3.4432 
STM3331 gltD Glutamate synthase, small subunit 3.4432 
STM1238 icdA Isocitrate dehydrogenase [NADP] 3.0434 
STM0066 carA Carbamoyl-phosphate synthase small chain 2.9543 
STM0067 carB Carbamoyl-phosphate synthase large chain 2.9543 
STM4081 tpiA Triosephosphate isomerase 2.4659 
STM2051 pduP Propanediol utilization CoA-dependent propionaldehyde dehydrogenase 2.4403 
STM3243 tdcC Threonine/serine transporter TdcC 2.3940 
STM0620 citX Putative cytoplasmic protein 2.3122 
STM1076 mgsA Methylglyoxal synthase 2.2486 
STM4119 ppc Phosphoenolpyruvate carboxylase 2.2374 
STM2952 Enolase (eno) Enolase 2.2164 
STM3614 dctA Aerobic C4-dicarboxylate transport protein 2.1898 
STM3225 sstT Serine/threonine transporter SstT 2.0860 
STM0158 acnB Aconitate hydratase B 1.9963 
STM0368 prpB 2-methylisocitrate lyase 1.9963 
STM0369 prpC 2-methylcitrate synthase 1.9963 
STM0370 prpD 2-methylcitrate dehydratase 1.9963 
STM1756 purU Formyltetrahydrofolate deformylase 1.9547 
STM0970 pflA Pyruvate formate-lyase-activating enzyme 1.9229 
STM0730 gltA Citrate synthase 1.6573 
STM3939 cyaA Adenylate cyclase 1.6222 
STM3968 udp Uridine phosphorylase 1.6196 
STM2555 glyA Serine hydroxymethyltransferase 1.6171 
STM0542 folD Bifunctional protein FolD 1.5923 
STM3334 NA Putative cytosine deaminase 1.4961 
STM1349 pps Phosphoenolpyruvate synthase 1.4561 
STM0732 sdhC 
 
Succinate dehydrogenase cytochrome 
b556 subunit 
1.4517 
STM0733 sdhD Succinate dehydrogenase hydrophobic membrane anchor subunit 1.4517 
STM0734 sdhA Succinate dehydrogenase flavoprotein subunit 1.4517 
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STM0735 sdhB Succinate dehydrogenase iron-sulfur subunit 1.4517 






STM0977 serC Phosphoserine aminotransferase 1.2319 
STM3062 serA D-3-phosphoglycerate dehydrogenase 1.2319 
STM4578 serB 3-phosphoserine phosphatase 1.2319 
STM1098 hpaC 4-hydroxyphenylacetate 3-monooxygenase reductase component 1.2234 
STM3359 mdh Malate dehydrogenase 1.2169 
STM2472 maeB NADP-dependent malic enzyme 1.1987 
STM4569 Phosphopentomutase Phosphopentomutase 1.1876 
STM1299 gdhA NADP-specific glutamate dehydrogenase 1.1292 
STM2200 lysP APC family lysine-specific permease 1.0783 
STM1627 NA S-(hydroxymethyl)glutathione dehydrogenase 1.0178 
STM3877 asnA Aspartate--ammonia ligase 1.0079 
 
(*) Protein code was obtained from S. Typhimurium LT2. The genome annotation of this strain 
was used for the genome-wide reconstruction of the metabolic network of S. Typhimurium. 
NA indicates that the gene is not annotated. Genes with a score>1 are shown. The higher the 
score, the more likely the deletion of the gene is to cause a metabolic shift in the mutant 
towards de wild-type state. 
 
- 179 - 
 
Table 4.3 List of genes that are predicted to shift the wild-type SL1344 metabolic 
state to the same as the AcrB D408A mutant. 
Protein 
code* Gene Description Score 
STM4086 glpK Glycerol kinase 1.4841 
STM4231 Maltoporin (lamB) Maltoporin 1.3621 
STM2927 surE 5'/3'-nucleotidase SurE 1.0724 
STM1883 purT Formate-dependent phosphoribosylglycinamide formyltransferase 1.0533 
STM2500 purN Phosphoribosylglycinamide formyltransferase 1.0282 
STM2947 cysI Sulfite reductase [NADPH] hemoprotein beta-component 1.0090 
STM2948 cysJ Sulfite reductase [NADPH] flavoprotein alpha-component 1.0090 
STM1193 fabH 3-oxoacyl-[acyl-carrier-protein] synthase 3 1.0073 
STM4087 glpF Glycerol diffusion MIP channel 1.0060 
STM3078 Agmatinase (speB) Agmatinase 1.0056 
STM0066 carA Carbamoyl-phosphate synthase small chain 1.0039 
STM0067 carB Carbamoyl-phosphate synthase large chain 1.0039 
STM2548 asrA Anaerobic sulfite reductase subunit A 1.0035 
STM2549 asrB Anaerobic sulfite reductase subunit B 1.0035 
STM2550 asrC Anaerobic sulfite reductase subunit C 1.0035 
STM2081 gnd 6-phosphogluconate dehydrogenase, decarboxylating 1.0018 
STM3186 tolC Outer membrane channel 1.0008 
STM0589 fepE Ferric enterobactin (Enterochelin) transporter 1.0006 
STM0051 rihC Non-specific ribonucleoside hydrolase RihC 1.0006 
STM0321 proB Glutamate 5-kinase 1.0004 
STM0322 proA Gamma-glutamyl phosphate reductase 1.0004 
 
(*) Protein code was obtained from S. Typhimurium LT2. The genome annotation of this strain 
was used for the genome-wide reconstruction of the metabolic network of S. Typhimurium. 
Genes with a score>1 are shown. The higher the score, the more likely the deletion of the 
gene is to cause a metabolic shift in the wild-type towards the mutant state. 
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AcrB D408A mutant was studied by RNA-seq and the differential gene transcription 
profile was compared against the previously reported acrB::aph microarray profile. 
Culture growth conditions and RNA extraction was carried out in the same way in both 
studies. A brief summary of the discussion is shown in Figure 4.24. 
More genes were differentially transcribed in the AcrB D408A than in the acrB::aph 
mutant. This difference is likely caused by the sensitivity of the techniques used, as 
the transcriptome of the AcrB D408A mutant was studied by RNA-seq, which is more 
sensitive than the microarray used to study the transcriptome of the acrB::aph mutant. 
Interestingly, little correlation was observed between the transcriptomes of the two 
mutants. Comparison of COG classes revealed that genes involved in motility, such 
as flagella synthesis and chemotaxis, were upregulated in the AcrB D408A mutant 
and downregulated in the acrB::aph mutant. Other classes, such as posttranslational 
modifications and replication followed the same trend.  
To further explore the discrepancy in transcription of motility genes, swimming and 
swarming on semisolid agar was measured. To determine if the motility phenotype 
was caused by loss of AcrB efflux function or loss of protein or was an artefact of the 
aph insertion, acrB mutants (AcrB D408A, ∆acrB and acrB::aph) derived from the 
same parental SL1344 strain were used. No antibiotics were used in these 
experiments as all mutants carried stable mutations on the chromosome. In 
accordance with the transcriptomic analyses, the AcrB D408A mutant swam more than 
the parental SL1344 strain, the same hyper-motile phenotype was observed in the 
acrB mutant. This observation is supported by a study in E. coli BW25113, in which 
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Figure 4.24 Summary of phenotypes affected by loss of AcrB efflux function and possible causes of these in S. 
Typhimurium. 
 
 A schematic of the points discussed in Chapter 4 is shown. Red and blue arrows next to a physiological activity/phenotype, indicate 
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an acrB mutant swam significantly more than the wild-type strain (Ruiz and Levy, 
2014). In contrast, the acrB::aph mutant was significantly less motile than the wild-
type in MOPS minimal agar, suggesting that the decreased motility phenotype is an 
artefact of the aph insertion. To confirm this, swimming and swarming assays in LB 
agar were carried out. Interestingly, no significant differences were observed between 
the acrB mutants and the parental wild-type strain when swimming was measured in 
LB. This observation will be discussed later.  
Swarming could not be measured using MOPS minimal agar as the medium does not 
have the adequate nutrients to induce swarming in S. Typhimurium. Swarming of S. 
Typhimurium is stimulated in rich media, such as LB or nutrient broth, supplemented 
with glucose (Harshey and Matsuyama, 1994, Kim and Surette, 2005); therefore, 
swarming was only measured in LB with glucose. No significant differences were 
found between the acrB, the AcrB D408A and the parental wild-type strain when 
swarming was measured. However, the acrB::aph mutant swarmed significantly less 
than the other three strains, confirming that the changes in the motility phenotype of 
the acrB::aph mutant are an artefact of the aph gene. The lack of changes in swarming 
motility in the AcrB D408A and the acrB mutant is not surprising, as only mutants 
with alterations in flagella and LPS synthesis have altered swarming phenotypes 
(Toguchi et al., 2000, Kim and Surette, 2005). The decreased swarming in the 
acrB::aph mutant is likely to be related to the significant decrease in transcription of 
flagella genes. In order to swarm, S. Typhimurium requires entering a hyper-flagellated 
state (Harshey and Matsuyama, 1994, Toguchi et al., 2000) and a significant 
downregulation of genes encoding flagella assembly is likely to stop Salmonella from 
becoming hyper-flagellated. The significant downregulation of genes involved in 
flagella synthesis may be accountable for the decreased overall motility of the 
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acrB::aph mutant. It may also be possible that the decreased motility in the acrB::aph 
mutant is related to the decreased transcription of genes in the “Posttranslational 
modification, protein turnover, chaperones” COG class. The significant decrease of 
genes in this COG class suggests that general protein synthesis is likely to be affected 
in the acrB::aph mutant. A recent study showed that reduced fidelity in general protein 
synthesis decrease motility of E. coli (Fan et al., 2016); thus, it may be that a decrease 
in posttranslational modifications leads to a decrease in motility. Another hypothesis 
involves the interaction of aph with “Salmonella factors”. A recent study showed that 
the aphA1 gene in combination with an “unknown Salmonella factor” enhanced 
swarming of MDR clinical isolates of S. Typhimurium (Brunelle et al., 2017). However, 
the motility phenotype was only observed in specific isolates and the phenotype was 
the contrary to what was reported in this study. Therefore, this hypothesis is deemed 
unlikely.  
No differences in swimming between the mutants and the wild-type were observed in 
LB medium, indicating that changes in the swimming phenotype of the acrB mutants 
depend on nutrient availability. Analysis of the RNA-seq of the AcrB D408A mutant 
shows that genes involved in amino acid, carbohydrate and nucleotide transport and 
metabolism were significantly downregulated in the mutant when compared against 
the parental wild-type strain. As a significant decrease in transport and metabolism of 
these essential nutrients is observed in the AcrB D408A mutant, it is likely that the 
mutant starves in MOPS minimal medium; therefore, it increases motility in order to 
move to a more favourable environment and gain more nutrients. As nutrients are 
readily available in LB medium, the hyper-motility phenotype is lost. 
S. Typhimurium exhibits positive chemotaxis towards most L-amino acids, expect for 
tryptophan and valine; it is also attracted towards multiple carbohydrates such as L-
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fumarate, L-malate, D-glucose, methyl-α,D-glucopyranoside, D-fructose, among 
others (Melton et al., 1978). All these chemoattractants are found in LB medium and 
are likely to influence swimming motility. It is hypothesised that the acrB::aph mutant 
is more sensitive to these chemoattractants than the other strains, resulting in a 
‘normal’ swimming phenotype in LB semisolid agar. It is unlikely that components of 
LB compensated any side effects caused by the aph gene as this would have also 
reflected in the swarming assays.  
Whether the effect of the aph gene on motility is S. Typhimurium-specific and/or acrB-
specific is unknown. The E. coli MG1655 acrB::aph, acrB and AcrB D408A mutants 
mentioned in the previous chapter could be used to address these questions. 
The decrease in transcription of metabolic genes and increase in motility can also be 
associated with the general upregulation of stress responses, such as recA, lexA, 
hslTS and cpxP, observed in the AcrB D408A mutant. Bacteria increase motility to 
escape from unfavourable environments; therefore, if the AcrB D408A mutant senses 
stress, it will increase flagella transcription in order to escape from the stress.  
Increased transcription of genes involved in general stress responses is hypothesised 
to be a consequence of accumulation of toxic by-products from metabolic pathways. 
The AcrB efflux pump is best known for its role in export of xenobiotics (for example, 
antibiotics); however, multiple authors have proposed that AcrB effluxes toxic 
metabolic by-products generated during normal bacterial growth (Helling et al., 2002, 
Piddock, 2006, Rosner and Martin, 2009, Ruiz and Levy, 2014). Interestingly, the 
proposed substrates of AcrB include products of cysteine and purine biosynthesis, 
products of gluconeogenesis and enterobactin or derivatives of enterobactin (Ruiz and 
Levy, 2014). These substrates can be classified as products of amino acid, nucleotide 
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or carbohydrate metabolism, which were COG classes dominated by significantly 
downregulated genes in the AcrB D408A mutant. Metabolic pathways have a feedback 
loop, where the end product of a pathway can repress its own biosynthesis to avoid 
accumulation of toxic metabolites or metabolic by-products (Sauro, 2017). If the end 
product of a metabolic pathway is a substrate of AcrB, then inactivation of AcrB may 
result in intracellular accumulation of said product, which may consequently cause 
feedback repression of the pathway and could potentially lead to decreased 
transcription of metabolic genes. At the same time, accumulation of metabolic 
products could cause activation of general stress responses and, possibly, 
overexpression of other efflux pumps that have similar substrate specificity to AcrB. In 
line with this hypothesis, increased transcription of the emrAB multidrug efflux pump 
in the AcrB D408A mutant was observed. EmrAB shares some substrates with AcrB, 
such as Rhodamine 6G and deoxycholate (Nishino and Yamaguchi, 2001),  and can 
efflux fatty acids from E. coli when acrAB is deleted (Lennen et al., 2013).  
Accumulation of metabolites also induces activation of the SOS response, involved in 
repairing damaged DNA, as shown recently in E. coli O157:H7 exposed to D-serine 
(Connolly et al., 2015). RecA and LexA are the main regulators of the SOS response 
system, which repairs damaged DNA. To confirm whether general DNA damage 
responses were significantly upregulated in the AcrB D408A mutant, induction of 
transcription of lexA was measured using a reporter plasmid, which encoded GFP 
under the control of the S. Typhimurium lexA promoter. The constructs were validated 
by testing induction of lexA in presence of varying concentrations nalidixic acid (NAL). 
A minimum of 1.6µg/mL of NAL is required to observe a significant increase in lexA 
induction, this result is in accordance with a previous study in which a significant 
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increase in transcription of lexA and recA was observed in a microarray of S. 
Typhimurium 14028S exposed to the same concentration of NAL (Dowd et al., 2007).  
Measuring induction of lexA in strains without exposure to NAL proved challenging. 
When measured in a fluorescence reader, the basal level of lexA induction was so low 
that the reporter strains were indistinguishable from the negative control strains, which 
carried the empty vector. Hence, a more sensitive method, such as flow cytometry 
was used. In the flow cytometer, a small induction of lexA in the absence of NAL was 
observed, the GFP signal was weak but it allowed differentiation of the test from the 
negative control strains. Activation of the SOS response is tightly controlled at multiple 
levels as it results in a high number of mutations and deletions that can be detrimental 
to bacteria (Kim et al., 1997, Simmons et al., 2008). Therefore, it was expected that 
the induction of the transcription of lexA, as a regulator of the SOS response, would 
be very low.  Interestingly, a significant increase of 31.4% in induction of lexA was 
observed in the AcrB D408A mutant when compared against the wild-type strain, 
indicating that loss of AcrB-mediated efflux induced transcription of lexA in S. 
Typhimurium. However, further experiments measuring induction of recA are desirable 
to complement this experiment, as well as Western blotting LexA and RecA.  
An interesting difference between the acrB::aph, the ∆acrB and the AcrB D408A 
mutant was the degree of transcription of ramA. ramA is a global transcription 
regulator, which induces transcription of acrAB by binding upstream of the promoter 
region of the operon (Weston et al., 2017). Transcription of this gene is induced in a 
S. Typhimurium SL1344 ∆acrB mutant and when wild-type SL1344 is exposed to efflux 
inhibitors, such as PaβN, and the antipsychotic drug chlorpromazine (CPZ) (Lawler et 
al., 2013). These observations led to the conclusion that induction of ramA occurs as 
a response to efflux inhibition; therefore, it was hypothesised that ramA would be 
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induced in the AcrB D408A mutant. However, ramA was not upregulated in the AcrB 
D408A mutant when compared against the parental SL1344 strain. To validate this 
observation, induction of the transcription of ramA was measured using a GFP-
reporter plasmid and compared against the ∆acrB mutant and the parental strain. In 
accordance with data reported by Lawler et al. (2013), a significant increase in ramA 
induction (average fold-change of 5.75) was observed in the ∆acrB mutant. However, 
no significant increase in ramA induction was observed in the AcrB D408A mutant, 
suggesting that the increased transcription of ramA is not a consequence of loss of 
AcrB-mediated efflux. It may be that the loss of the AcrB protein in the ∆acrB mutant 
triggers other physiological responses that result in increased transcription of ramA. 
For example, in the previous chapter it was discussed that loss of the AcrB protein 
results in overexpression of additional RND efflux pumps to fill in the empty spaces in 
the membrane where AcrB should be. It is possible that the loss of AcrB leads to 
membrane instability and the increased transcription of ramA is a response to 
membrane damage rather than loss of efflux function. In line with this hypothesis, 
PAβN and CPZ have been reported to cause extensive membrane damage at high 
concentrations (Lamers et al., 2013, De Filippi et al., 2007). 
An interesting observation in the AcrB D408A mutant was the decreased transcription 
of multiple genes encoding outer membrane porin from the omp family. Similar 
observations were previously reported in a S. Typhimurium acrB::aph mutant (Webber 
et al., 2009). The downregulation of omp genes suggested that loss of efflux causes 
decreased membrane permeability. In line with the hypothesis that loss of AcrB-
mediated efflux leads to accumulation of toxic metabolites, the decreased production 
of OMPs or decreased transcription of omp genes would serve to stop the influx of 
potential toxic compounds from the environment. However, as expression of OMPs is 
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regulated post-transcriptionally (Masi and Pagès, 2013), further experiments are 
required to determine if expression of OMP proteins is affected. 
The increased transcription of cpxP, which encodes the effector protein of the CpxRA 
two-component signalling system (TCSS) involved in the sensing of membrane stress, 
suggests that CpxRA was activated in the AcrB D408A mutant. This has been 
previously observed in a Vibrio cholerae mutant that lack all RND efflux pumps (Kunkle 
et al., 2017). Kunkle et al. (2017) hypothesised that the activation of CpxRA in the 
RND pump gene-deletion mutant was a response to intracellular accumulation of the 
siderophore vibriobactin, proposed to be exported by the VexGH RND pump in V. 
cholerae. Accumulation of vibriobactin would consequently decrease intracellular 
availability of iron and cause malfunction of cytochromes, making V. cholerae more 
susceptible to reactive oxygen species (ROS). ROS target disulphide bonds and 
causes denaturation of proteins. The denaturation of membrane proteins is detected 
by CpxA, which activates the TCSS in response. This hypothesis not only provides an 
explanation for the activation of the CpxRA TCSS, but also proposes that RND pumps 
in Enterobacteriaceae are involved in the export of siderophores, which are classified 
as virulence factors. The two main siderophores synthesised by S. enterica are 
enterobactin and salmochelin (Achard et al., 2013). Enterobactin was previously 
suggested to be exported by AcrB in E. coli (Ruiz and Levy, 2014). However, 
experimental evidence suggests that the majority of enterobactin is exported by the 
EntS MFS pump in E. coli and that only a small proportion of the siderophore is 
exported by AcrB and other RND efflux pumps (Horiyama and Nishino, 2014). The 
export of salmochelin in S. Typhimurium remains unstudied. Therefore, it is 
hypothesised that salmochelin is exported by AcrB and that its intracellular 
accumulation is responsible for the increased transcription of cpxP in the AcrB D408A 
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mutant. It is also possible that loss of export of salmochelin will impact the virulence 
of S. Typhimurium. 
A phenotype that is consistent throughout all S. Typhimurium acrB mutants is the 
attenuation of virulence. To determine if the virulence phenotype was an effect of loss 
of AcrB-mediated efflux or loss of AcrB protein, gentamicin protection assays were 
carried out using the AcrB D408A and ∆acrB mutants. Association and invasion of the 
mutants into polarised and non-polarised human intestinal epithelial cells (INT-407 and 
Caco2, respectively) and murine macrophages (J774A.1) was compared against the 
parental wild-type strain. In general, more bacteria were recovered at the association 
stage of the assay than at the invasion stage. At the 2 hours association time point, 
infected monolayers were washed to remove unattached bacteria, monolayers were 
then disrupted to recover attached Salmonella. A limitation of this assay is that S. 
Typhimurium invades the host cell as soon as 15 minutes post-infection (Lorkowski et 
al., 2014); therefore, bacteria recovered from the association time point was a mixture 
of non-internalised as well as internalised Salmonella. At the 4 hours invasion time 
point, infected monolayers were treated with gentamicin to kill non-internalised 
Salmonella, as gentamicin cannot penetrate eukaryotic cells, so only bacteria that 
have been internalised are recovered. These two time points provide a rough 
indication as to whether the acrB mutants fail to colonise the host cells or if there is a 
deficiency in invasion. Both acrB mutants tested showed a significant decrease in 
invasion into host cells when compared against the parental SL1344 strain, indicating 
that the mutants can colonise and but cannot invade host cells proficiently. Loss of 
AcrB-mediated efflux attenuated S. Typhimurium to the same extent as the ∆acrB 
mutant, indicating that is the efflux activity and not the AcrB protein that is required for 
virulence.  
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The attenuation of virulence was further studied in a BALB/c murine infection model, 
where the bacterial burden in liver and spleen was measured as an indication of 
systemic infection at five days post-inoculation. Two methods of inoculation were 
used: oral and intraperitoneal (IP). In the oral model, S. Typhimurium traverse the 
enteric barrier to be engulfed by macrophages and disseminated systemically via the 
lymphatic system. Additionally, ingested S. Typhimurium can be engulfed by CD18+ 
phagocytic cells in the gut and disseminated via blood (Vazquez-Torres et al., 1999). 
In the IP model, the lack of direct contact of the microorganism with the host gut 
reduces variability caused by differences in the pH of the stomach acid of each mouse, 
as the acidic pH can decrease the amount of Salmonella in the initial inoculum. In both 
models, the AcrB D408A mutant disseminated systemically, but to a lesser extent than 
the parental strain as significantly less mutant bacteria were recovered from spleen 
and considerably less were recovered from liver when compared against wild-type 
bacterial burdens. These results correlate with a decrease in the ability of the mutant 
to invade intestinal epithelial cells and macrophages; the first may reflect on its ability 
to traverse the enteric barrier. However, with the current results it is difficult to 
determine whether AcrB plays a role in invasion or survival of Salmonella in the host. 
Further experiments are required to assess the ability of the mutant to survive in 
mammalian cells. 
A previous study attributes the loss of virulence in an acrB::aph mutant to a decrease 
in transcription of genes essential for host invasion, encoded in the Salmonella 
Pathogenicity Island (SPI) 1 and 2 (Webber et al., 2009). In accordance with this, a 
significant decrease in transcription of SPI-1, 2 and 4 genes was observed in the AcrB 
D408A mutant when compared against the parental wild-type strain. SPI-1 genes are 
essential for invasion of non-polarised epithelial cells; whereas SPI-4, in combination 
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with SPI-1 are required for invasion of polarised epithelial cells (Lorkowski et al., 2014). 
In contrast, SPI-2 is required for maintenance of the intracellular lifestyle of Salmonella 
and survival in phagocytic cells such as macrophages (Jennings et al., 2017). 
Therefore, it is hypothesised that the decreased transcription of SPI genes is, at least, 
partially responsible for the attenuation of virulence in acrB mutants, as virulence 
regulation in S. Typhimurium is complex and is affected by multiple factors, which will 
be discussed later.  
It remains unclear why SPI genes have decreased transcription in acrB mutants. 
Interestingly, the decreased transcription of SPIs was accompanied by downregulation 
of the PhoPQ TCSS, which senses environmental changes and induces or represses 
transcription of SPIs in response. A hypothesis is that AcrB exports signalling 
molecules that are detected by TCSS; therefore, when efflux activity of AcrB is 
abolished, the signalling molecules accumulate in the periplasm causing 
overactivation of TCSS. To avoid overexcitation of PhoPQ, the transcription of the 
TCSS is reduced. Apart from PhoPQ, the transcription of rcsF, which encodes a 
lipoprotein essential for the function of the Rcs TCSS, was also decreased. The Rcs 
system senses changes in the periplasm and induces cytoskeleton rearrangements 
that are required for motility and expression of SPI genes (Bulmer et al., 2012a). The 
decreased transcription of rcsF suggests that the Rcs TCSS is only partially activated, 
which could account for the decreased expression of SPI genes.  
An alternative hypothesis to explain the decreased transcription of SPIs is that energy 
used in synthesis of SPI proteins is translocated to other essential functions such as 
replication and general maintenance of the bacterium, to survive the stress imposed 
by accumulation of toxic metabolites. This hypothesis is based on the observation that 
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the majority of genes in COG classes involving cell division and replication are 
significantly downregulated in the AcrB D408A mutant.  
A phenotype that would support the general stress response hypothesis is a change 
in the replication dynamics of the loss-of-efflux-function mutant, at a single-cell level. 
At a population level, no significant differences were observed between the growth of 
the AcrB D408A mutant and the wild-type; however, it is possible that the growth of 
the mutant is affected at a single cell level. Results obtained from studying the 
replication dynamics of the AcrB D408A mutant at a single-cell level were not 
conclusive. However, transcriptional signatures of persister formation, such as a 
decrease in expression of tRNAMet and changes in transcription of TAs were observed 
in the AcrB D408A mutant. Persisters are a subpopulation of growth-arrested bacteria, 
with minimal metabolic activity, that are associated with antibiotic tolerance and 
recurring infections (Fisher et al., 2017). S. Typhimurium persisters form naturally 
during infection of murine and human macrophages (Helaine et al., 2014, Rycroft et 
al., 2018) and can be studied in vitro using minimal media, such as MOPS or MgMES, 
which simulate the conditions Salmonella encounters inside a macrophage (Beuzon 
et al., 1999, Blair et al., 2013). It is worth noting that the poor annotation of the S. 
Typhimurium SL1344 reference genome made it difficult to identify which TAs were 
differentially transcribed in the acrB mutant. A recently published article identified all 
TAs in SL1344 (Lobato-Marquez et al., 2015); this information was used to identify the 
differentially transcribed modules. The transcription of three TAs was significantly 
affected by the loss of AcrB-mediated efflux: vapBC and the sehA toxin from the sehAB 
TA were significantly upregulated and the T4/A4 module was significantly 
downregulated. The vapBC module encodes the VapB antitoxin and VapC toxin; the 
latter is involved in induction of growth-arrest in S. Typhimurium LT2 via selective 
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cleavage of tRNAfMet (Winther and Gerdes, 2011). It is unlikely that increased 
transcription of vapBC on its own causes growth-arrest, since the effect of VapC is 
neutralised by VapB, the transcription of which was higher than vapC suggesting that 
most VapC activity was quenched. However, it is likely that the residual VapC activity 
is responsible for the significant underexpression of tRNAMet. Although tRNAMet  and 
tRNAfMet are different and VapC is highly specific to tRNAfMet (Winther and Gerdes, 
2011), a detailed analysis of the current annotation of the reference SL1344 genome 
revealed six tRNAMet and no tRNAfMet. Three of the six tRNAMet were significantly 
underexpressed by at least 1.1 log2 fold-change (2.14 fold-change) in the AcrB D408A 
mutant, the other three were also underexpressed, but the difference was not 
statistically significant. Since the annotation of the reference SL1344 genome has its 
flaws, it is possible that at least one of these tRNAs corresponds to tRNAfMet.  
If formation of persisters is increased by the loss of AcrB-mediated efflux, this is likely 
to be caused by the SehA toxin. Expression of SehA on a plasmid caused growth-
arrest in S. Typhimurium LT2 (De la Cruz et al., 2013), this observation was also 
reported in SL1344 (Lobato-Marquez et al., 2015). Furthermore, transcription of the 
antitoxin sehB was not significantly affected in the AcrB D408A mutant; therefore, no 
antitoxin is available to counteract the effects of the SehA toxin.  
Regarding the significantly downregulation of T4-A4 module, overexpression of T4 
induced growth-arrest in S. Typhimurium SL1344 (Lobato-Marquez et al., 2015). 
However, not much information is available as it is a recently discovered TA. Hence, 
the biological significance of the decreased transcription of T4-A4 cannot be 
elucidated. 
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TAs have a significant role in the virulence of S. Typhimurium. Previous studies have 
reported that activation of TAs is essential for survival of Salmonella inside the host 
(De la Cruz et al., 2013, Lobato-Marquez et al., 2015). It is hypothesised that this is 
due to the presence of ‘backup bacteria’ to ensure the survival of the population. I 
hypothesise that TAs help S. Typhimurium evade the immune system. TAs have 
multiple modes of action, including degradation of mRNA (Coussens and Daines, 
2016). The host immune system differentiates between live and dead bacteria by 
sensing bacterial mRNA (Sander et al., 2011), TAs reduce the number of mRNA 
copies, which would ‘trick’ the immune system into believing that Salmonella are dead. 
In the case of the AcrB D408A mutant, activation of TAs is likely to be a direct 
consequence of the stress induced by accumulation of toxic metabolites. IT is also 
hypothesised that the activation of TAs may increase the persister subpopulation, 
which might help the Salmonella mutant survive in the hostile environment of the host 
given that its ability to colonise and invade is impaired. 
Another physiological process that could have an effect on virulence is quorum 
sensing (QS), a population density-dependent mechanism of cell-to-cell 
communication that controls the expression of genes involved in biofilm formation and 
virulence at a population level in multiple bacterial species. Multiple types of QS 
signalling molecules exist; in S. Typhimurium, one has been studied thoroughly: 
autoinducer-2 (AI-2). This molecule is introduced into the bacterial cell via the 
LsrABCD ABC-type transporter, where it is immediately phosphorylated by LsrK to 
stop AI-2 from being exported again (Taga et al., 2003). In the AcrB D408A mutant, 
lsrABCDKR were significantly downregulated when compared against the parental 
strain; this suggested that AI-2 was not internalised into the mutant. Consistent with 
this, significantly more AI-2 was detected in the cell-free culture supernatant of the 
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mutant. However, this was only observed when the strains were grown in LB 
supplemented with 0.5% glucose. No difference was observed between strains grown 
in LB without glucose and minimal media, such as MOPS and autoinducer bioassay 
(AB) media. Surette and Bassler (1998) reported that production of AI-2 by S. 
Typhimurium was induced in LB supplemented with glucose; in the absence of 
glucose, AI-2 was barely detected. Maximum production of AI-2 is detected between 
mid-logarithmic and early stationary growth phase, after which AI-2 disappears from 
the culture supernatant as it is internalised into the bacterial cell (Surette and Bassler, 
1998, Wattanavanitchakorn et al., 2014). Consistent with this, culture supernatant 
harvested from early growth phases induced bioluminescence better than those 
obtained from overnight cultures. The increase in AI-2 in the cell-free culture 
supernatant of the AcrB D408A mutant grown in LB with glucose was consistent 
throughout the growth curve (from OD600=0.1 to 1.0), suggesting a deficient 
internalisation or increased production of AI-2. Increased production of AI-2 is an 
unlikely event in the AcrB D408A mutant as no significant changes were observed in 
transcription of luxS, essential for the synthesis of AI-2 in S. enterica and E. coli (Taga 
et al., 2003). This suggests that the increase in extracellular AI-2 is due to a decrease 
in internalisation of AI-2 caused by decreased expression of LsrABCD and/or LsrKR.  
In some bacteria such as Pseudomonas aeruginosa, autoinducers play an important 
role in virulence as they facilitate the expression of virulence factors (Whiteley et al., 
2017). In S. Typhimurium, the effect of AI-2 on virulence is debatable (Perrett et al., 
2009, Choi et al., 2012). However, QS has a role in sensing of metabolites (Goo et al., 
2015).  AI-2 is a by-product of metabolism of S-adenosyl-methionine (SAM) (Schauder 
et al., 2001), which regulates biosynthesis of cysteine and methionine through the 
SAM riboswitch (Batey, 2011). Cysteine biosynthesis products are hypothetical 
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substrates of AcrB (Ruiz and Levy, 2014); so the decreased intake of AI-2 might be 
related to accumulation of metabolic by-products regulated by the SAM-riboswitch. 
It is important to note that although internalisation of AI-2 is reduced in the AcrB D408A 
mutant, it is unclear whether QS activation and QS-mediated phenotypes are affected 
in the mutant. As a direct way to measure QS activation in S. Typhimurium, future 
experiments can be performed with the pBB1 reporter cosmid (Miller et al., 2002). This 
cosmid encodes the V. harveyi enzymatic machinery to bioluminesce when QS is 
activated and allows direct measurements of QS activity when introduced into the 
target Enterobacteriaceae. Regarding QS-regulated phenotypes, a well-studied 
phenotype regulated by QS is the formation of biofilms (Eberl and Riedel, 2011, 
Wolska et al., 2016). However, SL1344 is not an adequate strain to study biofilm 
formation as it forms biofilms poorly (Baugh, 2014). The reference strain for biofilm 
studies in S. Typhimurium is 14028S. In order to determine if biofilm formation is 
altered by decreased import of AI-2 in a S. Typhimurium AcrB D408A mutant, a 
14028S mutant must be constructed.  
A previous study showed that biofilm and curli production were significantly decreased 
in a 14028S acrB::aph mutant (Baugh, 2014). Curli is a proteinaceous fiber that is 
essential for the formation of biofilms and colonisation of the host. The curli protein is 
synthesised by CsgA and polymerised by CsgB (Barnhart and Chapman, 2006). 
Interestingly, csgB was significantly upregulated in the AcrB D408A mutant, but no 
other genes from the csg operons were differentially transcribed. To test if this had a 
phenotypic effect, overnight cultures of SL1344 and its acrB mutants were spotted 
onto agar containing Congo red to allow qualitative identification of curli production. 
For comparative purposes, 14028S and its acrB::aph mutant were used. In 
accordance with the previous report (Baugh, 2014), the 14028S acrB::aph mutant did 
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not produce curli. However, it is unclear if this is caused by the aph gene. In SL1344, 
a weak curli production phenotype was observed, the colony morphology was slightly 
drier than that of the acrB mutants, but no conclusions can be drawn from this 
experiment. Therefore, the experiment needs repeating with a 14028S AcrB D408A 
mutant and curli production needs to be measure qualitatively. 
Metabolic changes in the AcrB D408A mutant have been mentioned throughout this 
chapter. To identify the genes responsible for the metabolic change, a Metabolic 
Transformation Algorithm (MTA) was applied. The modelling results suggested that 
deletion of glpK and lamB in SL1344 would replicate the metabolic state of the AcrB 
D408A mutant in the wild-type strain; in contrast, deletion of fadB in the mutant would 
revert the metabolism of S. Typhimurium back to the wild-type state. These three 
genes encode a glycerol phosphatase, a maltoporin and the α-subunit of the fatty acid 
oxidation complex, respectively (Uniprot Consortium, 2014). Deletion of fadB would 
cause the AcrB D408A mutant to lose its ability to use fatty acids as a carbon/energy 
source, forcing Salmonella to use other carbon sources. In contrast, deletion of glpK 
and lamB in the wild-type strain would cause S. Typhimurium to become unable to 
utilise glycerol and maltose as carbon/energy sources, forcing the strain to use 
alternative sources of energy such as fatty acids. These results suggest that fatty acids 
play an important role in the maintenance of the metabolism of the AcrB D408A 
mutant. Supporting this observation is a study that shows that AcrB is the main 
exporter of free fatty acids in E. coli (Lennen et al., 2013); therefore, loss of AcrB-
mediated efflux is likely to cause intracellular accumulation of fatty acids. Under this 
assumption, it would be expected that β-oxidation would be increased in the mutant 
as a mechanism to cope with the excess of fatty acids. A long-term increase in β-
oxidation would cause a shift in metabolism towards an oxidative state in the AcrB 
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D408A mutant. Supporting this hypothesis, Zampieri et al. (2017) showed that 
antibiotic-induced overexpression of AcrB in E. coli caused carbon metabolism to shift 
towards a fermentative state when compared against a isogenic strain that expressed 
basal levels of AcrB. Changes in metabolism lead to loss of virulence in S. 
Typhimurium, as this microorganism requires a robust metabolism in order to survive 
in the host (Steeb et al., 2013, Herrero-Fresno and Olsen, 2018).  
 
4.14 Key findings 
 The transcription of 14.35% of the genome of S. Typhimurium SL1344 is 
significantly affected by the loss of AcrB-mediated efflux.  
 The decrease in motility in the acrB::aph mutant is an artefact of the aph insertion, 
unrelated to loss of acrB function. 
 The transcription of the global transcriptional regulator ramA is not significantly 
induced in the AcrB D408A mutant. 
 Genes encoding outer membrane porins from the omp family are significantly 
downregulated in the AcrB D408A mutant when compared against the parental 
SL1344 strain. 
 AcrB-mediated efflux is essential for virulence and maintenance of the metabolic 
state of S. Typhimurium. 
 AcrB-induced loss of virulence may be influenced by many factors including 
activation of stress responses, decreased transcription of TCSS, persister 
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4.15 Future work 
 Determine whether the aph effect on motility is S. Typhimurium-specific, additional 
motility assays using E. coli MG1655 acrB mutants will be carried out. To 
determine if the effect is acrB-specific, insertional inactivation and gene deletion 
mutants will be used in motility assays. 
 Assess if expression of OMPs is affected in the S. Typhimurium SL1344 AcrB 
D408A mutant. 
 Determine if replication dynamics at a single-cell level is affected by the loss of 
AcrB efflux function. 
 To study the effect of loss-of-efflux function on biofilm formation and curli 
production, construct a S. Typhimurium 14028S AcrB D408A mutant. 
 Determine if loss of AcrB efflux function causes accumulation of fatty acids and 
shifts metabolism of S. Typhimurium towards an oxidative state. 














Does AcrB efflux virulence factors?
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5.1 Background 
Deletion of AcrB or loss of AcrB-mediated efflux is associated with a drug 
hypersusceptible phenotype in Enterobacteriaceae. In S. Typhimurium, deletion or 
inactivation of AcrB/acrB is also associated with attenuation of virulence (Lacroix et 
al., 1996, Buckley et al., 2006, Nishino et al., 2006, Blair et al., 2015b). AcrB is involved 
in export of bile; therefore, an early hypothesis was that attenuation of virulence in vivo 
was due to the hypersusceptibility of the strain to bile (Lacroix et al., 1996). However, 
later studies showed that S. Typhimurium acrB mutants were also attenuated in 
cultured cell lines, where they were not exposed to bile (Buckley et al., 2006). Similarly, 
a Pseudomonas aeruginosa ∆mexAB-oprM mutant, homologue of acrAB-tolC, was 
significantly attenuated in Madin-Darby canine kidney (MDCK) cells and in a murine 
infection model (Hirakata et al., 2002). An increase in the virulence of the ∆mexAB-
oprM mutant on MDCK cells was observed when cell-free culture supernatants from 
cells infected with wild-type P. aeruginosa was added to the mutant. Supernatant from 
cells infected with the mutant also increased virulence of the ∆mexAB-oprM mutant, 
but the increase was 10-fold lower than what was observed with the wild-type 
supernatant. The conclusion of this study was that MexAB-OprM was involved in the 
export of a virulence factor in P. aeruginosa (Hirakata et al., 2002).   
Following the observations made by Hirakata et al. (2002), the hypothesis that AcrAB-
TolC was involved in the export of a virulence factor was explored by Blair (2010). 
Cell-free culture supernatant of S. Typhimurium SL1344 grown overnight in LB at 37°C 
(SL1344 ExM) was harvested and added to the isogenic ∆acrB mutant in gentamicin 
protection assays on INT-407 intestinal epithelial cells. Surprisingly, addition of the 
SL1344 ExM significantly increased virulence of the ∆acrB mutant without affecting 
the viability of the cells (Appendix VI, Figure A). Further experiments carried out in the 
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Piddock group (unpublished data) revealed that the restorative effect of SL1344 ExM 
was best observed at 4 hours post-infection (two hours after addition of gentamicin), 
when ExM was triple-concentrated (3X) and added in a 1:2 proportion to inoculation 
medium (final concentration of ExM of 1.5X) (Appendix VI, Figures B and C). To 
determine the chemical nature of the virulence-restoring molecule(s), SL1344 ExM 
treated with proteinase K was used. Interestingly, the virulence-restoration effect was 
partially lost, suggesting that a protein or peptide might be involved in restoration of 
virulence (Appendix, Figure D). However, SL1344 ExM heated for 10 minutes at 95°C 
or 1 hour at 70°C  remained fully active (Blair, 2010), as did ExM recovered after 
filtering through a 5kDa filter. Therefore, it is unlikely that the virulence-restoring 
factor(s) is a protein, but it is likely to have peptide bonds. Further efforts into 
identifying the virulence-restoring molecule(s) and other natural substrates of AcrB in 
S. Typhimurium and E. coli are described in this chapter. 
 
5.2 Aims 
 To discover a native AcrB substrate involved in the virulence of S. Typhimurium. 
 To identify native molecules exported by AcrB in S. Typhimurium and E. coli that 
are derived from bacterial metabolism. 
 
5.3 Hypotheses 
 One or more molecules exported by AcrB are involved in the virulence of S. 
Typhimurium.  
 Apart from xenobiotics, AcrB is used by E. coli and S. Typhimurium to export 
products of their own metabolism. 
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5.4 The effect of media composition on production of the virulence-
restoring factor(s) in SL1344 ExM  
In previous experiments, it was observed that the virulence-restoring effect of SL1344 
ExM was highly variable as some batches of ExM would restore virulence of a ΔacrB 
mutant better than others. This was likely a consequence of variation in the 
composition of LB medium; therefore, to reduce the variation in the biological effect of 
the SL1344 ExM, a chemically defined medium that favoured the synthesis of the 
virulence-restoring factor(s) was required.  
Initial experiments were carried out with MOPS minimal medium (MOPS). However, 
three-times concentrated SL1344 ExM (hereafter referred to as SL1344 ExM) 
produced from MOPS did not restore virulence to a ∆acrB mutant when compared 
against the ExM produced in LB. Therefore, this medium could not be used (Figure 
5.1). 
It was hypothesised that the lack of virulence-restoration observed with SL1344 ExM 
produced from MOPS was due to the low nutritional availability in the medium. 
Therefore, a chemically defined rich medium was tested. EZ Rich Defined Medium 
(EZ) is a MOPS-based medium, supplemented with a defined combination of amino 
acids, vitamins, nucleotides and other nutrients (Appendix I, section G). Similar to the 
results with MOPS, SL1344 EZ ExM restored virulence significantly less than the 
SL1344 LB ExM (Figure 5.2). As a strong virulence-restoration effect was required for 
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Figure 5.1 Virulence restoration effect of SL1344 ExM produced in MOPS 
minimal medium, on a ∆acrB mutant. 
 
Association and invasion were measured at 2 and 4 hours post-infection, respectively. An 
SL1344 ∆acrB mutant was exposed to 3X-concentrated SL1344 ExM. Each point represents 
a biological replicate, a line represents the mean of each dataset. An asterisk denotes a 
significant difference of P<0.05 between two groups, compared by Student’s t-test with 
Welch’s correction. 
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Figure 5.2 Virulence restoration effect of SL1344 ExM produced in EZ rich 
defined medium, on a ∆acrB mutant. 
 
Association and invasion were measured at 2 and 4 hours post-infection, respectively. An 
SL1344 ∆acrB mutant was exposed to 3X-concentrated SL1344 ExM. Each point represents 
a biological replicate, a line represents the mean of each dataset. An asterisk denotes a 
significant difference of P<0.05 between two groups, compared by Student’s t-test with 
Welch’s correction. 
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5.5 Chemical fractionation of SL1344 ExM 
As LB could not be replaced with a chemically defined medium, fractionation of 
SL1344 ExM was attempted to isolate the virulence-restoring molecule(s). 
Fractionation was carried out using the Diaion® HP-20 resin. This resin captures 
hydrophobic compounds by adsorption. Adsorbed compounds can then be recovered 
by washing the resin with the appropriate solvent. 
SL1344 ExM was exposed to HP-20 resin overnight to separate ExM into a 
hydrophobic (adsorbed to resin) and a hydrophilic fraction (non-adsorbed media). The 
resin was recovered and washed with acetone (Act ExM), methanol (MeOH ExM) and 
water (H2O ExM) to recover adsorbed compounds. These fractions were concentrated 
to test for biological activity. The residual media after resin exposure, or residual 
hydrophilic fraction (HF ExM), was also tested. 
The Act and HF fractions had the best restorative activities on the ∆acrB mutant, where 
they restored invasion to 1.72% and 1.24% of wild-type, respectively. The H2O ExM 
had the least restorative activity (0.11% of wild-type). However, none of the fractions 
significantly increased virulence of the ∆acrB mutant when compared against the 
mutant without exposure to ExM. Only the unfractioned ExM significantly increased 
virulence of the ∆acrB mutant (Figure 5.3). Therefore, unfractioned ExM was used for 
the rest of the experiments.   
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Figure 5.3 Virulence restoration effect of SL1344 LB ExM fractions on a ∆acrB 
mutant. 
  
Association and invasion were measured at 2 and 4 hours post-infection, respectively. An 
SL1344 ∆acrB mutant was exposed to 3X-concentrated SL1344 ExM or its fractions. Each 
point represents a biological replicate, a line represents the mean of each dataset.  An asterisk 
denotes a significant difference of P<0.05 between two groups, compared by Student’s t-test 
with Welch’s correction. 
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5.6 Restoration of virulence on a S. Typhimurium AcrB D408A mutant 
All previous experiments were carried out with a SL1344 ∆acrB mutant, which, as 
mentioned in Chapter 3, overexpresses additional RND efflux pumps as a 
consequence of loss of the AcrB protein. The additional pumps might give rise to 
confounding phenotypes in the ∆acrB mutant; hence, restoration of virulence was 
validated with a SL1344 AcrB D408A mutant.  
The virulence-restoration effect of ExM on intestinal epithelial cells was tested with a 
SL1344 AcrB D408A mutant. Non-polarised INT-407 and polarised Caco2 intestinal 
epithelial cells were used. The ∆acrB mutant was used for comparative purposes. 
As shown previously, the ∆acrB and the AcrB D408A mutant were significantly 
attenuated when compared against the parental wild-type strain. The AcrB D408A 
mutant had the same phenotype as the ∆acrB mutant under all conditions tested. 
Addition of SL1344 ExM increased invasion of both mutants to ~10% in INT-407 cells 
(Figure 5.4A) and ~50% of the wild-type invasion levels in Caco2 cells (Figure 5.4B). 
Addition of 3X ∆acrB ExM slightly increased invasion of the mutants into epithelial 
cells; however, this increase was not significant when compared against the respective 
mutant without exposure the ExM. The same increase in invasion was observed when 
3X AcrB D408A ExM and 3X LB were added to the AcrB D408A mutant, suggesting 
that this non-significant increase in virulence is a response to components of the media 
and not Salmonella-derived molecules. As only SL1344 ExM significantly restored 
virulence to the acrB mutants, it was concluded that export or synthesis of a 
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Figure 5.4 Restoration of virulence in S. Typhimurium acrB mutants on intestinal 
epithelial cells. 
 
Invasion of S. Typhimurium into A) non-polarised INT-407 and B) polarised Caco2 intestinal 
epithelial cells was measured at 4 hours post-infection, when the maximum restorative effect 
of ExM was observed. ∆acrB and AcrB D408A mutants of S. Typhimurium SL1344 were 
exposed to 3X-concentrated LB and ExM from SL1344 and acrB mutants. Each point 
represents a biological replicate, a line represents the mean of each dataset. An asterisk 
denotes a significant difference of P<0.05 between two groups, compared by Student’s t-test 
with Welch’s correction; two and three asterisks denote a difference of P<0.01 and P<0.001, 
respectively.
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5.7  Production of the virulence-restoring factor(s) is dependent on the S. 
Typhimurium growth phase 
To determine in which growth phase was the virulence-restoring molecule produced, 
ExM from SL1344 was harvested from different growth phases. To assess which time 
points correspond to which growth phase, growth kinetics of SL1344 was measured 
by viable count. Samples of SL1344 growing in LB were taken every hour for the first 
ten hours and at 18 and 24 hours to determine CFU/mL. Under the conditions tested, 
SL1344 had a short lag phase of approximately 2 hours, after which, it entered 
exponential growth phase (log phase) and continued to grow at the same rate until 6 
hours post-inoculation. Late log phase occurred between 6 to 8 hours as the growth 
rate was slower when compared to early time points. An early stationary phase was 
observed between 8 to 10 hours. Stationary phase continued until 18 hours, followed 
by a decrease in CFU/mL between 18 to 24 hours (Figure 5.5A).  
To make results comparable, the same number of bacteria were required for each time 
point. This was to ensure that if a significant change in virulence-restoration was 
observed, the effect would be a consequence of decreased export/synthesis of the 
factor(s) and not because of a difference in number of bacteria producing the 
molecule(s). To equalise the total CFU at each time point, cultures were scaled up. 
However, this could only be done with late logarithmic phase (7 hours), early stationary 
phase (8, 9 and 10 hours) and late stationary phase cultures (18 hours) as the number 
of bacteria in earlier growth phases was too low and a considerable amount of culture 
would be required to equalise the amount of bacteria to later growth phases. 
Harvested ExM was concentrated and added to the SL1344 AcrB D408A mutant to 
assess their virulence-restoration activity. ExM from all time points, except for 7 hours, 
significantly increased virulence of the AcrB D408A mutant (Figure 5.5B). Interestingly, 
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the later the ExM was harvested, the higher was its virulence-restoration effect on the 
AcrB D408A mutant. This observation was validated by linear regression, where a 
correlation between CFU/mL of AcrB D408A mutant recovered from infected cells and 
time of harvest of ExM was observed (Figure 5.5C).  
It is worth noting that the high CFU/mL obtained from the viable counts may be 
attributed to the method used. The Miles-Misra method was used for viable counting, 
in which an aliquot of 20µL of each dilution is spotted on to the agar. This aliquot is 
not spread and is left to be absorbed by the agar. In order to count the colonies 
accurately, two to 20 colonies per spot are required. As the spots are not spread, a 
higher dilution is required to accurately count well separated colonies, which may 
result in higher CFU/mL reads than when the spread plate technique is used. 
 
5.8 Effect of ExM on J774A.1 murine macrophages 
Previous experiments from the Piddock group showed that SL1344 ExM could not 
restore virulence in murine macrophages (Appendix VI, Figure E). To test this, 
J774A.1 murine macrophages were infected with SL1344 and its acrB mutants with 
and without exposure to ExM. Gentamicin protection assays were carried out in the 
same way as with intestinal epithelial cells; however, a disruption of the monolayer 
and a considerable loss of cells was observed in wells that contained ExM at 2 hours 
post-infection (Figure 5.6). The experiment was stopped at this point as a decrease in 
the total number of host cells would produce unreliable results.  
The disruption of the monolayer was not caused by S. Typhimurium invasion or 
addition of LB, as only the monolayers exposed to ExM from either wild-type SL1344 
or the AcrB D408A mutant were disrupted (Figure 5.6). This suggests that a  
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Figure 5.5 Effect of SL1344 ExM harvested from different time points on restoration of virulence of a SL1344 AcrB D408A 
mutant. 
 
A) CFU/mL of wild-type SL1344 was measured every hour. Mean and standard deviation of three experiments is shown. The start and end of 
each growth phase is indicated with dotted lines, with the name of each phase shown underneath the curve. Time points at which ExM was 
harvested are indicated with red arrows.  B) The virulence-restorative effect of the harvested SL1344 ExM on the AcrB D408A mutant was 
measured at 4 hours post-infection, when the maximum restorative effect of ExM was observed. Each point represents a biological replicate, a 
line represents the mean of each dataset. An asterisk denotes a significant difference of P<0.05 between two groups, compared by Student’s t-
test with Welch’s correction; two and three asterisks denote a difference of P<0.01 and P<0.001, respectively. C) The time of collection of ExM 
and the number of bacteria recovered at 4 hours post-infection was plotted, lineal regression, shown as a dotted line, was used to determine the 
correlation between the virulence-restoration effect of ExM and growth phase of SL1344. 
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Figure 5.6 Monolayers of J774A.1 murine macrophages infected with S.  Typhimurium SL1344 or its acrB mutants, in 
presence and absence of ExM and LB. 
 
J774A.1 monolayers were examined in an inverted microscope at 2 hours post-infection, following addition of 100g/mL of gentamicin.   Photos 
were taken with at 10X amplification. The S. Typhimurium strain infecting the monolayer as well as the condition tested is shown on top of each 
photo. 
SL1344 ∆acrB AcrB D408A
SL1344 + 3X SL1344 ExM SL1344 + 3X AcrB D408A ExM SL1344 + 3X LB
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macrophage-killing factor is being produced by S. Typhimurium independent of AcrB 
efflux activity. To determine the extent of the damage caused by addition of ExM, 
confluent monolayers of J774A.1 were exposed to sterile LB broth and ExM from 
SL1344 and its acrB mutants. Monolayers were washed at the 2 hours time point and 
macrophages were recovered for viable counting by trypan blue exclusion. A 
significant decrease in the number of viable cells was observed in monolayers 
exposed to ExM, where only ~50% of the macrophages survived the treatment (Figure 
5.7). However, no significant changes in cell viability were observed in monolayers 
exposed to LB, indicating that the decreased viability of J774A.1 cells is caused by 
Salmonella-derived molecules, the synthesis and export of which is independent of 
AcrB.  
 
5.9 Identification of bacterial metabolites effluxed by AcrB 
5.9.1 Untargeted metabolomics 
To identify molecules exported by AcrB in S. Typhimurium (including those that 
restored virulence), untargeted metabolomics by high-resolution liquid 
chromatography mass spectrometry (HPLC-MS) was carried out. To eliminate 
interference from components of the growth medium, peaks obtained from sterile LB 
medium were subtracted from the spectra of the S. Typhimurium samples. The relative 
abundance of each metabolite feature (hereafter referred to as feature), given by the 
area under the curve, was used to calculate fold-change in concentrations of each 
feature between the wild-type and mutant strains.  
Thousands of features were identified in each HPLC-MS run. To facilitate identification 
of AcrB substrates, the ExM of S. Typhimurium AcrB D408A and the ∆acrB mutant 
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Figure 5.7 The effect of 3X SL1344 ExM on viability of J774A.1 murine 
macrophages. 
 
Confluent monolayers of J774A.1 macrophages were exposed to 3X LB or 3X SL1344 
ExM. ExM was prepared in LB with and without NaCl. Each point represents a 
biological replicate, a line represents the mean of each dataset. A Student’s t-test with 
Welch’s correction was performed to compare each group against the inoculation 
medium. Two (**) and three asterisks (***) denote a significant difference of P<0.01 
and P<0.001, respectively. Statistical analyses were performed on raw, non-log 
transformed data. 
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were analysed. Following statistical analyses, 54 features were found in a significantly 
higher concentration in the wild-type SL1344 ExM when compared against the ExM of 
both acrB mutants and the sterile LB broth. A putative metabolite identity (ID) was 
assigned to each feature based on their masses and retention times. Multiple 
databases including the Human Metabolome Database, KEGG and Biocyc were 
screened for metabolites that would fit the mass and retention time obtained for each 
feature. Where more than one putative ID was assigned to a feature, literature 
research was conducted to find the most likely ID of the feature. Features were 
assigned to metabolite classes based on putative IDs. The full list of features is shown 
in Appendix VII (Table A). Most of the identified features were tryptophan degradation 
products (20%), followed by fatty acid and alcohols (15%), acylcarnitines and their 
degradation products (13%) and peptides (13%) (Figure 5.8). The top 20 metabolites 
with the highest fold-changes between wild-type and acrB mutants included fatty acids 
and alcohols, acyl-carnitines and tryptophan degradation products (Table 5.1). The 
feature with the highest fold-change was annotated as pyridoxamine (vitamin B6) or 
octadienol, a fatty alcohol. Two features, identified as homocysteine and arginyl-
asparagine, respectively, were not found in the sterile LB medium. 
To explore other native substrates of AcrB exported by Enterobacteriaceae, the ExM 
of E. coli MG1655 and its AcrB D408A mutant were also studied. Initial analyses 
revealed that 19 features were likely to be in a considerably higher concentration in 
the wild-type ExM when compared against the mutant. These features were 
annotated; however, annotation of the E. coli ExM proved more challenging than that 
of S. Typhimurium. Multiple features identified in the E. coli metabolomics were 
annotated as terpenes, aromatic phytochemicals and human metabolites (Appendix 
VII, Table B). In general, multiple fatty acids and fatty alcohols, aromatic compounds  
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Figure 5.8 Classification of metabolites identified in abundance in the ExM of S. 






Figure shows a graphic representation of the proportion of each metabolite group. A 
total of 54 features were found in a significantly higher concentration in the ExM of 
SL1344 when compared against its acrB mutants and sterile LB broth. Features were 
assigned into groups according to putative metabolite IDs.  
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Table 5.1 List of top 20 metabolites identified in abundance in the ExM of S. Typhimurium SL1344 relative to its acrB mutants 
and LB broth. 








Pyridoxamine; octadienol Others (vitamin B6); fatty acids/alcohols 37.54 23.26 4.45 
Tridecatrienediynol; methyl-oxooctanoic acid Fatty acids/alcohols 23.78 15.83 3.96 
Quinaldic acid Tryptophan metabolism 9.57 7.42 3.38 
Octenoylcarnitine Acylcarnitine 7.81 5.29 2.74 
Homocystine Sulphur metabolism 4.60 4.96 NDM 
Benzylsuccinate;D-4-O-methyl-myo-inositol 
Aromatic compounds and degradation 
products; others (inositol phosphate 
metabolism) 
5.77 4.86 3.09 
Methionyl-methionine Peptides 3.95 4.71 19.14 
Pantetheine 4'-phosphate Others (pantothenate –vitamin B5– and CoA biosynthesis) 3.57 4.67 1.35 
N-(2-hydroxyisobutyl)-2,4,8,10,12-
tetradecapentaenamide Others (acylamine) 3.65 4.25 2.51 
Kynurenic acid Tryptophan metabolism 4.65 4.21 2.83 
Arginyl-asparagine Others (polyamine derivative); peptide 3.38 3.75 NDM 
Hexenoylcarnitine; serinyl-lysine Acylcarnitine; peptide 3.38 3.45 1.70 
5-Hydroxyindoleacetaldehyde Tryptophan metabolism 3.80 3.39 2.15 
Glycyl-valine; N-acetylornithine Peptide; others (arginine biosynthesis) 3.28 3.35 2.05 
Heptanoylglycine Acylglycine 3.60 3.30 3.23 
Hydroxybutyrylcarnitine Acylcarnitine 2.97 3.29 2.82 
3-Methylglutarylcarnitine Acylcarnitine 3.85 3.28 2.94 
Pyridoxolactone; formylanthranilic acid Tryptophan metabolism 3.88 3.25 1.90 
Argininic acid; citrulline Biosynthesis of arginine 3.91 3.19 0.50 
Aspartyl-tryptophan Peptides 4.07 3.17 2.34 
NDM indicates that the metabolite was not identified in LB.  
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and some tryptophan metabolism products were identified. Further statistical analyses 
revealed that only five features were significantly changed between the MG1655 wild-
type and AcrB D408A mutant (P<0.05), two of which were unidentified (Table 5.2). 
The feature that had the greatest change between the wild- type and the AcrB D408A 
mutant had multiple putative identities, but was most likely to be a fatty acid/alcohol or 
an aromatic compound. 
5.9.2 RNA-seq 
Metabolomics studies are often complemented with RNA-seq, as changes in 
transcription of metabolic genes often lead to changes in the metabolome. To 
complement the metabolomics study, differential gene transcription analysis was 
carried out with RNA extracted from stationary phase cultures of S. Typhimurium and 
E. coli wild-type and AcrB D408A mutant in LB. Unfortunately, good quality RNA could 
not be extracted from 18-hour cultures (late stationary phase); therefore, 10-hour 
cultures were used (early stationary phase). 
Very few significant differential changes were observed in both species. In S. 
Typhimurium, most changes occurred in regulatory small or non-coding RNAs, such 
as the carbon storage regulator CsrB, the flavin mononucleotide (FMN) riboswitch and 
the SsrA tmRNA, which were significantly overexpressed in the AcrB D408A mutant. 
Salmonella Pathogenicity Islands (SPI) 1, 2, 4 and 11, StyR-44 sRNAs, as well as 
multiple rRNAs and repeat regions of unknown function were significantly 
downregulated in the mutant (Figure 5.9). 
In accordance with the metabolomics results, where fewer significantly changed 
features were found for E. coli than for S. Typhimurium, fewer differentially transcribed 
genes were observed in the E. coli AcrB D408A mutant when compared against  
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Table 5.2 List of metabolites identified in abundance in the ExM of E. coli MG1655 relative to the AcrB D408A mutant. 





1,3-Diphenyl-1-propanone; 1,3-Diphenyl-2-propanone;  
p-methoxystilbene; ethyl -Decatrienoate 
Fatty acids/alcohols; aromatic compounds 0.0029686 0.036145 
Ginsenoyne A linoleate Unknown (not a bacterial metabolite, eukaryotic membrane fatty acid) 0.083557 0.025242 
L-alpha-glutamyl-L-hydroxyproline; Lauric acid(d3);  
n-decanohydroxamic acid 
Others (glutamine metabolism); fatty 
acids/alcohols 0.10652 0.012811 
Unidentified Unknown 0.10876 0.021636 
Arginyl-Isoleucine;Arginyl-Leucine;Isoleucyl-Arginine;Leucyl-
Arginine; N5-Hexanoylspermidine Peptide; others (polyamine derivative) 0.19288 0.0086543 
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Figure 5.9 Transcriptional landscape of a S. Typhimurium SL1344 AcrB D408A mutant in early stationary phase in LB. 
 
Transcriptome of the mutant was compared to parental SL1344. Significantly upregulated genes in the mutant are marked in red and significantly 
downregulated genes are marked in blue. Black crosses denote genes with no significant changes between the two strains. The orange dotted 
line indicates the end of the chromosomal genes and start of the plasmid genes.
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S. Typhimurium (32 and 109 genes, respectively).  Among the upregulated genes in 
the E. coli AcrB D408A mutant were tisB and hipB from toxin-antitoxin modules; ibpAB, 
dnaK and grpE, which encode heat shock proteins, and the regulatory sRNA DsrA. 
Interestingly, all the downregulated genes were involved in metabolic processes, 
except for a repeat region of unknown function (Figure 5.10).  
RNA-seq data was validated by qRT-PCR. Up and downregulated genes were 
randomly selected and their number of transcripts was determined by qRT-PCR. For 
data normalisation, gyrB and 16S were used as housekeeping genes for E. coli. 
However, 16S could not be used for S. Typhimurium due to the general decrease in 
expression of rRNAs as shown in the transcriptome of the AcrB D408A mutant (Figure 
5.9). Therefore, rho and gyrB were used as housekeeping genes for S. Typhimurium 
as these housekeeping genes had been validated by others in previous studies 
(Rocha et al., 2015) and non-significant transcription changes were observed for these 
genes in RNA-seq. A positive correlation between RNA-seq and qRT-PCR datasets, 
with a R2>0.9, was observed for both species (Figure 5.11A,B).  
Differentially transcribed genes in S. Typhimurium and E. coli were assigned to their 
respective COG groups. COGs of the two species were compared against each other 
to find a common signature of loss of AcrB-mediated efflux. Only two COG classes 
had the same pattern in both microorganisms: “Energy production and conversion”, 
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Figure 5.10 Transcriptional landscape of a E. coli MG1655 AcrB D408A mutant in early stationary phase in LB. 
 
 
Transcriptome of the mutant was compared to parental SL1344. Significantly upregulated genes in the mutant are marked in red and significantly 
downregulated genes are marked in blue. Black crosses denote genes with no significant changes between the two strains. 
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Figure 5.11 Validation of RNA-seq results by qRT-PCR in S. Typhimurium 





Log2 fold-change in gene transcription between the AcrB D408A mutant and the wild-type A) 
S. Typhimurium SL1344 and B) E. coli MG1655 are shown. Gene transcription was measured 
by RNA-seq and qRT-PCR and correlation between the two datasets was determined by lineal 
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Figure 5.12 Comparison of COGs between an S. Typhimurium SL1344 and an E. coli MG1655 AcrB D408A mutant. 
 
COG classes are shown on the left side of the chart, the total number of genes in this class are indicated in brackets. Green bars show results 
for S. Typhimurium SL1344, yellow bars indicate results for E. coli MG1655. Percentage of downregulated genes in each class are shown in 
dark-coloured bars, whereas percentage of upregulated genes are shown in light-coloured bars.  
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5.10 Discussion 
The AcrAB-TolC MDR efflux system is well-known for its role in export of antibiotics 
and other xenobiotics, such as detergents, dyes and bile (Ma et al., 1993, Ma et al., 
1995, Lacroix et al., 1996, Nishino and Yamaguchi, 2001, Nikaido, 2009). This system 
is constitutively expressed and its expression is increased when bacteria are exposed 
to substrates of the pump; however, the constitutive expression of AcrB is very high in 
comparison to other RND pumps (Nishino et al., 2009). A hypothesis for the high basal 
expression of AcrB is that the pump has a general physiological role, such as exporting 
toxic metabolic by-products (Ruiz and Levy, 2014). Additionally, in S. Typhimurium 
and multiple other microorganisms, deletion of acrB or chemical inhibition of AcrB 
efflux causes attenuation of virulence (Lacroix et al., 1996, Hirakata et al., 2002, 
Buckley et al., 2006, Bina et al., 2008, Padilla et al., 2010, Perez et al., 2012, Spaniol 
et al., 2015, Alcalde-Rico et al., 2016). In the previous chapter, it was discussed that 
the loss of virulence could be a consequence of a general metabolic shift caused by 
intracellular accumulation of toxic metabolites. An alternative hypothesis was that AcrB 
exported a virulence factor or a signalling molecule required for virulence. 
To determine if AcrB exported molecules involved in the virulence of S. Typhimurium, 
Blair (2010) added cell-free culture supernatant (exometabolome or ExM) from 
overnight cultures of wild-type SL1344 in LB to a ΔacrB mutant. Addition of the ExM 
significantly increased virulence of the ΔacrB mutant. In accordance with the 
hypothesis that AcrB effluxes a virulence factor/regulator, addition of ExM from the 
ΔacrB mutant grown under the same conditions as SL1344 did not restore virulence 
to the mutant, indicating that a molecule(s) effluxed by AcrB was required for virulence. 
Further experiments showed that the maximum virulence-restoration effect was 
observed when SL1344 ExM was concentrated three times (Appendix VI, Figure A).  
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It is worth noting that the virulence-restoration activity of ExM was highly variable, with 
some batches of ExM having higher virulence-restoration activity than others. This 
was attributed to changes in the composition of the LB medium, used in the production 
of ExM. LB is composed of tryptone, NaCl and yeast extract (Bertani, 1951). The exact 
composition of tryptone and yeast extract has not been fully defined and there is 
variation in the concentration of the known compounds in between batches (Grant and 
Pramer, 1962, Rayner et al., 1990, Merck, 2018, Solabia Group Biotech, 2018). This 
variation between batches of LB medium could account for variations in biological 
activity of the ExM. To reduce variation, a chemically defined medium was required. 
As the exact composition of LB is unknown, the medium cannot be reproduced 
synthetically. Therefore, commercially available synthetic media, MOPS and EZ, were 
tested. MOPS minimal medium could not be used as ExM produced from this medium 
did not restore virulence of a ΔacrB mutant. This was attributed to the low availability 
of nutrients in the medium; thus, a synthetic rich medium, EZ, was then tested. This 
medium contains a mixture of amino acids, nucleotides, salts and vitamins B5 
(panthotenate) and B1 (thiamine) (Appendix I, section G). SL1344 ExM produced from 
EZ did not restore virulence of the ΔacrB mutant to the same extent as ExM produced 
from LB, suggesting that one or more components of LB is essential for the synthesis 
of the virulence-restoring molecule(s). An early study showed that LB medium is rich 
in amino acids and cyclic nucleotides, but also contains phospholipids, polyphosphate 
and sugar monophosphate esters (Rayner et al., 1990); which are not present in 
chemically defined media. Furthermore, the chemically defined media tested also lack 
aluminium, barium, cadmium and other trace elements found in yeast extract (Grant 
and Pramer, 1962), as well as multiple vitamins (Solabia Group Biotech, 2018). It is 
likely that synthesis of the AcrB-exported virulence molecule(s) is dependent on a 
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vitamin or a trace element that is absent in synthetic media, as these nutrients are 
essential cofactors of multiple enzymes involved in a variety of metabolic pathways 
(Garcia-Angulo, 2017, Fitzpatrick et al., 2007).  
During experiments with ExM, it was observed that liquid ExM stored at 4°C lost its 
restorative effect within 2 hours and freeze-dried ExM lost its biological effect within a 
month, suggesting that the molecule(s) is unstable. However, ExM boiled for 10 
minutes at 95°C or heated at 70°C for one hour did not lose its biological effect, 
indicating that the molecule(s) is heat resistant (Blair, 2010, Appendix VI, Figure D). 
Additionally, ExM filtered through a 5kDa filter retained its activity, indicating that the 
molecule(s) is unlikely to be a protein (Appendix VI, Figure D). However, treatment of 
ExM with proteinase K caused partial loss of activity, suggesting that 1) a molecule 
with peptide bonds is involved in virulence-restoration and 2) the biological effect of 
ExM may be produced by a mixture of molecules. To further aid the identification of 
the virulence-restoring molecules, SL1344 was chemically fractioned using the HP-20 
resin, which adsorbs hydrophobic compounds. After incubation in SL1344 ExM, the 
resin was washed with acetone, methanol and water to recover compounds that were 
adsorbed. Acetone has a lower polarity index than methanol and water (Reichardt and 
Welton, 2010); therefore, it was used to recover predominantly non-polar compounds, 
but some semi-polar compounds might be recovered as well. Methanol was used to 
recover predominantly semi-polar compounds and water was used to extract polar 
compounds adsorbed by the resin. Each of the individual fractions restored virulence 
of the ∆acrB mutant, but none of the fractions restored virulence to the same extent 
as the unfractioned ExM; further supporting the hypothesis that a mixture of 
compounds exported by AcrB is responsible for the restoration of virulence in the 
ΔacrB mutant. Fractionation of SL1344 ExM was previously attempted; hexane, 
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chloroform, methanol and a residual hydrophilic fraction were tested for virulence 
restoration activity (Appendix VI, Figure F). The hexane and chloroform fractions did 
not show any biological activity, whereas the methanol fraction partially restored 
virulence of a ΔacrB mutant and the residual hydrophilic fraction restored virulence of 
the mutant to the same extent as the unfractioned ExM. This experiment indicates that 
the virulence-restoring factors are predominantly polar and semi-polar compounds. In 
the present study, the acetone and the residual hydrophilic fractions had the highest 
restoration activity. Although acetone was used to extract non-polar compounds, the 
solvent is highly polar when compared to hexane and chloroform (Reichardt and 
Welton, 2010); thus, it is likely that semi-polar compounds were present in the acetone 
fraction, which could include some of the virulence-restoring compounds.  
All previous experiments were carried out in a SL1344 ΔacrB mutant, which 
overexpresses other RND pumps to compensate for the loss of the AcrB protein 
(Eaves et al., 2004, Blair et al., 2015b). In the ΔacrB model, it was unclear whether 
the virulence-restoration effect was related to overexpression of additional RND 
pumps; therefore, experiments were carried out with an isogenic AcrB D408A mutant 
and compared against the ΔacrB mutant. Both acrB mutants had the same phenotype 
in infection of INT-407 and Caco2 intestinal epithelial cells in the presence and 
absence of ExM. The virulence-restoring effect of the SL1344 ExM was better 
observed in Caco2 polarised epithelial cells than in INT-407 cells (~50% vs. 8-13%, 
respectively). However, as discussed in the previous chapter, basal invasion levels of 
the acrB mutants was higher in polarised than in non-polarised cells, which could 
account for the difference in restoration of virulence of the SL1344 ExM. This 
experiment indicates that the restoration of virulence in the ΔacrB mutant is 
independent of the overexpression of acrD and acrF, which correlates with previous 
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work indicating that these pumps are not involved in virulence in S. Typhimurium 
(Nishino et al., 2006, Buckner et al., 2016).  
 When compared against the mutants without exposure to ExM, ExM obtained from 
the acrB mutants slightly increased invasion of the mutants, but the difference was not 
statistically significant. This experiment provides evidence that a virulence factor or a 
virulence-signalling molecule is exported by AcrB in S. Typhimurium. 
The virulence-restoration effect was best observed in ExM harvested from an 
overnight culture of SL1344, which corresponds to late stationary phase in the growth 
curve of SL1344. ExM harvested from late logarithmic phase did not significantly 
restore virulence of the AcrB D408A mutant, suggesting that the virulence-restoring 
molecules are not produced at a high enough concentration in the logarithmic phase 
to induce a significant increase in invasion. Additionally, when the virulence-restoration 
activity of ExM was plotted against its time of collection, a positive correlation was 
observed, indicating that the virulence-restoring effect of ExM increased as the culture 
became ‘older’. This observation led to two hypotheses: 1) virulence-restoring factors 
derive from primary metabolism (generated as part of normal bacterial growth (Kumar, 
2018)) and are accumulated in ExM over time or 2) a second virulence-restoring 
molecule is produced at later time points, which enhance the effect of the first one. 
Secondary metabolites, such as antibiotics, are produced by microorganisms in late 
stationary phase, when nutrients are scarce and cell density is high (Mehta et al., 
2018). They are hypothesised to confer an ecological advantage by killing other 
microorganisms to reduce competition and generate more nutrients. Secondary 
metabolites also serve as signalling molecules and virulence regulators. For example, 
the aromatic alcohols farnesol and tyrosol control multiple biological processes in 
Candida albicans; farnesol was also associated with pathogenesis as it increases 
 
- 231 - 
 
resistance of Candida albicans towards reactive oxygen species (Dufour and Rao, 
2011). Similarly, aureusimines and phevalins, peptides derived from secondary 
metabolism, are used by Staphylococcus aureus to regulate expression of virulence 
factors and modulate survival in host cells (Wyatt et al., 2010, Blättner et al., 2016). 
The two hypotheses are not mutually exclusive and the virulence-restoration effect 
observed with 18 hours SL1344 ExM could be a combination of a primary metabolite 
that accumulated over time and a secondary metabolite.  
Previous experiments showed that SL1344 ExM could not restore virulence to a ΔacrB 
mutant in murine macrophages (Appendix VI, Figure E). While reproducing this 
experiment in J774A.1 murine macrophages, a considerable disruption of the 
monolayer was observed at 2 hours post-infection. The disruption was only observed 
on monolayers exposed to ExM either from SL1344 or the AcrB D408A mutant, it was 
not observed in macrophages exposed to LB broth. Therefore, it was concluded that 
the disruption of the monolayer was not caused by uptake and replication of S. 
Typhimurium in the macrophages, but by a factor in ExM that was produced 
independently of AcrB efflux activity. The identity and chemical nature of the 
macrophage-killing molecule is unknown. It has been speculated that S. Typhimurium 
might synthesise a toxin similar to the S. Typhi typhoidal toxin, which kills leukocytes 
at high concentrations (Song et al., 2013, Chong et al., 2017). Therefore, the virulence-
restoring effect of SL1344 ExM could not be studied in macrophages due to the 
presence of an AcrB-independent macrophage-killing secreted factor in S. 
Typhimurium. 
To identify the virulence-restoring molecules exported by AcrB, untargeted 
metabolomics by LC-MS was carried out. Fifty-four metabolites were found in 
abundance in the SL1344 ExM when compared against its acrB mutants. Most of 
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these metabolites were tryptophan degradation products, fatty acids and fatty 
alcohols, acylcarnitines and peptides. A large number of biological signalling 
molecules derive from tryptophan metabolism; for example, indole attenuates 
virulence of S. Typhimurium, although S. enterica cannot synthesise it (Nikaido et al., 
2012, Kohli et al., 2018). Other examples are quinolones, such as the Pseudomonas 
spp. PQS signal, which regulates virulence in P. aeruginosa and a precursor of which 
is exported by an RND efflux pump (Lamarche and Déziel, 2011). Interestingly, S. 
Typhimurium has a natural tropism towards tumours (Pawelek et al., 1997), which 
overproduce kynurenine, a tryptophan degradation product that attenuates the 
immune system (Brandacher et al., 2006, Kuan and Lee, 2016). It is suggested that 
S. Typhimurium is attracted towards tumours because it finds a favourable, nutrient-
rich environment in which to proliferate hidden from the immune system (Leschner et 
al., 2009). It is possible that S. Typhimurium is attracted towards tumours by the 
abundance of kynurenine, which was also found in excess in the SL1344 ExM. 
Therefore, it is hypothesised that kynurenine and other metabolites derived from 
tryptophan metabolism are involved in virulence-restoration of the AcrB D408A 
mutant. It is further hypothesised that any tryptophan degradation product is more 
likely to act as a signalling molecule than a virulence factor as no evidence was found 
in the literature of tryptophan degradation products acting as virulence factors (Figure 
5.13). 
Fatty acids/alcohols and acylcarnitines may also be involved in virulence restoration. 
A previous study demonstrated that fatty acids are exported by AcrB in E. coli  
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Figure 5.13 Summary of metabolites in the SL1344 ExM that could contribute 





S. Typhimurium (orange) infects the host cell (blue) and survives inside SCVs (red). It is 
hypothesised that intracellular survival of S. Typhimurium is favoured by addition of exogenous 
fatty acids. Fatty acids interact with carnitines to form acylcarnitines, which are transported 
inside the host cell and detected by PPAR-. Activation of PPAR- increases mitochondrial 
activity, which results in fatty acid oxidation and an increased production of glucose. The 
increased intracellular glucose availability favours replication of S. Typhimurium in the SCV. It 
is also hypothesised that a signalling molecule derived from tryptophan metabolism increases 
invasion of S. Typhimurium into the host cell. Vitamins and peptides are likely to be involved 
in virulence, but their contribution is unclear. Figure was constructed with elements from the 
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(Lennen et al., 2013). A direct correlation between Salmonella-derived fatty acids and 
virulence has not been established. However, there is evidence that the host fatty acid 
regulator PPAR- (peroxisome proliferator-activated receptor ) is required for the 
intracellular maintenance of S. Typhimurium (Eisele et al., 2013). PPAR- is a receptor 
found in the nucleus of mammalian cells, this receptor responds to intracellular 
availability of fatty acids and increases fatty acid oxidation in mitochondria, accordingly 
(Ravnskjaer et al., 2010). Activation of PPAR- also increases intracellular availability 
of glucose, which favours replication and survival of S. Typhimurium in the Salmonella-
containing vacuole (SCV) in macrophages (Eisele et al., 2013). This has not been 
shown in intestinal epithelial cells; however, PPAR- is present in all cells and S. 
Typhimurium can only replicate once inside a SCV. Thus, it is hypothesised that fatty 
acids present in the ExM of SL1344 interact with PPAR-, favouring intracellular 
survival of AcrB mutants. However, fatty acids cannot easily traverse the membrane; 
hence, they are attached to a carnitine and delivered into the host cell to increase the 
intracellular concentration of fatty acids that will consequently activate PPAR- (Figure 
5.13). To test this hypothesis in gentamicin protection assays, a Ppar intestinal 
epithelial cell line is needed; however, no cell lines with the required characteristics 
were found. A murine infection model could be used to indirectly test the hypothesis, 
as previous experiments were carried out in Ppar -/- 129/SvImJ mice (Eisele et al., 
2013). If the hypothesis is correct and fatty acids and acylcarnitines exported by AcrB 
are required for virulence, the AcrB D408A mutant would not be attenuated in a Ppar 
-/- mouse. The hypothesis could also be tested in bone marrow derived macrophages 
obtained from Ppar -/- mouse, where the same results would be expected. 
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Accumulation of fatty acids/alcohols seems to be a common characteristic of 
inactivation of AcrB. When compared against their respective wild-type strains, there 
were fewer fatty acids/alcohols in the ExM S. Typhimurium and E. coli AcrB D408A 
mutants. This observation is supported by RNA-seq data. For example, the CsrB 
ncRNA was overexpressed in S. Typhimurium. This ncRNA inhibits CsrA (Suzuki et 
al., 2002), which is involved in activation of glycolysis and inactivation of 
gluconeogenesis (Romeo, 1998). Overexpression of CsrB in the S. Typhimurium AcrB 
D408A mutant suggested that CsrA was less active in the mutant. Hence, glycolysis 
was likely to be decreased and usage of alternative carbon sources, such as fatty 
acids, would be required. In accordance with this observation, pduE, which encodes 
a protein essential for propanediol degradation (Uniprot Consortium, 2014), was 
upregulated, suggesting that fatty alcohols were being used. This supports the 
hypothesis of fatty acids accumulating intracellularly in the absence of AcrB-mediated 
efflux. In E. coli, genes involved in utilisation of carbon sources like tagatose (rcnB) 
and lactate (lldP) (Uniprot Consortium, 2014) and phospholipid biosynthesis (plsY) 
(Yoshimura et al., 2007) were significantly downregulated, which may also be linked 
to accumulation of fatty acids in the AcrB D408A mutant. If fatty acids were used as 
carbon sources and to make membrane lipids, then utilisation of alternative carbon 
sources and phospholipid biosynthesis would not be required. 
Previous experiments showed that SL1344 ExM treated with proteinase K partially lost 
its virulence-restoration activity, indicating that a molecule with peptide bonds may be 
involved in restoration of virulence. Multiple dipeptides were found in relative 
abundance in the SL1344 ExM. Peptides are likely to be substrates of AcrB as the 
peptidomimetic compound PAN binds tightly to AcrB (Yu et al., 2005, Sjuts et al., 
2016); however, the role of peptides in virulence of S. Typhimurium is unknown. The 
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biological function of peptides has been described for other species. For example, in 
Gram-positive bacteria, peptides are quorum sensing signalling molecules (Whiteley 
et al., 2017), in S. aureus, dipeptides contribute towards survival of the bacterium in 
host cells and regulate expression of virulence factors (Wyatt et al., 2010, Blättner et 
al., 2016); additionally, cyclic dipeptides produced by P. aeruginosa have a cytotoxic 
effect (Vázquez-Rivera et al., 2015). Therefore, it is hypothesised that dipeptides 
exported by AcrB have a role in pathogenesis of S. Typhimurium. Further studies are 
required to explore this hypothesis and determine their role (if any) in virulence-
restoration of the AcrB D408A mutant.  
The role of AcrB in export of native bacterial metabolites was further studied in E. coli 
by analysing the composition of the ExM of the wild-type MG1655 and its isogenic 
AcrB D408A mutant. Initial screening of raw data revealed 19 features; however, 
annotation of the features proved challenging and multiple features were 
misannotated. Although the annotation was incorrect, the structure of the compounds 
resembled that of xenobiotics exported by AcrB; for example, some metabolites were 
annotated as cucujolides, these are macrolide lactones derived from fatty acids and 
are used as pheromones by beetles and frogs (Hotling et al., 2014). Macrolide 
antibiotics, such as erythromycin and azithromycin, are substrates of AcrB (Chollet et 
al., 2004) and hence, cucujolides could be substrates of AcrB. 
Surprisingly, only five metabolites were found in a significantly lower concentration in 
the E. coli AcrB D408A mutant relative to its parental strain; this is approximately 10% 
of what was observed in S. Typhimurium. Similarly, fewer genes were differentially 
transcribed in the E. coli AcrB D408A mutant when compared against the S. 
Typhimurium mutant. These data either suggest that many of the metabolites were 
involved in virulence (or other Salmonella-specific traits) or that AcrB might not be as 
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essential in export of metabolites in E. coli as it is in S. Typhimurium. It is noted that 
E. coli has more RND and ABC transporters than S. Typhimurium (Elbourne et al., 
2017), which could export some of the substrates exported by AcrB in Salmonella.  
The metabolites found in E. coli were predominantly fatty acids, aromatic compounds, 
a peptide and an unidentified molecule. This correlates with upregulation of paaA, 
which is involved in degradation of aromatic compounds (Uniprot Consortium, 2014). 
In contrast to S. Typhimurium, acylcarnitines and tryptophan metabolism products 
were not significantly changed between the wild-type and the mutant E. coli. This could 
be due to differences in metabolism between E. coli and S. Typhimurium as the latter 
might synthesise more of these metabolites. Although S. Typhimurium and E. coli are 
phylogenetically related, their metabolism is very different, including the production of 
indole, which E. coli synthesises but S. Typhimurium does not (Sargo et al., 2015). 
Even metabolic pathways that have conserved genes in both microorganisms seem 
to act in different ways and depend on the species. For example, the toxic metabolite 
2-aminoacrylate is processed by E. coli via RidA pathway, which is conserved between 
E. coli and Salmonella. However, exogenous addition of 2-aminoacrylate to a ridA 
mutant had different effects, suggesting that the compound is detoxified in different 
ways depending on the species (Borchert and Downs, 2017) 
It is also likely that acylcarnitines and tryptophan metabolism products are important 
for virulence of S. Typhimurium. E. coli K-12 MG1655 is a non-virulent laboratory 
strain; therefore, it may be expected that its ExM would not contain virulence-restoring 
factors. To test this hypothesis, ExM from E. coli should be added to the S. 
Typhimurium SL1344 AcrB D408A mutant in a gentamicin protection assay.  
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To corroborate the metabolomics findings, RNA-seq was carried out. Due to the late 
growth phase at which RNA was harvested, not many significant differences in gene 
transcription was observed between the E. coli and S. Typhimurium wild-type and 
mutant strains (Hazen et al., 2015). Multiple genes involved in stress responses were 
upregulated in both S. Typhimurium and E. coli AcrB D408A mutants.  In E. coli, ibpA, 
ibpB, dnaJ and grpE encoding heat shock proteins; tisB toxin and hipB antitoxin, the 
bolA general stress response transcriptional regulator (Uniprot Consortium, 2014) and 
the DsrA stress regulator (Seo et al., 2017) were upregulated. In S. Typhimurium, 
increased transcription of dnaB involved in DNA replication, and yjiX involved in DNA 
damage response (Uniprot Consortium, 2014), suggest a degree of DNA damage in 
the AcrB D408A mutant.   
Interestingly, in S. Typhimurium, rRNAs were significantly underexpressed in the AcrB 
D408A mutant, suggesting that protein synthesis might be reduced. This was 
accompanied by underexpression of multiple StyR-44 ncRNAs. StyR-44 is found in all 
rRNA operons, upstream of the 23S rRNA in S. Typhi (Chinni et al., 2010). No 
biological activity has been attributed to StyR-44 and it is suggested to be an “RNA 
intermediate formed during maturation of rRNA” (Chinni et al., 2010). It is hypothesised 
that this may be a mechanism of stress response as decreased expression of proteins 
may lead to slower growth rates and dormancy, which may help S. Typhimurium 
reduce any potential damage caused by accumulation of toxic metabolites in the AcrB 
D408A mutant.  
Differential gene transcription also hints towards changes in the synthesis of vitamins. 
For example, in S. Typhimurium increased transcription of pabC may suggest changes 
in synthesis of folic acid (vitamin B9). Folic acid is transformed into tetrahydropholate 
and used as a cofactor in multiple biosynthetic pathways. Interestingly, folK, a gene 
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involved in biosynthesis of tetrahydropholate was upregulated in the E. coli AcrB 
D408A mutant, suggesting that the mutant might overproduce tetrahydropholate. 
These observations suggest that loss of AcrB-mediated efflux may cause an increase 
in the synthesis of folic acid or a derivative. It is hypothesised that this is related to an 
increase in transcription of genes involved in general stress responses, as 
tetrahydropholate is used in the synthesis of nucleic acids and amino acids that are 
required to fix damaged DNA and synthesise new proteins. 
Synthesis of riboflavin or vitamin B2 is likely to be decreased in the S. Typhimurium 
AcrB D408A mutant as ribH, involved biosynthesis of riboflavin (Uniprot Consortium, 
2014), is downregulated. This observation is in accordance with the overexpression of 
the FMN riboswitch, which inhibits synthesis of riboflavin in abundance of intracellular 
flavin mononucleotide (FMN) (Pedrolli et al., 2015).  
Vitamins have their specialised transporters in bacteria; however, it is possible that 
AcrB exports precursors or vitamins under certain circumstances. For example, a 
recent study showed that the AcrAB-TolC complex in Bacteroides vulgatus is involved 
in export of retinol (vitamin A1) (Hibberd et al., 2017). However, changes in export and 
synthesis of vitamins are also likely to be a consequence of the metabolic changes 
induced by loss of AcrB efflux function. Thus no conclusions can be drawn until more 
evidence is obtained.  
Precursors of vitamin B5 and B6, but not B2 and B9, were found in abundance in the 
SL1344 ExM. It is important to note that RNA-seq was carried out with early stationary 
phase cultures; whereas ExM was obtained from late stationary phase cultures, which 
might account for some of the differences between the exometabolome and the 
transcriptome of the AcrB D408A mutant. Additionally, changes in the transcription of 
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genes do not always translate into altered protein expression, since post-
transcriptional regulation that impacts the expression of proteins is not accounted for 
in RNA-seq. 
For future experiments involving late stationary phase cultures, proteomics is 
recommended instead of transcriptomics as proteins are more stable than RNA and 
may better reflect the metabolomic data. 
Comparison of differentially transcribed genes grouped into COG classes revealed 
that only carbohydrate transport and metabolism and energy production and 
conversion were equally affected by loss of AcrB efflux in both E. coli and S. 
Typhimurium. These changes are likely associated with the intracellular accumulation 
of fatty acids in the mutants. Fatty acids are used as carbon source by β-oxidation; 
therefore, they are likely to affect carbon metabolism and energy production, 
consequently.  
 
5.11 Key findings 
 An AcrB-independent macrophage-killing molecule is excreted by S. Typhimurium. 
 Multiple metabolites may be involved in restoration of virulence of a S. Typhimurium 
AcrB D408A mutant. Tryptophan metabolism products, fatty acids, acylcarnitines 
and peptides are the most likely metabolites involved in virulence-restoration. 
 Loss of AcrB efflux function causes increased transcription of general stress 
responses in S. Typhimurium and E. coli. 
 Loss of AcrB-mediated efflux function has a greater metabolic burden in S. 
Typhimurium than in E. coli. 
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 Fatty acids and alcohols are native substrates of AcrB in E. coli and S. 
Typhimurium. Inactivation of AcrB may cause intracellular accumulation of these, 
which may result in changes in carbohydrate utilisation and energy production. 
 Function of AcrB is likely to affect synthesis of vitamin B9 in E. coli and S. 
Typhimurium, and B2 in S. Typhimurium. 
5.12 Future work 
This study has provided a list of putative metabolites that could be exported by AcrB. 
The identity of these metabolites needs to be confirmed using untargeted 
metabolomics with purchased or synthesised standards. This method will also provide 
an indication of the concentration of each metabolite. Once identified, the metabolites 
(alone and in combination) should be tested in gentamicin protection assays for 
virulence-restoration activity on a SL1344 AcrB D408A mutant. To confirm that 
metabolites are substrates of AcrB, in silico simulations should be used. Where 
possible, simulation results should be confirmed experimentally using a 
proteoliposome system such as the one described by Verchere et al. (2015), where 
AcrAB is inserted into a liposome and TolC is carried by a biotinilated liposome. 
Metabolites should be added to the proteoliposome system and the TolC liposome 
should be recovered and analysed by mass spectrometry for the tested metabolite.  
Other experiments include: 
 Determine if ExM acts on host cells alone and/or on S. Typhimurium alone. 
 Assess if ExM harvested from wild-type E. coli MG1655 restores the virulence 
of the S. Typhimurium SL1344 AcrB D408A mutant. 
 Determine the link between vitamin biosynthesis and AcrB-mediated efflux, as 
this could be exploited for industrial purposes. 
 










CHAPTER 6.  
Overall Discussion and Conclusions
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6.1 Overall Discussion and Conclusions 
Multidrug resistance (MDR) efflux pumps confer innate and acquired resistance to 
antibiotics and other chemicals. The main MDR efflux pump in Enterobacteriaceae is 
AcrB. Inactivation or deletion of acrB or its homologues in other Gram-negative 
bacteria not only increases susceptibility of the bacterium to antibiotics but also 
attenuates virulence in S. enterica, Neisseria gonorrhoeae, Vibrio cholerae, Klebsiella 
pneumoniae, Enterobacter cloacae, Campylobacter jejuni, and Moraxella catharralis 
among other Gram-negative bacteria (Lacroix et al., 1996, Jerse et al., 2003, Buckley 
et al., 2006, Bina et al., 2008, Padilla et al., 2010, Perez et al., 2012, Spaniol et al., 
2015, Alcalde-Rico et al., 2016). This suggests that AcrB has a physiological role in 
virulence. However, the mechanism by which this occurs is unknown. Additionally, 
whether AcrB has additional biological functions in Gram-negative bacteria is 
unexplored.  
Previous virulence studies have been carried out in gene-deletion and/or gene-
inactivation mutants. A major conundrum was whether the observed phenotypes were 
an effect of loss of AcrB efflux function or an effect of loss of the AcrB protein. To 
address this question, an AcrB D408A mutant, which expressed the same amount of 
protein as the wild-type strain but showed no AcrB efflux activity, was constructed in 
S. Typhimurium SL1344 and E. coli K-12 MG1655. The AcrB D408A mutants had the 
same phenotype as an isogenic ΔacrB mutant and allowed differentiation of loss of 
AcrB protein from that of loss of efflux via this protein. Both mutants were 
hypersusceptible to AcrB substrates and accumulated more H33342 indicating that 
the D408A substitution in AcrB abolishes AcrB-mediated efflux in S. Typhimurium and 
E. coli. Thus, these mutants provide more suitable models to study the biological 
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effects of inhibition of AcrB efflux function than gene-deletion (or gene-inactivation) 
mutants, where loss of protein confounds the phenotype. 
To understand how AcrB contributed to virulence and which other biological processes 
are affected by AcrB function in S. Typhimurium, the transcriptome of the AcrB D408A 
mutant was determined. In accordance with the attenuation of virulence observed in 
the AcrB D408A mutant, SPI genes essential for invasion and survival of Salmonella 
in host cells were transcribed significantly less than in the parental wild-type strain. An 
interesting observation was that loss of efflux in the AcrB D408A mutant increased 
transcription of genes involved in nitrate and nitrite respiration from the nir and nap 
operons, essential for the survival of Salmonella in the inflamed host intestine 
(Sparacino-Watkins et al., 2014, Lopez et al., 2015). Increased transcription of these 
genes had been previously observed in an acrD::aph S. Typhimurium SL1344 mutant 
(Buckner et al., 2016). In contrast, transcription of these operons was significantly 
decreased in an acrB::aph mutant (Webber et al., 2009). This discrepancy may be due 
to the presence of the aph gene as discussed in Chapter 4.  
Increased nitrate and nitrite respiration and decreased expression of SPI genes 
suggest that the D408A mutant is more likely to adopt an intestinal lifestyle than an 
intracellular one. This hypothesis was prompted by a recent study in which a S. 
Typhimurium mutant lacking the ydi operon (butyrate utilisation) and carrying a 
truncated fepE gene (Fe3+ transport) and the viaB locus from S. Typhi (capsule) could 
not cause intestinal inflammation and adopted an intracellular lifestyle (because the 
mutant was at a disadvantage in the host intestine) (Bronner et al., 2018). Based on 
this report, it was hypothesised that the increased transcription of genes encoding 
proteins involved in nitrate and nitrite respiration in the S. Typhimurium AcrB D408A 
mutant favoured survival of the strain in the host intestine. It was further speculated 
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that this was related to the decrease in transcription of SPI genes as SPI effectors are 
essential for invasion and intracellular survival, the lack of which could force 
Salmonella to remain and survive in the host intestine. 
To explain the decrease in transcription of SPI genes, it was hypothesised that when 
AcrB was inactivated in S. Typhimurium, to ensure the survival of the bacterium, 
energy from non-essential functions, such as virulence, was translocated to essential 
functions, such as replication. Additional hypotheses to explain the loss of virulence in 
the S. Typhimurium AcrB D408A mutant were 1) lack of virulence-regulating factors 
exported by AcrB and 2) a general change in Salmonella metabolism caused by 
intracellular accumulation of metabolites.  
 To determine if a virulence-regulating factor is exported by AcrB, the exometabolome 
(ExM) of S. Typhimurium acrB mutants was compared against that of the parental 
wild-type strain. From the analysis of the ExM, it was hypothesised that two types of 
molecules were most likely to be exported by AcrB and affect the virulence of the 
bacterium. These were 1) signalling molecules to increase virulence of S. 
Typhimurium; most likely a tryptophan degradation product, and 2) metabolites that 
help intracellular survival of the bacterium, such as acylcarnitines. 
To find common substrates of AcrB in Enterobacteriaceae, the AcrB effluxome of the 
S. Typhimurium mutant was compared against that of E. coli.  Surprisingly, the 
effluxome of AcrB was different between E. coli and S. Typhimurium, which suggests 
that the role of AcrB varies depending on the bacterial species. It is possible that AcrB 
and its homologues have different natural substrates depending on the species as 
different bacteria have different metabolism and ecological niches. AcrB has a wide 
substrate-specificity and is highly conserved between species (Figure 1.5 from 
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Chapter 1), suggesting that the small differences in protein sequence between species 
may be a consequence of adaptation to the specific metabolites synthesised by each 
species.  
Interestingly, fatty acids/alcohols were found to be a common group of compounds 
exported by AcrB in both S. Typhimurium and E. coli.  Fatty acids were previously 
reported to be substrates of AcrB in E. coli (Lennen et al., 2013), thus it was 
hypothesised that inactivation of AcrB caused intracellular accumulation of fatty acids 
in the AcrB D408A mutants. The hypothesis was further supported by the Metabolic 
Transformation Algorithm (MTA) analysis, which showed that fadB, a gene required 
for utilisation of fatty acids by β-oxidation, was essential in the maintenance of the 
metabolic state of the S. Typhimurium AcrB D408A mutant. Intracellular accumulation 
of fatty acids may cause a shift in the metabolism of the bacterium, but loss of 
translocation of long-chain fatty acids could also impact the composition of the outer 
membrane. An early study showed that the “envelope” of S. Gallinarum is formed of 
approximately 60% long-chain saturated fatty acids (Cho and Salton, 1966). Recently, 
it was shown that the overall lipid composition of Acinetobacter baumannii is 
significantly affected upon deletion of genes encoding RND efflux systems and that 
deletion of the three major RND efflux systems in this species alters the relative 
proportion of glycerophospholipids found in its membrane (Leus et al., 2018). Another 
study on Mycobacterium smegmatis and Corynebacterium glutamicum showed that 
RND efflux pumps are required for exporting mycolic acid precursors, an important 
component of the membrane of these bacteria (Varela et al., 2012). Therefore, it is 
proposed that AcrB may be involved in export of membrane lipids in S. Typhimurium 
and E. coli and that loss of export of these lipids changes the proportion of membrane 
lipids, which may affect the permeability and elasticity of the outer membrane. 
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Consequently, the drug hyper-susceptibility phenotype observed in acrB mutants 
could be partially caused by the changes in the composition of the outer membrane 
rather than being completely attributed to retention of higher concentrations of drug 
within the cell. Similarly, the increased transcription of general stress responses 
observed in different growth phases in S. Typhimurium and in stationary phase in E. 
coli may be caused by the partial loss of outer membrane stability as well as the 
intracellular accumulation of toxic metabolites.  
COG analysis of RNA-seq from stationary phase cultures revealed that energy 
production was compromised in both S. Typhimurium and E. coli when AcrB efflux 
function was abolished. Decreased energy production is associated with slower 
bacterial growth, which decreases damage caused by antibiotics and other toxic 
substances (Eng et al., 1991). In accordance with the previous hypothesis, energy 
production is decreased in the AcrB D408A mutants to minimise further damage 
caused by accumulation of toxic metabolites.  
Decreased energy production and increased transcription of toxin-antitoxin modules 
in the AcrB D408A mutants also suggested that a larger subpopulation of persister 
cells is formed when compared to the parental strains. This hypothesis was confirmed 
in S. Typhimurium and is supported by a recent study in which the acrB gene was 
identified to be essential for antibiotic-induced persister formation in E. coli, alongside 
multiple DNA repair genes involved in general stress response (Cui et al., 2018). 
Persisters allow survival of bacteria under adverse conditions. In the AcrB D408A 
mutant, it is possible that persisters are formed as a response to the general stress 
caused by accumulation of metabolites and membrane instability.  
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There are possible limitations in the data arising from the D408A mutant. The AcrAB-
TolC efflux complex assembles spontaneously. However, energy derived from the 
proton-motive force (PMF) is required for the disassembly of the complex (Bavro et 
al., 2008, Ntsogo Enguene et al., 2015). Therefore, in the AcrB D408A mutant, where 
the PMF is abolished, the complex cannot disassemble due to lack of energy. This 
may limit the availability of TolC, which interacts with other efflux pumps from diverse 
families. However, this is unlikely to be significant as only ~5% of the total amount of 
synthesised TolC is required to keep full efflux function in E. coli (Krishnamoorthy et 
al., 2013). Therefore, the limited availability of TolC should not cause pleiotropic 
phenotypes. Another concern with using the AcrB D408A mutant is that the assembled 
efflux complex may cause stretching of the inter-membrane distance, which could 
interfere with signalling in the periplasmic space (Asmar et al., 2017). The width of the 
periplasmic space in S. Typhimurium and E. coli ranges from 17 to 32nm (Matias et 
al., 2003, Cohen et al., 2017, Asmar et al., 2017), but the current model of the AcrAB-
TolC efflux complex measures 317.4Å (equivalent to 31.74nm) (Du et al., 2014), which 
is at the upper limit of the inter-membrane distance. In a wild-type strain, the efflux 
complex is constantly assembled and disassembled, which transiently changes the 
distance between the inner and the outer membrane. In the AcrB D408A mutant, the 
complex cannot disassemble. Consequently, the distance between the bacterial 
membranes may be increased in the mutant. Increasing the inter-membrane distance 
inhibited activation of the Rcs two-component signalling system in E. coli (Asmar et 
al., 2017). The activation of the Rcs system is closely related to cytoskeleton 
rearrangements necessary for expression of SPI-encoded T3SS and flagella genes in 
S. Typhimurium (Bulmer et al., 2012b). Further studies are required to determine if 
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there are any changes to the size of the periplasmic space in the AcrB D408A mutant 
and that could contribute to its phenotype. 
Although a potential increase in the width of the periplasmic space may be a limitation 
towards the study of the physiological role of AcrB, addition of efflux inhibitors is likely 
to have the same effect on the AcrAB-TolC complex as the D408A substitution. AcrB 
exposed to inhibitors becomes ‘locked’ in one conformation (Wang et al., 2017), which 
suggests that proton translocation through the pump is abolished. Therefore, no PMF 
would be available for the disassembly of the complex in the presence of chemical 
inhibitors. The D408A substitution in AcrB simulates this effect as it abolishes proton 
translocation through the pump (Takatsuka and Nikaido, 2009, Seeger et al., 2009). 
This makes the AcrB D408A mutant an excellent model to study the consequences of 
exposure to efflux inhibitors, particularly those developed to target only AcrB.  
Inhibition of efflux pumps has been proposed as an alternative to restore effectiveness 
to antibiotics, reduce virulence and reduce biofilm formation (Li et al., 2015, Reens et 
al., 2018, Du et al., 2018). Understanding the physiological role of the pumps allows 
the assessment of the risks of using efflux inhibitors as it determines any adverse 
effect their use might have on treatment of infections. The research described in this 
thesis suggests that AcrB, apart from being a MDR efflux pump, may function as a 
general ‘detoxification’ system in E. coli and S. Typhimurium, by freeing the bacterial 
cell from toxic metabolic by-products. It was also hypothesised that AcrB may 
contribute to outer membrane stability by exporting long-chain fatty acids. Inhibition of 
AcrB alters the cellular homeostasis of E. coli and S. Typhimurium, which results in a 
variety of phenotypic alterations, including increased motility and decreased AI-2 
import, which is likely to affect quorum sensing, and virulence in S. Typhimurium. Of 
the observed phenotypes, the only possible adverse consequence of inhibiting AcrB 
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may be an increase in the subpopulation of persisters. However, further studies are 
required to confirm this phenotype and the clinical and environmental importance of 
persisters is yet to be confirmed. 
6.2 Future work in addition to that proposed in sections 3.12, 4.15 and 5.12 
Two additional hypotheses have been generated: 
 Inhibition of AcrB in S. Typhimurium and E. coli may cause a change in the 
proportion of lipids in the outer membrane due to lack of export of long-chain fatty 
acids. This could impact the stability of the outer membrane. The proportion and 
composition of lipids in the bacterial membranes can be easily measured by 
extracting the lipids with organic solvents, followed by lipidomics analysis by LC-
MS with a reverse phase column. Testing the impact of any changes in membrane 
lipid composition on stability of the membrane is very challenging, as any compound 
that damages the membrane and most basic dyes are likely to be substrates of 
AcrB. Therefore, it may not be possible to differentiate lack of efflux activity from 
outer membrane instability using whole cells. Specific efflux assays for substrates 
that do not confer membrane instability will need to be developed to explore this 
hypothesis. 
 Inhibition of AcrB may increase the width of the periplasmic space with adverse 
effects on signalling via the Rcs two-component signalling system. Cryo-electron 
microscopy can be carried out to measure the width of the periplasm in the AcrB 
D408A mutant and in the wild-type strain post-exposure to efflux inhibitors. To 
determine if changes in the intermembrane distance are caused by AcrB, the 
protein could be tagged with an fluorescent antibody before electron microscopy, 
as described by  Zhang et al. (2007). 
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Publications resulting from this study 
Wang-Kan X, Blair JMA, Chirullo B, Betts J, La Ragione RM, Ivens A, Ricci V, 
Opperman TJ, Piddock LJV. 2017. Lack of AcrB efflux function confers loss of 
virulence on Salmonella enterica serovar Typhimurium. mBio 8:e00968-17. 
 
Conference presentations resulting from this study 
“The D408A substitution in the AcrB multi-drug efflux protein of Salmonella 
Typhimurium SL1344 confers loss of function”. Xuan Wang-Kan, Vito Ricci, Jessica 
M.A. Blair, Laura J.V. Piddock. Poster no. S1/P2 at the Microbiology Society Annual 
Conference, 2016. Liverpool, UK. 
“Lack of AcrB function confers loss of virulence to Salmonella Typhimurium”. Xuan 
Wang-Kan, Vito Ricci, Alasdair Ivens, Jessica M.A. Blair, Laura J.V. Poster no. 61 at 
the Gordon Research Conference on Multi-Drug Efflux Systems, 2017. Galveston, 
USA.   
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APPENDIX I. Composition of buffers and media 
 
A. 10X Tris-buffered saline (TBS) 
Component Brand Cat. no. Amount 
Tris base (TRIZMA 
base) 
Sigma, USA T1503 24.2g 
NaCl Sigma, USA S6191 80g 
Add 800mL of distilled water and adjust pH to 7.6 with HCl. Make up to 1L. 
To prepare 1X TBS, add 100mL of 10X solution to 900mL of distilled water. 
To make washing buffer, add 0.1% of Tween 20 (Sigma, USA, cat. no. P9416). 
 
 
B. 1M potassium phosphate buffer (PPB) 
For making 100mL of 1M PPB: 
Component Brand Cat. no. Amount 
1M K2HPO4 Sigma, USA P5504 61.5mL 
1M KH2PO4 BDH Chemicals, UK 296084J 38.5mL 
To make 1L of 0.1M PPB, add 100mL of 1M PPB to 900mL of distilled water. Filter-
sterilise in a 0.22m pore, Stericup Filtration Unit before use. 
 
 
C. SOC medium 
Component Brand Cat. no. Amount 
Tryptone Oxoid, UK LP0042 20g 
Yeast extract Oxoid, UK LP0021 5g 
NaCl 5M Sigma, USA S6191 2mL 
KCl 1M Sigma, USA P5405 2.5mL 
MgCl2 1M Sigma, USA M4880 10mL 
MgSO4 1M Sigma, USA M7506-M 10mL 
Glucose 1M Sigma, USA G8270 20mL 
Add distilled water to make 1L of medium. Autoclave medium to sterilise. 
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D. MgMES minimal medium 
Component Brand Cat. no. Concentration 
2-[N-morpholino] ethane-
sulphonic acid (MES)* 
Sigma, USA M3058 170mM 
KCl Sigma, USA P5405 5mM 
(NH4)2SO4 Sigma, USA A3920 7.5mM 
KH2PO4 Sigma, USA P8541 0.5mM 
K2SO4 Sigma, USA P5655 1mM 
MgCl2 Sigma, USA M4880 10mM 
Glycerol Sigma, USA G5516 38mM 
Casamino acids BD Biosciences, 
USA 
223050 0.1% 
(*) adjust to a pH of 5.0 with HCl or KOH if needed.  
Mix all the components of the medium and filter-sterilise. Store prepared media at 4C. 
 
 
E. Autoinducer bioassay (AB) medium  
The base for this medium is prepared as follows: 
Component Brand Cat. no. Amount 
NaCl Sigma, USA S6191 17.5g 
MgSO4 Sigma, USA M7506-M 12.3g 
Casamino acids BD Biosciences, USA 223050 2.0g 
Add ingredients to 970mL of distilled water and adjust pH to 7.5 with KOH. Add more 
distilled water to make 1L of base medium. Autoclave at 121°C and add the rest of the 
components to the medium: 
 Component Brand Cat. no. Amount 
1M Potassium Phosphate buffer pH 
7.0* * * 
10mL 
0.1M L-arginine Sigma, USA A5006-100G 10mL 
Glycerol Sigma, USA G5516-100L 10mL 
(*) see Appendix I, section A. 
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F. MOPS minimal medium 
 
This medium was purchased from TEKNOVA (USA, cat. no. M2106) 
Component Concentration 
MOPS (MW 209.3) 40mM 
Tricine (MW 179.2) 4.0mM 
Iron sulfate stock 0.01mM 
Ammonium chloride 9.5mM 
Potassium sulfate 0.276mM 
Calcium chloride 0.0005mM 
Magnesium chloride 0.525mM 
Sodium chloride 50mM 
Ammonium molybdate 3x10-9 M 
Boric acid 4x10-7 M 
Cobalt chloride 3x10-8 M 
Cupric sulfate 10-8 M 
Manganese chloride 8x10-8 M 
Zinc sulfate 10-8 M 
Potassium phosphate dibasic 1.32mM 
Glucose 0.2% 
 
Make up to 1L in distilled water and filter-sterilise. Store at 4°C for up to one month. 
 
 
G. EZ rich defined medium 
 
This medium was purchased from TEKNOVA (USA, cat. no. 2105). The medium uses 
MOPS minimal medium as a base and is supplemented with: 
Component Concentration 






L-Arginine HCl 5.2mM 
L-Asparagine 0.4mM 
L-Aspartic acid, potassium salt 0.4mM 
L-Glutamic acid, potassium salt 0.6mM 
L-Glutamine 0.6mM 
L-Glycine 0.8mM 
L-Histidine HCl H2O 0.2mM 
L-Isoleucine 0.4mM 
 











L-Cysteine HCl 0.1mM 
L-Tyrosine 0.2mM 
Thiamine 0.01mM 
Calcium pantothenate 0.01mM 
Para-Amino benzoic acid 0.01mM 
Para-Hydroxy benzoic acid 0.01mM 
Di hydroxy benzoic acid 0.01mM 
 
Make up to 1L in distilled water and filter-sterilise. Store at 4°C for up to one month. 
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APPENDIX III. Phenotype of S. Typhimurium and E. coli on XLD agar. 
Figure A. Growth of S. Typhimurium SL1344, E. coli K-12 MG1655 and their 
respective acrB mutants on XLD agar. 
 
Deoxycholate, a bile salt and a substrate of AcrB, inhibits growth of acrB mutants on 
XLD agar. Mutants can sometimes grow on the first streak. S. Typhimurium forms 
translucent colonies with black centres and a bright pink halo around the colonies. E. 
coli forms opaque, pale yellow colonies with a yellow halo. 
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APPENDIX IV. Comparison of RND transporters in E. coli K-12MG1655 and S. 
Typhimurium SL1344. 
 




SL1344 Escherichia coli MG1655 
mdsB (Not annotated) SL1344_0346 - 
secD SL1344_0402 b0408 
acrB SL1344_0468 b0462 
cusA - b0575 
ydhJ SL1344_1374 b1644 
mdtB (yegN) SL1344_2104 b2075 
mdtC (yegO) SL1344_2105 b2076 
acrD SL1344_2444 b2470 
aaeA (yhcQ) SL1344_3337 b3241 
acrF SL1344_3364 b3266 
mdtF (yhiV) - b3514 
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APPENDIX V.  Measuring bacterial replication by flow cytometry 
Figure A. Assessment of changes in replication dynamics of S. Typhimurium SL1344 using pDiGi. 
Experiment 1 SL1344 pDiGi
(re  to green)
0 hours 2 hours 4 hours 6 hours 8 hours
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A representative plot of each time point from six experiments is shown. Similar to 
Figure A(6), plots of BL1 against YL1 are shown. Fresh, prewarmed, MgMES with 
glucose and IPTG was inoculated with an overnight culture of SL1344 or its AcrB 
D408A mutant expressing only DsRed. At 2 hours post-inoculation, almost all bacteria 
from the initial inoculum expressed GFP causing the population to shift towards a 
higher fluorescence intensity on the BL1 channel. Eventually, as S. Typhimurium 
replicates, the DsRed signal was completely diluted giving rise to a population that 
only expressed GFP. As the population entered death phase and IPTG was depleted 
from the media, the GFP fluorescence signal decreased until a non-fluorescent 
population was observed. 
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Figure B. Controls and gating strategy. 
In (1), bacteria expressing GFP and DsRed were identified and separated from debris 
by adjusting the voltage of the forward and side scatter. A gate was set to cover as 
much bacteria as possible without including debris. Only counts within the “Bacteria” 
gate were considered for the experiments.  (2) GFP fluorescence was identified in the 
BL1 channel  and DsRed fluorescence was identified in the YL1 channel (3).   To 
determine if bacteria expressing GFP could be separated from those expressing 
DsRed, a mixture of bacteria expressing solely GFP or DsRed and bacteria expressing 
both fluorescent proteins was used. Results for the BL1 channel are plotted in (4), 
where two distinct groups were observed: a population with high GFP fluorescence on 
the right of the plot and a second population with low GFP fluorescence on the left. 
The same trend is observed in channel YL1 (5), where a population with  high DsRed 
fluorescence intensity is observed on the right of the plot and a low fluorescence 
intensity population, on the left. When BL1 was plotted against YL1 (6), four 
populations were observed: a GFP-only population on the top left quadrant, a 
population that expressed both fluorescent proteins on the top right qudrant, a small 
population of non-fluorescent bacteria on the bottom left quadrant and, on the bottom 
right quadrant, a population that only expressed DsRed. Bacteria expressing only GFP 
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Figure A. Toxicity of 3X SL1344 ExM on INT-407 cells. 
 
 
INT-407 cells were exposed to inoculation medium (IM) or IM with 3X SL1344 
ExM for 2 hours. Cells were recovered and viable counting was carried out by 
trypan blue exclusion. A total of three replicates was carried out. Each dot 
represent a replicate and the line in the middle of the dots indicate the average. 
Data generated between Dr. Jessica Blair and Dr. Michelle Buckner.
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Figure B. Effect of SL1344 ExM concentration on restoration of virulence of a ∆acrB mutant. 
 
Association (2 hours) and invasion (4 hours) of a S. Typhimurium SL1344 ∆acrB mutant exposed to different concentrations of SL1344 
ExM is shown. Each dot indicates an experimental replicate, the average of all replicates is shown by a black line. An (*) in this case 
indicates that there is no significant difference between the condition and SL1344 (P>0.05) as tested by a Student’s t-test with Welch’s 
corrections. All other conditions were significantly different from SL1344 (P<0.05).  Data generated by Dr. Jessica Blair. 
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Figure C. Restoration kinetics of 3X SL1344 ExM. 
 
The average of a three replicates with its standard deviation is shown. S. Typhimurium SL1344 and its ∆acrB mutant with and without 
exposure to 3X SL1344 ExM were added to confluent INT-407 cells. Bacteria were recovered every 30 minutes for the first 2 hours. 
Gentamicin was added at 2.5 hours post-infection and amount of intracellular S. Typhimurium was measured every hour for 8 hours. 
Data generated by Dr. Michelle Buckner. 
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Figure D. Virulence-restoration effect of SL1344 ExM pretreated with proteinase K (1), heat-treated (2) and filtered through a 
5kDa filter (3). 
 
The virulence-restoration effect of SL1344 ExM after proteinase K treatment (1), 70°C heat treatment for an hour (2) or filtered through 
a 5kDa filter (3) was tested on a SL1344 ∆acrB mutant during infection of INT-407 cells. Invasion was measured at 4 hours post-
infection (2 hours after addition of 100g/mL of gentamicin). Each dot represents an experimental replicate. The line in the middle of 
the dots shows the average of all experiments. An (*) indicates a statistically significant difference between two groups (P<0.05) as 
determined by a Student’s t-test with Welch’s corrections. Data generated between Dr. Jessica Blair, Dr. Michelle Buckner and Amelia 
Lawler. 
 
- 283 - 
 
Figure E. Effect of 3X SL1344 ExM on restoration of virulence of a ΔacrB mutant in J774A.1 murine macrophages.  
 
Association (2 hours) and invasion (4 hours) of a S. Typhimurium SL1344 ∆acrB mutant exposed to different concentrations of SL1344 
ExM is shown. Each dot indicates an experimental replicate, the average of all replicates is shown by a black line. 
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Figure F. Effect of hexane, chloroform and methanol extracts of SL1344 
ExM on restoration of virulence of an ΔacrB mutant. 
 
SL1344 ExM was sent to Professor Simon Gibbons (University College London, 
United Kingdom) for chemical fractionation. Each point indicates a biological 
replica. A line indicates the mean of all replicates. Data was generated by Dr. 
Jessica Blair. 
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APPENDIX VII. ExM analyses 
Table A. Metabolites identified by LC-MS in the ExM of S. Typhimurium SL1344 compared against its acrB mutants. 
Assay Mass Retention time Metabolite putative ID 













Acyl-carnitines and degradation products 
HILIC NEG 258.0732521 445.171953 Propenoylcarnitine 3.28 2.86 1.90 1.12E-07 2.17E-03 
HILIC NEG 292.1402204 450.196686 Hydroxybutyrylcarnitine 2.97 3.29 2.82 3.10E-04 3.98E-04 
HILIC POS 348.1187439 323.811762 3-Methylglutarylcarnitine 3.85 3.28 2.94 3.35E-11 2.11E-12 
HILIC POS 360.1340239 193.58106 Octenoylcarnitine 7.81 5.29 2.74 3.77E-08 4.59E-08 
RP NEG 492.2128004 73.086789 Tetradecadiencarnitine 2.15 2.34 3.21 1.85E-05 2.98E-06 
HILIC POS 302.1328395 51.455442 Hexenoylcarnitine;Serinyl-Lysine 3.38 3.45 1.70 1.65E-03 1.72E-03 
HILIC POS 161.0784486 34.2596097 Trimethylaminoacetone 2.99 2.4 26.79 4.80E-08 1.21E-07 
Acyl glycines 




3.06 2.43 54.73 5.10E-08 1.26E-07 
HILIC POS 232.0917143 39.5436798 Heptanoylglycine 3.6 3.3 3.23 3.30E-07 5.54E-07 
Aromatic compounds and degradation products 
HILIC NEG 247.0700526 245.524542 Amino-3-(4-aminophenyl)propanoic acid;Tyrosinamide 3.05 2.42 2.78 1.82E-07 1.60E-07 
HILIC NEG 251.0307655 176.03811 Benzylsuccinate;D-4-O-Methyl-myo-inositol 5.77 4.86 3.09 1.50E-06 2.96E-06 
HILIC POS 259.0646416 371.76504 Dimethyl-ethylazulene 2.62 2.42 4.45 3.12E-09 1.73E-09 
HILIC POS 391.101902 234.24063 3-O-Feruloylquinic acid 2.77 2.28 1.72 2.51E-08 1.49E-07 
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RP NEG 546.1365963 233.23221 Gravacridonediol glucoside 2.25 2.26 2.37 1.29E-10 1.92E-11 
Biosynthesis of arginine 
HILIC POS 213.0634243 41.0311578 Glycyl-Valine;N-Acetylornithine 3.28 3.35 2.05 5.83E-07 2.62E-06 
HILIC POS 260.0634923 369.169008 Argininic acid;Citrulline 3.91 3.19 0.50 3.89E-11 3.80E-08 
Fatty acids and alcohols 
HILIC NEG 161.0005871 85.781022 Heptadiynediol;heptatrienoic acid 2.38 2.25 5.61 1.50E-06 1.12E-04 




4.24 2.58 2.29 6.07E-05 6.75E-05 
HILIC NEG 229.0616456 51.7106058 Tridecatrienediynol;methyl-oxooctanoic acid 23.78 15.83 3.96 1.15E-06 1.69E-06 
HILIC NEG 235.0338791 147.26013 Methoxy-heptanethiol;Diaminosalicylic acid 1.98 2.6 4.26 1.13E-04 3.07E-05 
HILIC POS 253.0580762 51.780753 Pyridoxamine;Octadienol 37.54 23.26 4.45 9.15E-08 1.26E-07 
HILIC POS 507.2806926 169.481586 6-bromo-heptacosadienoic acid 3.24 2.39 2.80 5.42E-10 5.45E-10 
HILIC POS 521.2962622 144.010764 6-bromo-octacosadienoic acid 2.04 2.2 1.92 3.93E-08 1.30E-08 
RP NEG 507.2822155 309.295308 Hydroxynervonic acid 2.24 2.08 2.91 8.89E-09 1.14E-07 
Peptides 
HILIC NEG 305.0738808 315.828969 Threoninyl-Proline 2.54 2.44 2.42 1.03E-05 1.14E-05 
HILIC NEG 325.0886776 84.647397 Methionyl-Methionine 3.95 4.71 19.14 1.32E-06 2.19E-07 
HILIC NEG 354.0871382 294.628926 Hydroxyprolyl-Tryptophan 2.09 2.29 2.06 4.00E-05 2.02E-05 
HILIC POS 320.1252048 295.83276 Aspartyl-Tryptophan 4.07 3.17 2.34 4.70E-09 1.43E-08 
HILIC POS 334.0780381 98.399466 Gamma-Glutamyl Glutamine 3.25 2.72 1.21 5.60E-08 6.88E-08 
RP NEG 292.140411 76.03977 Arginyl-Proline 2.28 2.3 4.81 5.20E-10 1.50E-08 
HILIC POS 302.1328395 51.455442 Hexenoylcarnitine;Serinyl-Lysine 3.38 3.45 1.70 1.65E-03 1.72E-03 
HILIC POS 213.0634243 41.0311578 Glycyl-Valine;N-Acetylornithine 3.28 3.35 2.05 5.83E-07 2.62E-06 
RP NEG 355.1363503 76.50735 Arginyl-Asparagine 2.38 2.21 6.66 8.25E-07 3.94E-06 
HILIC NEG 355.1358 447.598872 Aspidospermidine;Arginyl-Asparagine 3.38 3.75 NDM 1.47E-03 1.36E-03 
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Phospholipids 
HILIC POS 484.1509792 172.426503 PC[12:4] 2.89 2.75 2.62 6.86E-07 9.00E-07 
HILIC POS 505.3462169 242.807634 PC(O-16:0/0:0);PC(O-8:0/O-8:0) 2.34 2.14 2.35 4.56E-10 7.74E-09 
RP NEG 633.2252304 269.93487 Lactodifucotetraose;PI[14:0] 2.27 2.06 2.43 9.80E-13 2.35E-12 
RP NEG 762.3537815 245.209146 PS[29:2] 2.25 2.1 2.05 8.29E-09 1.90E-08 
Sulfur metabolism 
HILIC NEG 199.9691243 420.953532 Cysteine-S-sulfate 2.11 2.13 0.61 4.51E-04 4.31E-04 
HILIC POS 286.0895123 85.915542 Homocystine;Tetrahydrobiopterin 4.6 4.96 NDM 9.63E-10 1.35E-11 
Tryptophan degradation products 
HILIC NEG 188.0350862 174.963696 Kynurenic acid 4.65 4.21 2.83 4.26E-06 7.92E-06 
HILIC NEG 235.0722472 372.204723 6-Hydroxy-1H-indole-3-acetamide 2.79 2.44 2.67 5.27E-06 1.49E-05 
HILIC POS 175.0865767 242.65002 Indole-3-acetamide 2.19 2.11 2.46 3.11E-08 7.83E-08 
HILIC POS 197.0683914 242.60394 1H-Indole-3-acetamide 2.93 2.64 1.91 3.97E-08 7.79E-10 
HILIC POS 203.0800026 390.270726 5-Hydroxykynurenamine 2.35 2.08 0.95 5.89E-09 3.68E-08 
RP NEG 235.0724742 131.446632 N'-Formylkynurenine 3.12 2.58 4.08 1.27E-09 3.50E-08 
RP POS 146.0602319 283.353345 1H-Indole-3-carboxaldehyde 2.57 2.43 1.98 2.40E-09 3.58E-09 
RP POS 161.0801954 126.978843 Indoleacetaldehyde 5.88 3.01 12.10 4.30E-16 1.77E-11 
HILIC POS 174.054775 109.519884 Quinaldic acid 9.57 7.42 3.38 3.52E-09 5.03E-09 
RP NEG 164.0360592 271.164708 Pyridoxolactone;Formylanthranilic acid 3.88 3.25 1.90 2.10E-08 5.06E-08 
HILIC POS 193.0969989 126.6984 Cotinine N-oxide;Hydroxycotinine;5-Hydroxyindoleacetaldehyde 3.8 3.39 2.15 4.80E-13 7.25E-11 
Others 
HILIC NEG 268.9476175 232.581666 2-Phosphoglyceric acid;3-Phosphoglyceric acid 2.39 2 1.68 1.76E-06 2.70E-05 
HILIC NEG 487.2197627 73.242414 sn-3-O-(geranylgeranyl)glycerol 1-phosphate 2.34 2.65 2.57 1.15E-06 1.88E-06 
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HILIC POS 193.101794 248.888241 Epithiomenthane;Menthenethiol; Thiogeraniol 2.46 2.1 1.58 3.72E-09 3.47E-09 
HILIC POS 219.0875002 302.118372 Isoputreanine;Methyllysine 4.91 2.84 2.74 5.83E-08 2.39E-07 
HILIC POS 364.1448486 91.062954 N-(2-Hydroxyisobutyl)-2,4,8,10,12-tetradecapentaenamide 3.65 4.25 2.51 1.91E-08 9.65E-09 
HILIC POS 376.1288616 123.763314 Pantetheine 4'-phosphate 3.57 4.67 1.35 1.01E-05 5.68E-06 
HILIC NEG 355.1358 447.598872 Aspidospermidine;Arginyl-Asparagine 3.38 3.75 NDM 1.47E-03 1.36E-03 
HILIC NEG 251.0307655 176.03811 Benzylsuccinate;D-4-O-Methyl-myo-inositol 5.77 4.86 3.09 1.50E-06 2.96E-06 
 
NDM indicates that the metabolite was not found in LB. Where more than one putative ID was assigned, the metabolite that belongs 
to the indicated class is shown in red. 
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Table B. Metabolites identified by LC-MS in the ExM of E. coli MG1655 and its AcrB D408A mutant. 








RP POS 256.13516 226.55747 4'-Methoxychalcone; cinnamyl benzoate Aromatic compounds 9 1 








1(7),5-dien-2-ol acetate;Perillyl acetate 
Aromatic compounds; 
fatty acids/alcohols 9 0 
HILIC POS 332.23706 513.08261 Hexanal hexyl isoamyl acetal;iso-1,2-heptadecanediol Fatty acids/alcohols 8 2 
HILIC POS 345.24947 474.61652 
11-methyl-1,2-heptadecanediol; anteiso-1,2-
octadecanediol; hexanal dihexyl acetal; iso-1,2-
octadecanediol 
Fatty acids/alcohols 8 2 
HILIC NEG 264.0003 54.021506 4-Amino-2-methylenebutanoic acid; D-Proline; L-Proline Fatty acids/alcohols; others (amino acids) 10 2 





HILIC NEG 285.10269 467.31401 
O-Phospho-4-hydroxy-L-threonine; 2-Amino-3-
phosphonopropionic acid; D-Aspartic acid;Iminodiacetic 
acid; L-Aspartic acid 





HILIC POS 166.04973 501.83192 4-Pyridoxolactone; 5-Pyridoxolactone; Formylanthranilic acid 
Others (vitamin B6 
metabolism); 9 0 
 




RP POS 148.07997 50.331454 
Alanylglycine;D-Glutamine;L-Glutamine; 1,5-Octadien-3-




(amino acids); fatty 
acids 
8 1 









Phospholipids 9 2 




Phospholipids 9 2 




































Bornyl acetate;4-Hydroxy-6-dodecenoic acid 
lactone;Aleprylic acid;Allyl 3-cyclohexylpropionate;alpha-




dodeca-3,6-dienoic acid;Cucujolide II;Cucujolide 
VIII;Dihydro-5-(2-octenyl)-2(3H)-
furanone;Dihydrocarveol acetate;Ethyl-decadienoic 
acid;gamma-Terpinyl acetate;Geranyl acetate;Isopulegol 
acetate;Linalyl acetate;Methyl 2-undecynoate;p-Menth-1-
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HILIC NEG 400.25675 492.67748 Urothion Unknown (not a bacterial metabolite) 8 2 
HILIC POS 446.27694 522.05348 PGF2alpha-EA(d4) Unknown (not a bacterial metabolite) 8 2 
HILIC POS 579.35296 502.74869 Ginsenoyne A linoleate Unknown (not a bacterial metabolite) 8 1 
HILIC POS 86.751898 511.03425 Unidentified Unknown 9 1 
HILIC POS 347.69734 501.79559 Unidentified Unknown 10 2 
HILIC POS 389.2954 560.43464 Isotope Unknown 8 0 
An arbitratry count was assigned to each feature (putative metabolite) to identify those metabolites that were in a high concentration in the wild-
type strain and low in the mutant strain. Where more than one putative ID was assigned, the metabolites that belong to the designated classes 
are shown in red. 
 
